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Abstract 
Data on adult mortality are very limited in sub-Saharan Africa where only small 
proportions of deaths occur in health facilities. In such settings, ascertainment of causes 
of death from data obtained from relatives or associates of the deceased through 
interviews in surveys or longitudinal surveillance systems appears to be an attractive 
option. This technique, known as verbal autopsy (VA) is based on the assumption that 
important causes of death have distinctive symptoms and signs, and these can be 
recognised, remembered and reported by lay respondents, and that based on the reported 
information causes of death can be reached. The existing experience of VA for adult 
death is limited mainly to maternal deaths and the validity of VA for adult death is 
unknown. 
We developed a VA questionnaire, mortality classification system and "expert opinion" 
based algorithms for reaching diagnoses for adult deaths and tested their validity on 
deaths occurring at hospitals in Tanzania (n=315), Ethiopia (n=249) and Ghana 
(n=232). Hospital records of adult deaths occurring at study hospitals from June 1993 
to April 1995 were collected prospectively. VA interviews were conducted by trained 
non-medical interviewers. Caused of death from VA data were reached by a panel of 
three physicians and by a computerised algorithm. The validity of VA was assessed by 
comparing the VA diagnoses with hospital diagnoses. 
Specificity of VA fell below 95% only for few common causes of adult death. 
Sensitivity and kappa of VA for all common causes of adult death were low and this 
suggests that the accuracy of VA at the individual level is low. However, the 
misclassification of causes of death was bi-directional and the number of false positive 
and false negative diagnosis for most common causes of adult death tend to be similar. 
Thus there was robust agreement between the true and VA estimates of cause specific 
mortality fractions of common causes of adult death and VA is useful for assessing 
cause specific mortality fractions of common causes of adult death. 
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1. Introduction and overview of the thesis 
1.1. Mortality data and Health Policy 
Much attention in recent years has been given to the determination of levels and causes 
of mortality among children in developing countries. Relatively little attention, 
however, has been paid to the problem of adult mortality, despite the potentially severe 
economic and social consequences of the premature death of adults, both for the family 
and for the national economy. Communicable tropical diseases and child health in 
general have been major determinants in setting priorities for intervention, operational 
and research activities in the last decade. Only recently has the awareness in large 
international bodies, development agencies and academic groups grown that health 
problems of adults not caused by tropical diseases represent a large gap in our 
understanding on their aetiologies as well as their impact. ' Cause specific adult 
mortality data are very limited in most developing countries, and especially in sub- 
Saharan Africa, where only a small proportion of deaths are usually officially reported 
and even fewer are certified by medical practitioners. Yet information on mortality, 
morbidity and cost-effective interventions is urgently needed for national governments 
and donor agencies to be able to target their limited resources efficiently and equitably. 
The World Bank has attempted to quantify the global burden of diseases in order to 
identify cost-effective interventions against priority health problems. Although their 
report is very useful, the authors acknowledge that several guestimates had to be used in 
this report due to the lack of accurate data on mortality and morbidity in many 
developing countries. 2 The authors of this report reiterate that the knowledge of levels, 
causes, distribution and determinants of morbidity and mortality among adults in 
developing countries is extremely deficient compared with the information available for 
children, and this lack of knowledge has been an important determinant of the policy 
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vacuum on adult health that exists within governments and agencies. 3 
The main reason for the lack of useful data on mortality is reliance on conventional 
systems of death registration, with diagnoses made by qualified physicians. The data 
collected through vital registration systems and routine health information systems are 
incomplete and unrepresentative in many developing countries. For instance, only 3 
countries from the Africa regions (Egypt, Mauritius, & South Africa), 18 countries from 
the central and Latin America region (Bahamas, Barbados, Trinidad, Costa Rica, 
Argentina, Chile, Columbia, Ecuador, Guyana, Paraguay, Surinam, Uruguay, & 
Venezuela) and 10 countries from the Asia region excluding former Soviet republics 
(China, Israel, Japan, Korea, Kuwait, Mongolia, Philippines, Qatar, Singapore, & 
Thailand) have reported causes specific death rates in the UN demographic year book 
for the year 1999.5 There are several reasons for this inadequacy: (i) data for urban 
areas are likely to be more complete than rural areas; (ii) particular causes may be more 
readily recognised and therefore recorded; (iii) those of higher social class, who are 
more likely to have sought and obtained medical care prior to death, are more likely to 
have a detailed cause of death recorded. Furthermore usefulness of data collected 
through routine health information systems depend on the accuracy of clinical diagnosis 
by attending physicians, completion of death certificates by physicians, transcription of 
data from death certificate, classification and coding of data from death certificate, and 
processing, analysis, interpretation and dissemination of data. Inaccuracies and biases 
may occur in any of these processes involved in the collection and publication of routine 
statistics and this may affect their value to health policy-makers. 
Policy decisions made on the basis of mortality data collected through formal health 
services alone may be erroneous in that they are derived from a particular segment of the 
population, often the urban middle class, and do not reflect the overall burden of disease 
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in the national population. Thus there is a need for alternative approaches to obtain data 
on mortality in developing countries. 
1.2. Approaches to obtain mortality data 
There are two dimensions in the mortality data - one is age and sex specific mortality 
and the other is the cause specific mortality. In countries with poor data on mortality, 
vital registration systems are weak and the proportion of people who die while under 
medical care is low. In such settings several indirect methods to assess the level of all 
cause mortality in specific age groups have been developed and used successfully in 
census, surveys and surveillance systems. These methods include the following: 
precedent birth5 and birth history6 techniques for under-five mortality, sisterhood 
method for maternal mortality? and orphanhood method for adult mortality8. Although 
these methods give robust estimates of age group specific all cause mortality they do not 
give estimates of cause specific mortality. 
Attempts have been made to ascertain causes of death from information on history of 
illness preceding the death of an individual obtained from relatives or associates of the 
deceased through retrospective questioning in surveys or in demographic surveillance 
systems. 9 This technique is known as verbal autopsy (VA) and has been used in several 
settings to assess causes of childhood deaths. VAs have also been used to assess causes 
of adult deaths, but almost exclusively for maternal deaths. 
Although VA appears to be a simple and attractive method to ascertain causes of death 
it is based on several assumptions, and there are several factors and processes, which 
can affect their reliability and validity. Nevertheless, the current recognition of the need 
for data on adult mortality and morbidity may require wider use of VAs. This highlights 
the need for understanding the factors and processes influencing the validity of VAs, 
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and also to develop and validate a standard VA tool for adult deaths for use in sub- 
Saharan Africa. 
1.3. Outline of the thesis 
The objectives of this thesis are as follows: (1) to describe and discuss the assumptions 
under pinning the VA method for assessing causes of adult death; (2) to present the 
results of a multi-centre validation study of a model tool,; (3) to identify causes of death 
that can be estimated accurately at population level using VA; (4) to explore the 
application of the results of the validation study for interpreting mortality estimates 
obtained using VA in demographic surveillance systems in sub-Saharan Africa. 
This thesis examines the issues involved in the development and validation of VAs for 
adult deaths, and describes a study that developed and validated an adult VA tool. First 
the assumptions underlying VAs and the factors influencing their validity are described, 
and the existing literature on VAs is reviewed (Chapter 2). Then the process used to 
develop a model VA tool for assessing causes of adult deaths and the methods used to 
test the validity of the VA tool in a multi-centre study are described in Chapter 3. 
Validity of the VA tool for common causes of adult death and maternal death are 
described in Chapter 4. Methodological limitations of the study, interpretation of the 
observed validity of VAs, factors influencing the validity of VAs and caveats in the 
application of results of validation studies are discussed in Chapter 5. Main conclusions 
reached from the study are summarised in chapter 6. 
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2. Literature review 
2.1. Introduction 
The VA of childhood deaths was reviewed in an international workshop in 1989,10 and 
discussed in the context of adult mortality in another workshop in 1993 at the London 
School of Hygiene and Tropical Medicine. The VA technique is based on the 
assumption that most causes of death have distinct symptom complexes, and that these 
can be recognised, remembered and reported by lay respondents. It also assumes that it 
is possible to classify deaths, based on the reported information, into useful categories 
of causes of death. The validity of VAs is influenced by the cause of death per se and 
characteristics of the deceased and by several other factors, relating to the classification 
of causes of death, the design and content of the questionnaire and field procedures. 
Some of the key factors and processes are summarised in Figure 1. The determinants of 
validity shown in the figure are far from complete and their relationships may be more 
complex than the framework shown. Using this conceptual framework, studies that 
have used VA and found published up to September 2001 are reviewed in this chapter. 
Studies using VA were identified from electronic databases mainly Medline and Popline 
by searching for the following key words: verbal autopsy, verbal post-mortem, 
demographic surveillance system, causes of maternal death. Few reports that were 
missed by this key word search were identified from the reference list of those studies 
yielded from the electronic database search. 
Sixty two studies using VA for assessing causes of death were identified through 
searching electronic databases of published studies and unpublished reports. The 
country, study period, age group, main objectives, number of deaths, approach to 
mortality classification, format of questionnaire, characteristics of interviewer, recall 
period, type and number of assessors and the procedures used to derive diagnosis are 
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identified for each study. The methodological approaches applied in these studies are 
described and discussed in order to identify the critical issues in the development, use 
and validation of VAs to determine causes of adult deaths. 
A brief description of 62 studies that are reviewed is presented in Table 1. A summary 
of the methods used in these studies is presented in Table 2. Thirty six studies have 
been done to assess causes of childhood deaths, three to assess adult deaths, eleven to 
assess both adult and childhood deaths, and twelve to assess maternal deaths. 
2.2. Uses of VAs 
VAs of childhood deaths have been applied to evaluate the impact of interventions r 
against acute respiratory infections12-i6 and malaria, 17-20 to evaluate the impact of 
vitamin A supplementation 21-25 and of a primary health care project on cause specific 
mortality, 26 to establish the relative public health importance of causes of childhood 
death, 27-38 and to assess the determinants of common childhood deaths. 3946 VAs also 
have been used to to establish the relative importance of causes of deaths in all age 
groups52-6a to identify the common causes of maternal deaths. 65-79, and to describe 
symptoms and signs associate with HIV related deaths80-82 
2.3. Issues in the development of VAs 
Mortality classification 
Two approaches can be adopted to develop and to derive diagnoses from VAs. In the 
first, a mortality classification is produced and then VA tools (a questionnaire together 
with diagnostic algorithms or procedures to derive diagnoses) are designed to classify 
deaths into these pre-defined categories. This is called the "restricted" approach. In the 
"open" approach, a mortality classification is defined post hoc on the basis of the 
diagnoses derived from the VA. For the latter, the VA tools are not determined by a 
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mortality classification defined prior to data collection. A special case of the 
"restricted" approach is the investigation of a single cause of death in the evaluation of a 
targeted intervention. For example, a VA tool to establish specifically whether a person 
died of AIDS or not. 
Among the 69 published studies, 36 studies did not report the approach to mortality 
classification, 24 studies had used the restricted approach and 9 studies had used the 
open approach. The studies that used the restricted approach did not report the criteria 
and the process used to develop the mortality classification. The use of different 
approaches to mortality classification may affect the validity of VAs because of its 
influence on the design of the questionnaire, on the methods of deriving a diagnosis, and 
on the number and the combination of categories of causes of death diagnosed. For 
example, the use of filters and modules related to specific disease categories in VA 
questionnaires (see below) and predefined diagnostic algorithms is more appropriate for 
the restricted approach. The implications of differences in the design of questionnaires 
and methods of derivation of diagnoses are discussed in the respective sections of this 
review. 
The categorisation of causes of death in the mortality classification of the reported 
studies varied significantly. The number of categories ranged from 5 to 15 for 
childhood deaths, 5-16 for maternal deaths and 8-29 for adult deaths. The choice of 
categories will affect the complexity of diagnostic algorithms and the ability of assessors 
to reach a diagnosis. For example, diagnosing malaria, meningitis, typhoid, hepatitis 
and relapsing fever as separate categories will be more difficult and inaccurate than 
diagnosing just two categories, malaria and all other infections. A classification with 
fewer categories will lead to causes of death with closely related symptom complexes 
being grouped together and this will tend to increase the validity of the VA at the 
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expense of less detailed information. Thus the validity of VA in the study in Yemen59 
where 8 categories of causes of death were classified would be expected to differ from 
that of the study in Papua New Guinea53 which classified causes of death into 29 
categories even if the cultural background and the methods used were the same. 
A desirable feature of a broad mortality classification is that it could be used in different 
settings with minor modifications. Ideally, it should have a core that would be 
applicable in all settings, and it should also accommodate changes to reflect site-specific 
causes of death. A broad mortality classification should include all causes of death 
which are important public health problems and others for which there are well- 
recognised intervention strategies, and its disease categories should, as far as possible, 
have distinct and easily recognisable symptom complexes. 
Knowledge of the cause structure of mortality of the population in which the VA is 
going to be applied would facilitate the development of a broad mortality classification 
according to the above criteria. However, this is unlikely to be available in most 
situations where VAs are needed. As an alternative, mortality and morbidity data from 
health facilities could be used to assist the development of an appropriate mortality 
classification. 
Classification of causes of death can be vary between communities as there are culture 
specific causes of illness. In many settings in Africa one of the common causes of death 
is witch craft. For example a frequently reported cause of childhood death in Ghana is 
"spirit child" which means the ancestoral spirits were upset by an unacceptable practice 
in the house. It can be argued that the locally perceived causes of death should be 
included in the mortality classification. However, it would make the classification very 
complex and incomparable between settings. Furthermore the development of criteria 
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for reaching locally perceived causes of death will be difficult and hard to convince 
panel of physicians to apply those criteria. Hence it is not surprising that none of the 
reported studies has included the local classification of causes of death, instead the 
studies have focused on biomedical causes of death. 
Design of VA questionnaires 
VA questionnaires can have a number of different formats: open; checklist of 
symptoms; checklist with filter questions; or a combination of these. An open 
questionnaire is a blank page on which a trained interviewer enters reported signs and 
symptoms leading to death, and related information. A checklist is a list of signs and 
symptoms, for each of which the interviewer establishes their presence or absence. A 
checklist with filters is a list of major symptoms and signs which, if present, are 
followed by a list of related questions or "modules". For example, in a "cough module", 
a positive response to a filter question on history of cough would be followed by a 
module with questions on the duration and severity of cough, and the type of sputum. A 
module can be related not only to a symptom but also to a specific category of cause of 
death. In this case it will include questions on all symptoms required to diagnose the 
disease category in question. For example, "cough" could be a filter question for 
entering into a "pneumonia module" which will include questions on cough and also on 
symptoms such as difficulty in breathing, rapid breathing and fever, to reach or reject 
the diagnosis of pneumonia; while "cough for more than 4 weeks" could be a filter for 
entering into a "pulmonary TB" module which will include questions on symptoms such 
as haemoptysis, weight loss, fever and difficulty in breathing. Combinations of an open 
section followed by a "closed" checklist, either with or without filters, can also be used. 
Of the 69 published studies, 3 used an open questionnaire, 19 used a structured 
questionnaire (checklist with or without filters), 26 used a mixed format and 21 did not 
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report the format used. 
The advantages and disadvantages of open or structured questionnaires for health 
interview surveys have been discussed. 83'84 However, the relative merits of the various 
formats of VA questionnaire have not been formally assessed. An open format VA 
questionnaire would require more skilled, and probably medically trained, interviewers 
and would increase inter-interviewer variability. A check list without filters would not 
require medically trained interviewers and would reduce interviewer bias, because 
interviewers are forced to consider all symptoms even if they make their own diagnosis 
while interviewing. However this format may not capture all details of the symptoms 
leading to death and may also increase the number of symptoms that are falsely reported 
to have been present. A checklist with filters again would not require medically trained 
interviewers, may be more efficient for data collection, and may reduce interviewer bias. 
A potential limitation of this format is that a false negative response to a filter question 
will result in the exclusion of a disease category and thus in lower sensitivity of the VA. 
Filters and modules based on a specific category of cause of death have been used in 
VAs of childhood deaths where only a few causes of death were studied. However this 
format may be less useful for VAs for adult deaths because the mortality classification is 
likely to have a larger number of categories of cause of death. 
The importance of qualitative field research into local concepts of disease and 
terminology, to facilitate the process of translation and back-translation of VA 
questionnaires, has been described. 86-89 The presence of several languages and dialects 
within small populations will pose problems for the choice of language for VA 
questionnaires. In these situations, one could design VA questionnaires in all the local 
languages in the study population or in one major language with an accompanying list of 
symptoms translated into all other local languages. Ideally, a "model" VA questionnaire 
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should be adaptable for different settings by incorporating the local concepts of disease 
and phraseology of symptoms. 
Interviewers 
Twenty four of the published studies used medically trained interviewers (13 by 
physicians and 11 by medical assistants/nurses), 38 studies used lay interviewers and 
one used a combination. Four studies did not report the type of interviewer. The 
educational level of lay interviewers varied from 7 years of education to university 
degree (24 studies did not describe the level of education of the lay interviewers). It has 
been argued that medically trained interviewers are preferable, but the relative merits of 
the use of lay versus medically trained interviewers for VAs have not yet been studied. 
Medically trained persons are costly. They are more likely than lay interviewers to 
interpret the responses to reach a diagnosis during the interview and this may affect the 
repeatability of the diagnosis. If lay interviewers are to be used, a carefully designed, 
highly structured questionnaire is needed and this has several implications, which are 
discussed earlier (see above). The preferred age, gender and education of lay 
interviewers will vary between different settings and with the choice of format of VA 
questionnaires. 
Respondents 
The best respondent is obviously the person who knows the most about the final illness 
of the deceased. Mothers are the principal respondents for childhood deaths. However, 
identifying the most appropriate respondent for adult deaths may be difficult because the 
relationship between carers and sick adults is likely to vary in different settings. For 
example, a spouse may not be the best respondent for female deaths and it has been 
suggested in the context of studies of maternal mortality that sisters are better 
respondents than husbands. 87 Thus it is important to enquire about the persons who 
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cared for or who lived with the deceased during the illness prior to death as well as 
about specific relationships to identify the most appropriate choice of respondent. In 
some cultural settings it may not be appropriate to restrict to a single respondent. 
Recall period 
The recall period in the reviewed studies ranged from 1 to 52 weeks in most studies. 
Two studies had used 37 and 42 months respectively, in one study it was up to 10 years 
and in another up to 50 years. Thirty eight studies did not report the range of recall 
period used. Accurate reporting of illness occurs when the illness in question is salient, 
and social and psychological barriers to reporting absent. Severe symptoms are 
remembered longer than mild ones and few physicians consultations better than frequent 
ones. Social and personal barriers are shaped by recall period and thus levels of recall 
error is different for different people at different time. Recall period of illness reporting 
as long as 12 months or more were used until recently but this is no longer thought to be 
sufficiently reliable. Furthermore, illness history can be telescoped ie. past events can 
be brought forward in retrospective interviews. Telescoping past events into the 
reference period of surveys will lead to an over estimation of death rates. This can also 
affect cause specific mortality rates if an illness unrelated to death is telescoped and 
reported during VA interviews. The implications of different recall periods for verbal 
autopsy interviews have not been studied. It is assumed that a period exceeding 52 
weeks is not advisable for childhood deaths, but there is no empirical evidence for this. 
Adult deaths are relatively rare events and in some societies premature death of an adult 
is likely to be regarded as more significant than that of a child. Therefore it may be 
possible to use longer recall periods for adult deaths. On the other hand, one could 
argue that mothers are intimately involved in the care of a sick child and so they may 
report the symptoms preceding death of a child more accurately than a relative caring 
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for an adult. This would suggest that shorter recall periods might be necessary for adult 
deaths. Asking about a death soon after its occurrence may cause distress and so it may 
be advisable to define a minimum, as well as a maximum, recall period, as in several of 
the studies reviewed. 
Derivation of Diagnoses 
Diagnoses have been derived at differing stages in the VA process and by different types 
of assessors. The interviewers reached a diagnosis at the stage of interview in 13 studies 
(by a physician or medical assistant in 10 and by a lay interviewer in 3). Assessors who 
were different from the interviewers derived a diagnosis at a later stage in 39 studies. 
Seventeen studies did not report the stage of diagnosis or the type of assessors. 
The procedures used to derive a diagnosis from VAs also varied in the reported studies. 
In 23 studies a pre-defined algorithm was used to derive diagnosis. In these 23 studies, 
an algorithm was used by one assessor in 9 studies, by a panel of assessors in 7 studies 
and by a computer in 2 study and the number of assessors was not reported in 5 studies. 
Thirty three studies did not use a pre-defined algorithm or criteria for reaching a 
diagnosis. In these 33 studies, diagnosis was reached by one assessor in 17 studies and 
by a panel of assessors in 16 studies. The procedure used for deriving diagnosis was 
reported by13 studies. 
A diagnostic algorithm consists of standard criteria based on the duration, severity and 
sequence of symptoms and signs used to reach a diagnosis. The specificity of an 
algorithm will increase, and the sensitivity will decrease as the number of symptoms and 
conditions included in the algorithm increase. Algorithms can be developed from text 
book descriptions of symptoms, from existing clinical algorithms, from local clinical 
experience or from a combination of these. 
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Derivation of a diagnosis at the stage of interview raises several problems. The validity 
of a diagnosis derived at the interview by lay interviewers without algorithms is likely to 
be poor. Although derivation of a diagnosis at this stage by medical interviewers may 
reduce the proportion of deaths that remain unclassified, the repeatability of the 
diagnosis might be low if the diagnosis is derived without algorithms. Diagnostic 
algorithms for mortality classifications with 20 or more categories may be too 
complicated to be used during interviews, even by medically trained personnel. It 
would thus appear that diagnoses should be derived at a later stage, not at the interview. 
Diagnoses derived according to diagnostic algorithms are likely to have better 
repeatability compared to diagnoses derived without algorithms. Therefore deriving 
diagnoses according to predefined diagnostic algorithms would be preferable for inter- 
population comparisons and to study changes in cause specific mortality over time. 
Although 20 studies reported the use of algorithms only one described the process used 
to define the algorithms. The validity of certain diagnostic algorithms for common 
causes of childhood deaths has been discussed. 88 However, the differences in the 
algorithms defined by different processes have not been studied. Algorithms developed 
from local clinical expertise may vary between different settings and may not be 
appropriate for international comparisons. Algorithms defined from text book 
descriptions may not be appropriate in some settings due to differences in cultural 
perceptions of symptoms and signs of diseases. It is likely that a combination of 
approaches would be the best way to develop a first draft of diagnostic algorithms, 
which could then be refined by field tests. 
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Single versus multiple causes of death 
Classification of causes of death into underlying, immediate and associated causes, and 
into primary and secondary causes, is complex and it is not clear that these terms are 
always used consistently. The ability to distinguish between an underlying and 
immediate cause based on VA information is doubtful. Insistence on a single cause of 
death is an attractive option, which would keep the analysis and presentation simple. 
However, ignoring multiple causes of death could lead to misleading results. One way 
of handling multiple causes of death would be to treat a common combination of causes 
as a category in its own right (e. g. having AIDS/tuberculosis (TB) as a separate 
diagnosis from either AIDS or TB) and to take this into account in the analysis and 
presentation of data. Alternatively, analysis could be performed by individual diagnosis, 
so that AIDS/TB contributes once to the AIDS category and once to the TB category. 
The presence of multiple causes of death will have an impact on the estimated 
sensitivity and specificity of VA diagnoses. 
2.4.1 Issues in validation of VAs 
The reported validity of VAs for childhood deaths varied considerably between 
studies 47 51 and between different causes of death. For example, in Kenya47 the 
sensitivity was 89% and specificity was 96% for malnutrition and 28% and 91 % 
respectively for acute respiratory infections (ARI). Furthermore, the sensitivity and 
specificity for the same cause of death varied between different settings and tools. For 
example, in Philippines48 the sensitivity of VAs for ARI was 41%-86% and the 
specificity was 47%-93% depending on the diagnostic algorithms. These estimates of 
validity of VAs for ARI are quite different from those reported from Kenya. 
Before the study reported in this thesis, there was virtually no information on the 
validity of VAs for adult deaths. There has been only one small validation study of 10 
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deaths in Liberia. 52 It is likely that the validity will vary in different settings, and so 
tools should be tested in several settings before being used to assess cause-specific 
mortality rates. 89 
Reference diagnosis 
In order to assess the validity of diagnoses derived from a VA it is necessary to compare 
them with a reference diagnosis. Validation studies will thus involve identifying deaths 
whose causes have been diagnosed by a procedure taken as reference standard, and 
subsequently subjecting these deaths to verbal autopsy and comparing the diagnoses 
reached by VA versus the reference diagnoses. Reference diagnoses for validation 
studies should ideally be accurate and reliable, and the deaths studied should ideally be 
representative of the distribution of causes of death in the community. The following 
three options have been considered for reference diagnosis: (i) diagnosis of all deaths 
occurring in a given community; (ii) diagnosis reached by clinical necropsy (iii) 
diagnosis reached by a reference standard at hospital. 
The choice of diagnosis of all deaths occurring in a community as reference would be 
less susceptible to selection bias. However, in places where VAs are needed only a 
small proportion of deaths in the community are likely to be seen by a physician and it 
will be impossible to establish a robust procedure to reach diagnoses of reference 
standard for all deaths. Thus is this is not a realistic option. 
Diagnosis by necropsy may be accurate, but would be very difficult to achieve in many 
places where only a small proportion of deaths go to necropsy, and where necropsy is 
not culturally accepted. This may result in a strong selection bias as the deaths that go 
for necropsy tend to be atypical. 
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Choice of hospital diagnosis as reference may also introduce selection bias due to 
selective access, differential treatment success and the socio-economic characteristics of 
those who use hospitals; and the influence of hospitalisation on respondents' perception 
of cause of death. The standard of hospital diagnosis depends on several factors such as 
the training and experience of physicians, local diagnostic preferences and availability 
of diagnostic facilities. Snow and colleagues have illustrated some of the inherent 
biases of the hospital based approach to validate Vas47'86. Nevertheless those studies47ý 
51 which have tested the validity of VAs using hospital diagnosis as reference have been 
valuable in illuminating the limitations of VAs for childhood deaths. 
2.5. Conclusion 
VAs have been widely used for childhood deaths, but adequate appraisal of their validity 
has not always been addressed. The marked variations and imprecise reporting of the 
procedures applied in the reported studies have made comparisons of results from these 
studies difficult. Furthermore, it can not be assumed that methods appropriate for 
childhood deaths are necessarily applicable for adult deaths. 
A considerable amount of methodological work needs to be done before VAs can be 
used on a wider scale to obtain useful and comparable data on causes of adult mortality 
for a range of developing countries. The increasing recognition of urgent need for data 
on adult mortality and morbidity may require wider use of VAs for adult deaths and this 
highlights the need for answers to the methodological questions discussed. 
The best approach and the approach used for the development and validation of the 
model VA tool is shown in Panel 1. 
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Panel 1. Key issues involved in the development and validation of VA tools 
Issues Best approach 
1. Restricted or ICD-10 Mortality 1. unclear 
classification? 
2. Open, closed, mixed or modules 2. Probably mixed 
format Verbal Autopsy questionnaire? 
I. Medically qualified or lay 3. Unknown 
Interviewer? 
4. Appropriate recall period? 4. may be 2-24 months 
5. Algorithmic or physician review 5. unknown 
approach for reaching diagnosis 
6. Appropriate reference diagnosis? 6. population based 
medically confirmed 
causes of death 
Chosen approach 
1. restricted 
2. mixed 
3. Lay 
4.2-24 months 
5. both approaches 
6. hospital based 
medically certified 
causes of death 
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3. Methods 
3.1. Development of the VA tool 
A standard VA tool consists of a mortality classification, procedures for deriving 
diagnoses and a VA questionnaire. The prevalence and symptomatology of different 
causes of death and the factors related to data collection (interviewer, respondent and 
recall period) would alter the validity of VAs. However, the VA tool itself plays a 
significant role in the validity and repeatability of diagnoses reached by VAs. For 
instance, in a study in the Philippines the sensitivity and specificity of VAs for selected 
childhood deaths varied considerably depending on the diagnostic criteria used. 
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Similarly, the repeatability of VA diagnoses reached by a panel of physicians without 
diagnostic algorithms was low in the Gambia. In 27% (38/141) of cases, the first and 
subsequent diagnoses reached through agreement of at least two physicians differed 
when the VAs were reviewed on two occasions by the same three physicians-90 This 
highlights the need for a standard VA tool. We made an attempt to develop a standard 
VA tool for assessing causes of adult death and in this chapter, the process used to 
develop the classification of mortality, procedures for deriving diagnoses and the 
questionnaire are described. 
3.2. Mortality classification 
First some existing mortality classifications were considered whether they were 
applicable for VAs: the ones recommended by the WHO91 and the ones used previously 
by Preston92 and the World Bank93. The "core" classification of the International 
Classification of Diseases (ICD-10), which is the mandatory level of coding for 
international reporting to the WHO mortality database has 21 chapters and 2046 
categories of diseases, syndromes, external causes or consequences of the external 
causes. 1 The ICD-10 recommends a condensed list with 103 categories of causes of 
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adult death and a selected list with 80 categories for international comparisons and 
publications. Several causes of death from these lists are unlikely to be diagnosed 
through VAs (e. g. leukaemia, Alzheimer's disease and rheumatic fever) and, therefore, it 
is clear that these lists as they stand are not suitable for VAs. 
Preston has used a broad mortality classification to quantify cause specific mortality 
rates from vital registration data for 43 national populations. This classification has 
eleven categories of causes of death (respiratory tuberculosis, other infectious and 
parasitic diseases, neoplasm's, cardiovascular disease, influenza/pneumonia/bronchitis, 
diarrhoea, certain chronic diseases, maternal diseases, diseases of infancy, violence, and 
other/unknown). Recently, Murray and colleagues further developed this classification 
for analysing causes of adult mortality in selected developing and developed countries. 3 
They classified the causes of death at three levels; group level, subgroup/categories 
level and specific causes level. They had three groups of causes of death 
(communicable and reproductive diseases, noncommunicable diseases, and injuries). 
These groups were further divided into 16 categories of causes of death. Some of these 
categories were further divided into specific causes and there were 25 causes/categories 
at this level. Although this classification would be very useful for making policy 
relevant statements about adult mortality, some of the causes of death at the categories 
level (e. g. venereal disease, helminths) and several at the specific causes level (e. g. 
atherosclerosis) would not be easily diagnosed through VAs. 
Having considered the above mentioned classifications, the frequency distribution of the 
causes of adult admissions and deaths reported during 1992 from the hospitals from our 
study sites (Jimma, Ethiopia; Ifakara, Tanzania; Bawku, Ghana) was obtained as an 
example of causes of adult deaths in rural hospitals in sub-Saharan Africa. The 
constellation of recognisable symptoms of the causes of deaths included in the mortality 
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classifications discussed earlier and also of those causes reported from the study 
hospitals were studied. 
Then the mortality classification used by Murray and colleagues was modified to be 
suitable for VAs of adult deaths. Our working mortality classification (Table 3) 
includes six groups of causes of death; subdivided into 25 subgroups/categories and 
some of them are further divided into specific causes. At the group level, maternal 
causes were separated from communicable diseases since they would be easily 
differentiated in VAs. A "symptoms, signs and syndromes not classified elsewhere" 
group was introduced in order to accommodate categories of causes of death like 
anaemia which could be caused by communicable and non-communicable diseases. We 
also introduced "undetermined" as a separate group since a certain proportion of deaths 
would remain undetermined at this level. At the next level certain categories were 
perceived as difficult to diagnose through VAs (helminths, venereal diseases, 
endocrine, digestive) were excluded and some of them were replaced with syndromes 
(e. g. acute febrile illness (AFI)) or with combined categories (TB/AIDS). Although AFI 
is not a specific disease category, we assumed that it would be useful to analyse AFI 
mortality differentials between populations and over time. We also included certain 
categories (AIDS, tetanus and acute abdominal conditions) because they are policy 
relevant and could be diagnosed through VAs. We arrived at a classification consisting 
of 25 categories of causes of death at this level. At the third level, some of the 
categories are further divided into specific-causes/sub-categories; this level would apply 
only to those categories, which were possible to be differentiated into certain disease 
categories in a VA. The sub-categories of cardiovascular diseases and injuries are 
similar to the one used by Murray and colleagues; the sub-categories of AFI and 
maternal causes are very different. Several specific causes have been added at this level 
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(e. g. meningitis, typhoid and hepatitis) since they have well recognised control measures 
although the accuracy of their diagnosis through VAs is uncertain. Congestive cardiac 
failure (CCF) has been included as a sub-category although it could be due to several 
causes because of a lack of specific symptoms to diagnose the underlying causes. 
Malnutrition and hypertensive heart disease were not included as specific causes due to 
potential lack of accuracy in the diagnosis of these causes by VAs. 
3.3. Procedures to derive diagnoses 
There are several methods to derive diagnoses from verbal autopsies (Figure 2). We 
tested the validity of physician review and a hierarchical algorithm. 
Physician revie, v 
We used three physicians who applied their own diagnostic criteria and reached a 
diagnosis independently. A cause of death was accepted when two or three of the 
physicians agreed upon a cause. If there was no agreement, the three physicians 
reviewed the available information as a group and attempted to reach a diagnosis 
through consensus. As we did not use pre-defined criteria for physician review of VA 
questionnaires, this procedure did not involve a developmental stage. 
Diagnostic Algorithms 
Essex has suggested diagnostic pathways for 49 common presenting symptoms for 
clinical diagnosis in primary health care delivery settings. 94 The identification of a 
single presenting symptom is an important step for the application of these pathways. 
Since it would be difficult to identify a single presenting symptom from a VA we 
deemed this approach unsuitable for VAs. We decided to identify constellations of 
positive and negative symptoms as criteria for reaching certain diagnoses rather than 
algorithms based on a presenting symptom. An example of such an algorithm to reach a 
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diagnosis of pulmonary tuberculosis (PTB) could be as follows: cough with sputum for 
>28 days + haemoptysis + loss of weight + absence of recurrent breathlessness on 
exertion and wheezing = PTB. 
The first step was to draft diagnostic criteria for each category of causes of death 
included in the mortality classification by listing all the symptoms given in the Oxford 
text book of medicine95. Then, myself and two other physicians with working 
experience in Ethiopia, Tanzania and Zimbabwe classified the symptoms as essential, 
supportive or associate for each diagnosis in the proposed classification, according to 
their clinical experience and the definitions mentioned below, after reviewing the 
symptoms recorded in the hospital notes of 361 adults who had died in Ifakara Hospital, 
Tanzania in 1992. 
Bang and colleagues have classified symptoms as essential, confirmative and supportive 
to derive diagnostic criteria for childhood deaths. 85 We classified symptoms as 
essential, supportive, differential and associate depending on the purpose for which they 
are included in or excluded from the algorithm. 
Essential symptoms: These are criteria, which are necessary but not sufficient to reach 
a diagnosis. Ideally these symptoms should be present among all the patients with the 
diagnosis of interest. However, usually they will be present among most of the patients 
with the diagnosis of interest, but they may also be present among patients with other 
diagnoses. For example, in the above mentioned algorithm for PTB, cough with sputum 
>28 days is an essential symptom because it is usually present in most of the cases of 
PTB, but it is also likely to be present in most cases of chronic obstructive airway 
disease (COAD), lung cancer and CCF. It is a prerequisite to diagnose PTB, but is not 
sufficient to reach this diagnosis. 
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Supportive symptoms: These are symptoms which if present in combination with an 
essential symptom(s) help to exclude false diagnoses from the diagnosis of interest. 
However, they may not be present among many patients with the diagnosis of interest 
and they may also be present in other conditions. For example, haemoptysis and loss of 
weight are supportive symptoms as they in combination with a history of cough for >28 
days, would differentiate PTB from COAD and CCF respectively. Haemoptysis, 
however, may also be present in lung cancer and CCF, and loss of weight in AIDS, 
malignancies and certain nutritional disorders. 
Differential symptoms: These are symptoms, which should be absent in order to 
exclude false diagnoses from the diagnosis of interest. They are typically absent among 
the patients with the diagnosis of interest, but present among most of the patients with 
the false diagnoses that are based on essential symptoms. For example for PTB, 
wheezing is a differential symptom as this is present in most of the patients with COAD 
and its absence in combination with productive cough >28 days would differentiate PTB 
from COAD. 
Associate symptoms: These are non-specific symptoms, which are present in many 
seriously ill patients or too difficult to recognise. For example, loss of appetite could be 
added to the above algorithm for PTB. Associate symptoms, however, are not included 
in the algorithm since they may be present in many life threatening diseases. 
The next step was to simplify the diagnostic criteria in order to start with the most 
sensitive criteria; in this process all associate symptoms were excluded from the criteria. 
If a cause of death had more than one supportive symptom, then several diagnostic 
criteria were drafted by including only one supportive symptom in each criterion. The 
next step was to identify the potential misclassifications by each diagnostic criterion and 
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the differentiating symptoms for those misclassifications. Then, the differentiating 
symptoms were added to the criteria based on essential and supportive symptoms in 
order to improve their specificity. Associate symptoms were left out of the algorithms 
because we assumed that their inclusion would not improve the sensitivity or the 
specificity of the criteria. The process of developing diagnostic criteria is illustrated in 
Figure 3 using malaria as an example. Diagnostic criteria for the causes of death 
included in the working classification are shown in appendix 1. 
The algorithms can be used in several ways. Diagnostic criteria, which include all 
differentiating symptoms, could be applied in any order without terminating the 
algorithm once a diagnosis is reached. In this approach more than one diagnosis is 
likely to be reached for some cases. The diagnostic criteria could be applied in a 
hierarchical fashion starting with the most specific ones; once a diagnosis is reached, the 
algorithm is not used any further for that individual. In hierarchical algorithms the 
differentiating symptoms of the diagnosis appearing in a given step may not be included 
in the next step since most records with the first diagnosis would have been excluded 
from the next stage of the process of diagnosing, provided the sensitivity of the 
diagnostic criteria is close to 100%. The hierarchical algorithm that was used to derive 
diagnoses in our multi-centre validation study of VAs is shown in Figure 4. 
3.4. VA questionnaire 
After reviewing the content and format of several VA questionnaires, and discussing the 
options of the formats in an international workshop, we opted to produce a combined 
open/closed format VA questionnaire (appendix 2). The open section allows the 
interviewer to record the respondent's verbatim account of the illness and in order to 
facilitate this we included a table to list the reported symptoms, their duration and 
severity. To draft the modules of questions for the closed section, all the essential, 
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supportive, associate and differential symptoms which form the diagnostic criteria 
related to the mortality classification and also certain other symptoms which are not 
included in the suggested criteria were listed (e. g. paraplegia, pale looking, puffiness of 
face). The questions to elicit the presence or absence of these 40 symptoms form the 
stem questions of the modules and the questions on duration, severity and other qualities 
of these symptoms form the sub-questions which are to be asked only when the answer 
to the stem question is positive. Several questions on socio-economic and demographic 
information of the deceased person and the respondents, and on general circumstances 
and events leading to the death were also included in separate sections in order to study 
the influence of these factors on the validity of VAs. 
The VA questionnaire was translated in the local languages spoken in our study sites 
(Amharic and Orominga in Jimma, Ethiopia; Kiswahili in Ifakara, Tanzania and Kusaal 
in Bawku, Ghana). In each site to start with several patients, traditional healers and 
birth attendants were asked about symptoms of illness and their descriptions were 
recorded. These symptoms were translated into English by three non-medical and two 
medical translators individually. Then, as a group, they discussed the differences in the 
translations and agreed on a list of symptoms (local symptoms). Following this, they 
incorporated the local symptoms into the proposed VA questionnaire and translated 
individually into the local language. Then as a group they agreed on a draft 
questionnaire after discussing the differences between their translations. Another group 
which also included three non-medical and two medical person back-translated the draft 
questionnaire into English. Any question, which differed from the proposed 
questionnaire, was discussed by both groups and the final draft was produced. Two 
interviewers were trained to use this questionnaire and 15 VAs were conducted to field 
test the questionnaire. Finally, the proposed VA questionnaires in the local languages 
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were produced by incorporating the changes made during the field testing. 
The pilot studies showed that some of the symptoms included in the questionnaire (e. g. 
types of rashes, puffiness of face, pale looking) and their severity may not be recognised 
in certain cultures. Although the questionnaire has been carefully translated it was 
noted during the pilot study that many symptoms needed further explanations using 
certain gestures or demonstrations for the respondents to understand them. For instance, 
stiffness of whole body was better understood when demonstrated rather than just asked. 
Furthermore, the attitude and intonation of interviewers may vary and this could alter 
the responses to the questions. We carefully considered the issues such as the use of 
appropriate gestures, demonstrations, intonation and attitude while training interviewers 
for the validation study. 
3.4. Study sites 
Through the existing research links between LSHTM and local research councils, we 
identified one district hospital each in Ethiopia, Tanzania and Ghana for validating the 
VA tool. The selection of these countries were based on the assumption that the sample 
population would represent the population of East, South-central and west Africa and 
also that the a validated VA tool would be useful for the demographic surveillance 
systems (DSS) operating in these countries. At the time of selecting the study sites, 
there was a DSS in at least one district in these countries - Butajira district in Ethiopia, 
Hai, Morogoro and Dar es Salaam districts in Tanzania and Navrongo district in Ghana. 
We considered the following factors for selecting these hospitals: (i) type of catchment 
area should be rural village township; (ii) number of in-hospital adult deaths per year 
should be>150 per year; (iii) number of physicians be at least I physician per 50 beds, 
quality of the clinical laboratory services; (iv) the hospital admission and discharge 
registration system should be robust; (v) the VA should be local research priority. Thus 
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the he study was conducted in Jimma Hospital, Jimma, Ethiopia; St Francis hospital, 
Ifakara, Tanzania; and Bawku Hospital, Bawku, Ghana. 
3.5. Recruitment of Study Subjects 
All adults (Age >14 years) who died in the study hospitals were recruited into the study 
over a period of 18 months. The registration clerks were motivated to improve recording 
of addresses of patients who are admitted to the hospitals. The clerks recorded for each 
patient the house number, an identifiable landmark such as bus stop, shop, School etc. 
In addition they recorded the name of the peasants' association in Jimma and the name 
of the ten- household-unit leader in Ifakara. These are identifiers were very useful in 
Jimma and Ethiopia since they have been in use for a long time in the local 
administrative system. In addition to this, a surveillance system to identify all seriously 
ill adult patients and to improve the quality of hospital records of identification and 
clinical data was started in all three hospitals. Two medical assistants who were 
employed in the project identified and completed a proforma of identification and 
clinical data for all patients who were admitted to the hospitals with life threatening 
diseases. 
3.6. Reference diagnoses 
All the study hospitals had physicians with good clinical experience, and also had 
facilities to do X-ray investigations and essential laboratory tests including the ones for 
HIV. In addition Ifakara Hospital had facilities for sonography and endoscopy, and 
Bawku Hospital had sonography. 
A local physician and I reviewed the seriously ill patient proforma and the hospital 
records in each site. If a certified cause of death was supported by a postmortem, 
surgical operation findings, laboratory tests or typical clinical signs then that 
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diagnosis was classified as "confirmed". If a certified cause of death was not 
supported by any of these criteria, but the clinical history was suggestive of the 
diagnosis then it was classified as "suggestive". If a diagnosis could not be reached 
based on the information given in the hospital notes then it was classified as 
"unknown". However, the suggestive and unknown categories of cases were not 
excluded from the reference diagnoses to estimate the sensitivity and specificity of 
VAs and the reasons for this are discussed in chapter 5. 
3.7. VA tool and data collection: 
The process which was used to develop the verbal autopsy questionnaire (VAQ), the 
mortality classification and the diagnostic criteria is described earlier on. We used 
the same VAQ, adapted and translated into the local languages after qualitative 
research in the three sites. 
Although the advantages of lay interviewers compared to medically trained ones are 
debatable we opted for lay interviewers since medical personnel would be more 
expensive and are often not readily available in sub-Saharan Africa. The interviewers 
had at least 12 years of formal education but were not medically qualified. They each 
received ten days of training in conducting VA interviews, covering all aspects of the 
process. 
The training aimed to equip them with appropriate knowledge, skills, attitude and 
practice in order to obtain accurate information from the respondents. The interviewers 
were made to understand the questionnaire; to anticipate and deal with difficult and 
different responses; to understand, translate and record accurately the responses; and to 
improve interviewing skills, the ability to understand and deal with difficult responses 
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and the team spirit. Training materials included a VA manual (Appendix 3) and 
teaching/learning methods included short presentations on overview of study objectives, 
tools and procedures, and reading, small group discussions, role-plays and practical field 
work under supervision. Each interviewer conducted at least 2 VA interviews in my 
presence during the practical fieldwork. 
There were eight interviewers (7 male, 1 female) in both Ifakara and Jimma, and ten 
interviewers in Bawku (7 male, 3 female). The VA interviews were conducted during 
"home" visits in October/November 1994 in Ifakara, February/March 1995 in Jimma 
and May/June 1995 in Bawku. The recall period was 1-15 months in Ifakara and 1-21 
months in Jimma and Bawku. 
3.8. VA Interviews 
The interview process had the following six steps: (i) identification of the household of 
the deceased/respondent; (ii) expressing sympathy for the loss of the deceased; (iii) 
introduction of the objectives and obtaining consent; (iv) identification of an appropriate 
respondent(s) (v) interviewing the respondent(s) using the VA questionnaire; (vi) 
closing the interview with an expression of thanks. 
The interviewers were provided with a letter from the local health authorities to 
introduce them and the objectives of the interview. The head of household and the 
respondent(s) were assured that the information given by them will be confidential. The 
lack of information on common causes of death and the need for such information to 
identify appropriate interventions were explained to them. After the introduction, verbal 
consent was obtained from the head of household and the respondent(s) to proceed with 
the interview. 
The appropriateness of the respondent was graded into the following two categories. (1) 
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Appropriate: looked after the deceased during the final illness at home and/or hospital 
and or lived in the same house and knows about the illness of the deceased but did not 
look after during the final illness. (2) Probably appropriate: lived at a different house 
but visited the deceased frequently and knows about the illness. 
Whenever possible we interviewed a respondent from the appropriate category, but in 
situations where such a respondent did not exist or was unavailable, a person from the 
probably appropriate category was selected. All potential respondents were first listed in 
the respondent identification form (appendix 4) and, graded for their appropriateness 
and availability. After the best respondent was identified we established whether he or 
she was present at the time of visit (present) or away at the time of visit but could 
be 
contacted if revisited or moved house but could be reached(absent) or impossible to 
contact for some reason e. g. gone for a long trip, moved house to a far away place 
(unavailable). If the best respondent was absent the household was revisited at a later 
date. If the interviewer failed to contact any respondent on three occasions or the 
respondents refused to participate, that death was excluded from the study. In situations 
where more than one respondent were encountered, the additional respondents were 
allowed to participate in the interview. 
The purpose of the study and uses of results of the study were explained to the head of 
the household and the selected respondents. Talking about the circumstances and illness 
history of a close relative or friend is sensitive. It can cause emotional and 
psychological stress especially when the death of young adults. The interviewers were 
carefully trained to cope with such situations and to provide emotional support to 
bereaved relatives. Only after obtaining verbal consent from the head the household and 
respondents verbal autopsy interviews were conducted. Surprisingly majority of the 
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head of households and respondents were very co-operative and willing to share any 
information regarding the death. Only on two occasions the respondent burst into tears 
and the interviews had to spend a long time to calm them down. 
3.9. Reaching diagnoses from VAs: 
Two methods were used to reach diagnoses from VAs. Three physicians who had 
worked in sub-Saharan Africa independently reviewed the completed questionnaires 
from all three sites and where possible assigned a primary underlying cause of death 
and where appropriate co-primary and immediate causes of death. The physicians 
were aware of the study objectives and sites, and were given a copy of the proposed 
mortality classification. They were not given diagnostic algorithms and they were 
allowed to reach diagnoses not included in the mortality classification. A diagnosis 
was considered to be reached if two of the three physicians agreed on the primary 
cause of death. If all three disagreed on the primary cause of death, the VAQ was 
reviewed by the panel and where possible a diagnosis was reached by consensus. 
Although the physicians were instructed to assign multiple causes of death if 
appropriate, if two physicians agreed on the primary cause of death, then the VAQ 
was not reviewed even if they all disagreed on the co-primary or immediate cause. 
We also derived primary causes of death using a computerised hierarchical algorithm 
based on "expert opinion" (Figure 4) discussed in section 3.3. 
3.10. Sample size 
Ideally the sample size for a study to validate a VA tool should be estimated to give a 
sufficient number of deaths due to the rarest cause of interest to provide an acceptable 
confidence interval around the estimated validity of the VA for that cause. If the desired 
confidence limits are +/-10% for a sensitivity of 80% for a diagnosis, then 
approximately 100 deaths due to the given cause are required. Thus if the expected 
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proportion of the total deaths due to that cause is 10% then 1000 deaths are required in 
total. The specificity will generally be estimated more precisely than the sensitivity, but 
will also vary with the proportional mortality of the cause in question. 
The number of adult deaths in the study hospitals ranged from 200 to 250 per year and 
the recruitment of study subjects was planned over a period up to 18 months. A 10% 
loss to follow up was anticipated due to inadequate address and migration. Thus a total 
of 250 to 350 VAs was expected in each study site giving a total of 900-1000 VAs. 
This sample size will not be adequate to estimate the validity measures precisely for 
each and every causes of adult death. However, it would include adequate samples of 
common causes of death i. e. malaria, meningitis, gastro-enteritis, AIDS, and TB; also 
certain useful broad categories of causes ie. AFI, maternal causes, disorders of 
cardiovascular system, acute abdominal conditions and external causes. 
3.11. Analysis 
We calculated sensitivity and specificity of VA for each causes of death. We also 
assessed the agreement between the observed and estimated number for each cause of 
death by kappa statistics. For the comparison of the overall performance of VA 
between the three sites and for assessing the effect of the characteristics of 
respondents on the validity of VA, we calculated weighted sensitivity, specificity and 
kappa. We used the cause specific mortality fractions as weights for each cause of 
death and summed up the weighted measures of each cause of death for estimating the 
weighted sensitivity, specificity and kappa. For example the weighted sensitivity = 
ysensitivity of cause of death; * CSMF of cause of death; where there were n number 
of causes of death. 
Initially the analysis of sensitivity, specificity and kappa was performed for six groups 
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of causes: (1) communicable diseases (acute febrile illness(AFI), TB/AIDS, diarrhoeal 
diseases, tetanus and rabies, and other specified diseases); (2)maternal causes; (3) 
non-communicable diseases (CVS disorders, cirrhosis of liver, acute abdominal 
conditions, neoplasms, renal disorders and other specified diseases), (4) non-specific 
signs and syndromes, (5) injuries, and (6)undetermined. Within the communicable 
and non-communicable diseases groups, analysis was then performed for individual 
causes of death. 
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4. Results 
4.1. Characteristics of respondents and recall period 
A comparison of selected characteristics of respondents and recall period that might 
influence the accuracy of VA between the three study sites are shown in Table 4. 
Nearly half of the respondents were males in Ifakara and Jimma, but the proportion of 
male respondents was significantly higher in Bawku (69%). There was no significant 
difference in the age distribution of respondents between the sites. Most of the 
respondents were 15 to 59 years of age. The proportion respondents who did not have 
any formal education at all was slightly higher in Ifakara compared to Jimma (28 vs 
20%; P=. 04) and was significantly higher in Bawku (81 %). Most of the respondents 
were either spouses or close relatives (brothers, sisters, sons, daughters, or parents). The 
proportion of spouses was higher in Jimma compared to Ifakara (30 vs 18%: P<. 001). 
More than 80% of respondents in all three sites were appropriate i. e. they had cared for 
the deceased during the illness that lead to death. However the proportion of very 
appropriate respondents was significantly higher in Bawku (95%) compared to Ifakara 
(82) and Jimma (86). The primary language of the respondents was the same as the VA 
questionnaire for a high proportion of respondents in Ifakara (91 % spoke Kiswahili) and 
Jimma (86% spoke Amaringa or Orominga). However only 57% of the respondents' 
primary language was Kussal (the VAQ language) in Bawku. The recall period was 
similar between Ifakara and Jimma but the proportion of VAs with a recall period more 
than 13 months was higher in Bawku compared to Ifakara and Jimma. 
4.2. Response rate 
The response rate ranged from 76 to 85% in the three sites (Table 5). The most 
common cause for non-response was lack of adequate contact address. There were only 
four refusals 2 in Ifakara and 2 in Bawku. A comparison of the distribution of cause 
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specific mortality between those eligible for inclusion and those actually studied are 
shown in Table 6. Although we were unable to trace 22% of the eligible deaths the 
selection bias arising from this exclusion would minimal as there were no substantial 
differences in cause specific mortality fractions (CSMFs) between the eligible and the 
actual study populations. 
4.3. Reference diagnoses 
Diagnosis of the cause of death was confirmed in just under 80% of deaths overall (ie. 
Supported by laboratory of typical clinical signs - none these cases were confirmed by 
post-mortem examination): 78% of diagnoses were confirmed in Ifakara, 76% in Jimma 
and 79% in Bawku (Table 5). However, only 50% of deaths due to malaria were 
confirmed with a positive blood film in all three sites. Only 25% of deaths due to 
hepatitis were confirmed in Ifakara. The proportion of deaths confirmed was low for 
pneumonia was low in Ifakara (50%) and in Bawku (10%). 
There was considerable variation in the distribution of causes of death between the sites. 
In Ifakara 63% of all deaths were due to communicable diseases and 24% due to non- 
communicable diseases, while the corresponding figures were respectively 51% and 
31 % in Jimma and 56% and 27% in Bawku. In Bawku there were relatively higher 
proportions of death from meningitis, hepatitis, and neoplasms and lower proportions 
from malaria, TB/AIDS and liver diseases than in the other sites. In Jimma the 
proportions of death from acute abdominal conditions (including strangulated hernias 
and gastrointestinal haemorrhages) and injuries were higher, and those from meningitis, 
diarrhoeal diseases and anaemia were lower, than at the other sites. In Ifakara, the 
proportion of deaths from diarrhoeal diseases was high, and of direct maternal causes 
(including abortion, obstructed labour, eclampsia, haemorrhage and puerperal sepsis) 
45 
was low, compared to Jimma and Bawku. 
4.4. Effect of respondents' characteristics and recall period of VA 
A comparison of the weighted sensitivity, specificity and Kappa between different 
classes of respondent characteristics in each site is shown in Table 8. In Ifakara there 
was no statistically significant difference in weighted sensitivity or specificity between 
different classes of characteristics. In Jimma the weighted sensitivity was higher for 
respondents with 7+ years education compared to respondents without any formal 
education (71 versus 55%; p<. 05). In Bawku respondents with 7+ years had lower 
specificity compared to those without any formal education (32 versus 60%; p<. 05). 
Interestingly the recall period had very little effect on the sensitivity or specificity of 
VA. Although the respondent characteristics and recall period had no significant effect 
on the sensitivity and specificity of VA, certain characteristics had an effect on the 
agreement between the true and estimated numbers of certain causes of death. In Ifakara 
kappa was low for close relatives compared to spouses (0.47 versus 0.80); for probably 
appropriate respondents compared to most appropriate respondents (0.39 vs 0.58); for 
respondents with primary language other than Kiswahili (0.44 vs 0.56) and for recall 
period 1-6 months compared to 7+, months (0.48 vs 0.57). In Jimma the kappa was low 
for 60+ year old respondents compared to 15-59 year old ones (0.53 vs 0.69); for 
respondents with no formal education compared to those with 7+ years of education 
(0.53 vs 0.72); for spouses compared to distant relatives and friends (0.60 vs 0.76). In 
Bawku the kappa was low for 15-59 year old respondents compared to 60+ year old 
ones (0.54 vs 0.64); for respondents with 7+ years of formal education compared to 
those with none (0.32 vs 0.60); for probably appropriate respondents compared to 
appropriate respondents (0.01 vs 0.59) and for respondents with primary language other 
than Kusaal (0.48 vs 0.61). The relationship between respondent characteristics and the 
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agreement between true and VA estimates of causes of death is inconsistent between 
sites. For example the respondents with better education had good agreement in Jimma 
while they had poor agreement in Bawku. This not entirely surprising since the 
agreement between true and VA estimates of number of each cause of death is affected 
by the complex relationship between prevalence of each cause of death, sensitivity, and 
specificity.. 
The over overall weighted specificity was lower in Jimma and Bawku compared to 
Ifakara (89 vs 94%; p<. 05) and the Kappa was higher in Jimma (0.70) compared to 
Ifakara (0.55) and Bawku (0.56). These differences were not explained by the effect of 
any particular factor - this is an inherent operational characteristic of VA by site per se 
than due to any differential effect of respondent characteristics or recall period. 
4.5. Validity of VAs by physician review 
There was agreement between the independent diagnoses of at least two physicians for 
78% of deaths in Ifakara, 74% in Jimma and 70% in Bawku. The remaining VA 
diagnoses were agreed by the panel after reviewing the VAs. Table 9 shows the 
sensitivity, specificity and Kappa for the six groups of causes of death. At all sites the 
specificity was greater than 85% for all groups except communicable diseases, and 
greater than 95% for maternal causes, non-specific syndromes and injuries. The 
sensitivity was always lower than specificity, but exceeded 75% for all causes except 
non-communicable diseases and non-specific syndromes. However the level of 
agreement between the true and VA estimate of number of each cause of death was 
variable. There was a good agreement for communicable causes of death in all three 
sites (Kappa ranged from 60 to 67%). For direct maternal causes there was very good 
agreement in Ifakara (kappa 83%) and good agreement in Jimma (76%) and Bawku 
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(62%). For non-communicable causes the agreement was good in Jimma (Kappa 67%) 
and fair in Ifakara (57%) but poor in Bawku (47%). For nonspecific syndromes the 
agreement was fair in Ifakara (kappa 51%) and poor in Jimma (0%) and Bawku (35%). 
There was very good agreement for injuries in all three sites (kappa raged from 79 to 
100%). 
When the individual communicable and non-communicable diseases were analysed 
(Table 10) the specificity fell below 95% in only a few instances: AFI in all three sites; 
TB/AIDS in Ifakara and Jimma; and diarrhoea! diseases in Ifakara. Sensitivity, 
however, varied both across the sites and between causes: sensitivity was greater than 
75% for rabies, tetanus (Ifakara, Jimma), acute abdominal conditions (Ifakara), and 
pneumonia and neoplasms (Jimma). Sensitivity was 60-74% for diarrhoea (except 
Bawku), meningitis (Ifakara), TB (Jimma), AIDS (Jimma) and renal disorders (Bawku). 
When malaria, meningitis, hepatitis, pneumonia and other acute febrile illness were 
amalgamated into a single category the sensitivity ranged between 60 and 75%. 
Similarly the combined category of TB/AIDS had a sensitivity above 75% in Ifakara and 
Jimma and 56% in Bawku. Among communicable diseases the PPV was >75% for 
tetanus and rabies in all three sites, for hepatitis and TB in Ifakara and Bawku, for 
meningitis in Ifakara, and for pneumonia in Jimma. 
VA estimates of acute febrile illness as a subgroup had fair agreement with the true 
number of acute febrile illness deaths in Ifakara (57%) and Jimma (63%), but kappa was 
only 48% in Bawku. Individual febrile diseases had poor agreement with the exception 
of meningitis in Ifakara (68%) and Bawku (54%), hepatitis in Bawku (50%) and 
pneumonia in Ifakara (89%). TB/AIDS as a subgroup had good agreement in all three 
sites - kappa ranged from 62 to 70%. However when this subgroup was broken down 
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into TB or AIDS the agreement was weak. For TB the kappa was fair in Ifakara (59%) 
and Bawku (53%) but poor in Jimma (41%). For AIDS kappa was good only in Bawku 
(61 %). There was fair agreement for diarrhoeal diseases in Ifakara (60%) and Jimma 
(52%) but this was poor in Bawku (25%). Tetanus had a perfect agreement (100%) in 
Ifakara and Jimma and good agreement in Bawku (66%). Rabies also had a good 
agreement in Ifakara (83%) and Bawku (100%). 
In Ifakara, acute abdominal conditions is the only subgroup of noncommunicable causes 
of death that had a good agreement (61%). In Jimma, all subgroups of non- 
commuicable causes of death had a fair agreement (kappa 54 to 61%) with the exception 
of cirrhosis of liver (kappa 47%). In Bawku, CVS disorders and acute abdominal 
conditions are the only subgroups of non-communicable diseases that had a good 
agreement (kappa 62% and 51 % respectively). 
4.6. Validity of VAs by diagnostic algorithm 
The algorithm classified 11 % of VAs as unknown in Ifakara, 7% in Jimma and 10% in 
Bawku. The sensitivity, specificity and Kappa of VA diagnoses reached by the 
algorithm for the six groups of causes of death are shown in Table 11. The sensitivity 
was >75% for injuries in all three sites and for communicable diseases in Ifakara and 
Jimma. The specificity was >85% for direct maternal causes, noncommunicable causes, 
nonspecific syndromes and injuries and <85% for communicable diseases in all three 
sites. The agreement between the true and VA estimates causes of death was poor 
(kappa <50%) for communicable and noncommunicable diseases and nonspecific 
syndromes in all three sites. The agreement was good (kappa >60%) for direct maternal 
causes and injuries in all three sites. 
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The sensitivity, specificity and Kappa of VA diagnoses reached by the algorithm for 
selected communicable and noncommunicable diseases or subgroups of diseases are 
shown in Table 12. None of the subgroups of diseases had sensitivity more than 75%. 
For several communicable diseases the specificity fell below 95%: for AFI in all three 
sites; for malaria and meningitis in Jimma and Bawku; for hepatitis in Bawku; for 
TB/AIDS in Ifakara and Jimma; for TB in Jimma; for AIDS in Ifakara and Jimma. For 
noncommunicable diseases the specificity was >95% for all subgroups of causes except 
CVS disorders in Ifakara. 
The agreement between the true and VA estimates of individual causes of death was 
low. The kappa was more than 50% for a few causes only - for unspecified febrile 
illness, TB/AIDS, tetanus and rabies in Ifakara and for TB/AIDS in Jimma. 
4.7. Comparison of validity of physician review versus algorithm 
A comparison of the validity of VAs using these two diagnostic procedures in the 
combined population (data from all three sites pooled together) is shown in Table 13 
and 14. At the group level specificity was similar for the two methods except for 
communicable diseases for which the diagnoses reached by physicians had a 
significantly higher specificity (78% vs 68%; p<. 01). However, the sensitivity of VA 
diagnoses by physicians' review was consistently higher for all groups of causes and the 
kappa was also higher for all groups of causes of death. Although the 
specificities of VA by the two methods for the individual communicable and non- 
communicable diseases were similar, the sensitivities of VA by physicians were 
consistently higher for all causes except for rabies and diarrhoeal diseases. The kappa 
of VA by physician was consistently higher than VA by algorithms for all 
communicable and noncommunicable diseases. Generally there was good agreement 
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between reference standard CSMFs and VA estimates reached by physician review and 
algorithms (Figures 6,7,8). Physician review over estimated diarrhoeal diseaes and 
acute abdominal conditions in Ifakara. The algorithms over estimated acute abdominal 
conditions in Ifakara, TB/AIDS and diarrhoea in Jimma, and underestimated acute 
abdominal conditions in Jimma and CVS disorders in Bawku. 
4.8. Validity of VAs by physician review for maternal causes of death 
For the individual direct causes of maternal deaths the specificity was 98% or higher 
(Table 15) except for ante/postpartum haemorrhage (97%) and the sensitivity was more 
than 60% except for eclampsia (40%). For common indirect causes of maternal death, 
the specificity was more than 98%, but the sensitivity was less than 50%. The kappa 
was >60% for abortion, obstructed labour and haemorrhage. For rest of the individual 
causes the kappa was <50%. 
4.9. Validity of VAs by algorithm for maternal causes of death 
When the VA diagnosis was reached by algorithm the specificities remained high but in 
general the sensitivities were lower. For individual direct maternal causes, the 
specificity was 98% or more for all causes (Table 15), but the sensitivity was generally 
low ( >60% for ante/postpartum haemorrhage only). Similarly for individual indirect 
causes, the specificity was 98% or more for all causes except for acute febrile illness 
(95%), but the sensitivity was low (>60% for hepatitis only). Kappa was also generally 
lower for VA diagnoses by the algorithm than by physician review. None of the causes 
had a kappa >60%. Kappa was >50% for abortion, obstructed labour, haemorrhage and 
hepatitis. 
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4.10. Misclassification of causes of death by physician review of VA 
The patterns of misclassification of causes of death by physician review in the three sites 
are shown in Tables 16,17 and 18. There was no clear pattern of misclassification in 
causes of deaths in all three sites. Misclassification was observed among all causes, 
with the exception of injuries and to some extent, direct maternal causes. However, the 
false negative and false positive rates varied among causes of deaths and for any given 
cause of death between sites. For example, the false negative rate of AFI (the 
proportion of AFI cases misclassified as other causes) ranged from 0% to 9% in Ifakara 
(0/82 was misclassified as direct maternal causes and 7/82 was misclassified as 
TB/AIDS or CVS disorders); 0% to 5% in Bawku (0/93 was misclassified as injuries 
and 5/95 was misclassified as direct maternal causes); and 0% to 16% in Jimma as 
injuries (0/61 was misclassified as injuries and 10/61 was misclassified as TB/AIDS). 
Furthermore, the proportion of false negatives of a causes of death contributed by a 
given cause of death differed between the sites. For instance, the proportion AFI 
misclassified as TB/AIDS was 9%(7/82) in Ifakara while this misclassification was only 
1%(1/93) in Bawku. 
4.11 Misclassification of causes of death reached by VA algorithm 
Misclassifications of causes death occurring when VA diagnoses reached by the 
algorithm are shown in Tables 19,20,21. Similar to the VA diagnoses by physician 
review all causes of death had false positive and false negative diagnoses with the 
exception of injuries. The differential misclassifications between causes of death and 
between sites observed in the VA diagnoses reached by physician review was also seen 
in the VA diagnoses reached by the algorithm. The level of misclassification in VA 
diagnoses by the algorithm was generally higher than that occurred in the diagnoses 
reached by physician review of VAs. 
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4.12. Misclassifications maternal causes of death by physician review 
The misclassifications between individual causes of maternal death were mostly bi- 
directional and often the numbers of false positives and false negatives were similar 
(Table 22) . For 
instance 2 cases of abortion were misclassified as non-maternal causes 
(NMC) and 2 cases of NMC were misclassified as abortion. However, there were 
exceptions. For example, there was no false negative diagnosis of haemorrhage, but 
there were 8 cases of false positive diagnoses for cases of obstructed labour, puerperal 
sepsis, acute febrile illness (AFI), TB/AIDS, anaemia and other maternal causes. On the 
other hand, while 6 cases of AFI complicating pregnancy were misclassified as NMC, 
only one NMC was misclassified as AFI 
4.13. Misclassifications of maternal causes of death reached by the algorithm 
The pattern of misclassification of maternal causes of death by the algorithm is shown in 
Table 23. The number of misclassifications between individual causes was higher in the 
VA diagnoses reached by the algorithm than the VA diagnoses reached by physicians. 
For instance the following bi-directional misclassifications occurred in addition to those 
occurring in the VA by physicians: between obstructed labour and TB/AIDS; hepatitis 
and NMC; TB/AIDS and AFI; TB/AIDS and anaemia/CCF; AFI and anaemia/CCF. 
However, the numbers of false positives and false negatives were more balanced in the 
VA diagnoses by algorithm than the VA diagnoses by physicians. 
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5. Discussion 
5.1. Reference diagnoses 
Any validation study of a verbal autopsy tool faces the question of how to obtain a 
suitable reference diagnosis. We chose to use a population of hospital deaths and to 
accept the hospital diagnosis as our "gold standard". In our study population 22% of the 
reference diagnoses were not confirmed and had only a suggestive clinical history. 
These could have been classified as undetermined, or excluded from the analysis, but we 
included them, taking all suggestive and confirmed diagnoses as our reference. 
Inclusion of the unconfirmed cases into the undetermined category would distort the 
cause specific mortality proportions and the estimates of validity measures. Total 
exclusion was felt to be inappropriate since we believe that VAs would be a useful tool 
if the VA diagnoses could correlate with hospital diagnoses irrespective of the certainty 
of hospital diagnoses - in other words if the VAs give information which is as good as 
the hospital physicians are currently giving. As deaths due to malaria had the maximum 
level of unconfirmed cases we assessed the effect of inclusion of unconfirmed cases on 
the estimates of sensitivity, specificity and kappa by estimating these measures for 
confirmed cases of malaria. In this analysis, VA diagnosis reached by physician review 
had a slightly higher sensitivity (41 vs 33%), specificity (94 vs 93%) and Kappa (0.31 vs 
0.26) than in the analysis that included both confirmed and unconfirmed cases of 
malaria; the VA diagnosis reached by the algorithm also had a slightly higher sensitivity 
(21 vs 19%); specificity (91 vs 90%) and kappa (0.10 vs 0.09). However none of these 
differences were statistically significant and thus we believe the effect of inclusion of 
unconfirmed cases in our analysis on the estimates of validity measures would be small. 
Although there was no difference in the distribution of causes of death between the 
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eligible and the actual study populations, the observed cause specific mortality 
fractions 
may not be applicable to the overall population in the study sites because 
deaths from 
some causes may be more likely to occur in hospital than from others. 
The varying 
CSMFs observed between the sites could be due to differences in health care seeking 
behaviour of the study populations, quality of health services and treatment success, or 
to prevailing morbidity patterns. The high maternal mortality seen in Ghana and 
Ethiopia is consistent with previous reports96'97 and the low mortality due to injuries 
in 
Ifakara could be due to the fact that the hospital is far away from main roads. The low 
mortality from maternal causes and injuries in Ifakara may partly account for the low 
proportion of both male and female deaths in the 15-44 year age group. The low 
mortality from TB/AIDS in Bawku may be due to differences in the stage of the AIDS 
epidemic. 
One of methodological question is that can we combine the data from the three sites in 
order to increase the sample of deaths for specific causes. We selected the three sites on 
the basis that socio-cultural background and the epidemiological pattern of causes of 
death would be different in the east, southern and west African regions. Our data shows 
that the distribution of causes of death is different at rural district hospitals in these three 
regions. However it not clear whether this difference is due to the differential use of 
hospital services between the three sites or indeed due to the difference in the 
underlying causes of death in the community. If we assume that the distribution of 
causes of death in the community is similar between the three sites and the observed 
differences are primarily due to differences in the health services related factors then 
combining the data is justified. However it appears that there is a difference in the 
underlying morbidity and mortality in these communities and thus we decided not to 
combine the data for estimating the sensitivity, specificity and kappa of VA. We have 
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combined the data while comparing the validity of VA reached by physician review 
versus the algorithm. The estimates of sensitivity, specificity and kappa observed in this 
analysis are meaningful as a relative measure for comparing the efficiency of physician 
review versus the algorithm - they are not applicable to any particular population. 
5.2. Characteristics of respondents 
The variation in the characteristics of respondents between Ifakara and Jimma was small 
but the respondents in Bawku differed on several characteristics. This substantial 
difference in the characteristics of respondents between Bawku and the other two sites is 
in part due to the differences in the social structure of families in these sites. In Bawku 
several families live in large compounds headed by an elderly person (often a man) who 
was responsible for taking care of births, illness and other important events occurring in 
the compound. Such a system did not exist in Ifakara and Jimma. This explains why 
there were more male respondents with no formal education in Bawku than in the other 
two sites. While Tanzania (Kiswahili) and Ethiopia (Amharinga and Orominga) had 
their own national languages, northern Ghana, Bawku district in particular did not have 
a common local language. There are five different tribes (Kusassi, Mamprusi, Frafra, 
and Hausa) living in Bawku and English is the common language in this population. 
Thus it is not surprising that the proportion respondents who spoke Kusaal (the local 
language used for the VAQ) was small compared to the proportion of population who 
spoke Kiswahili in Ifakara and Amharinga or Orominga in Jimma. 
5.3. Effects of characteristics of respondents and recall period on validity of VA 
Within the three sites the influence of characteristics of respondents and recall period on 
sensitivity and specificity of VA was small. From this observation of association 
between length of recall period and the sensitivity and specificity of VA, we can 
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speculate that the memory of events leading to a death is retained for long periods, may 
be up to three years or so. Thus it appears that it is acceptable to extend the recall 
period of VAs, may be up to three years. Although the appropriateness and the primary 
language of respondents had very little effect on the sensitivity and specificity of VA, 
the kappa was considerably low for less appropriate respondents and for those whose 
primary language was not the same as the language of the VA questionnaire. This can 
be explained by the plausibility of misunderstanding of VA questions and misreporting 
of symptoms and signs. This highlights the point that every attempt should be made to 
identify the most appropriate respondent and to develop the VA questionnaire in the 
primary language of the respondents. However when large community based studies 
using VA are carried out it is inevitable that certain proportion of respondents would be 
less appropriate. Furthermore developing a VA questionnaire in all principal languages 
spoken in a region like northern Ghana is not feasible as there are too many languages. 
Thus we did not exclude the VAs done with less appropriate respondents and/or with 
non-VAQ language from the analysis. 
5.4. Effect of CSMFs on sensitivity and specificity of VA 
The sensitivity and specificity of VA and CSMFs differed among the three sites. The 
sensitivity for acute febrile illness (AFI) was lower and specificity was higher in Ifakara 
than in Bawku (60 vs 74% and 94 vs 75% respectively; P<0.05) and the CSMF of AFI 
also differed between these two sites (26 vs 40%; p<0.05). Similarly, the specificity 
differed significantly for TB/AIDS and direct maternal causes between Bawku and 
Ifakara (93 vs 99.5% and 99 vs 96% respectively; p<0.05) and so did their CSMFs (24 
vs 8% and 3 vs 8% respectively; p<0.05). Between Ifakara and Jimma, the sensitivity 
for direct maternal causes (90 vs 77%; p<0.05) and the specificity for diarrhoeal 
diseases (94 vs 98%; p<0.05) differed significantly, and the CSMFs of these CODs also 
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differed (3 vs 9% and 10 vs 5% respectively; p<0.05). 
Since the same VA tool and data collection method were applied in all the three sites, 
the effects of these factors on the validity of VA would not vary by site. Furthermore 
the effect of respondents' characteristics and recall period on the sensitivity and 
specificity of VA was small within the three sites. Thus the differences in the sensitivity 
and specificity of VA observed between the sites for various causes of death are unlikely 
to be due to the differences in the distribution of respondents' characteristics between 
the sites. The observed variation in the sensitivity and specificity between sites is most 
likely due to the underlying differences in the CSMFs between the sites. 
5.5. Effects of pattern of misclassification on sensitivity and specificity 
The influence of the distribution of causes of death (COD) on the specificity of VA can 
be explained by the following expression of specificity. Given N possible COD (CODs 
..... CODN) then the specificity for a given COD, denoted COD1, is = 1- (M2P2 + M3P3 
+ ..... MNPN), where M; = proportion of true COD; misclassified as COD1 (that is false 
positive rates for COD;; and Pi = proportion of true negative CODi that are true CODi 
(that is CSMF for COD; among the true negatives). For example, in Ifakara (Table 16) 
the specificity for AFI equals 
1- {(3/33)(33/233) + (3/75)(75/233) + (3/25)(25/233) + (0/10)(10/233) + (0/9)(9/233) + 
(6/81)(81/233)}. Thus specificity is a function not only of the cause-specific false 
positive rates but also of the cause-specific fraction of the true negative cases. 
The misclassification error associated with TB/AIDS reduced the specificity of VA for 
AFI by 1.3% in Ifakara compared to 3% in Bawku. In Ifakara, only 4% (3/75) of 
TB/AIDS deaths were misclassified as AFI, but since 32% (75/233) of true negative 
cases were TB/AIDS this misclassification error reduced the specificity of VA of AFI by 
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1.3%. Although 22% (4/18) of TB/AIDS was misclassified as AFI in Bawku this error 
reduced the specificity by only 3% since TB/AIDS contributed just 13% (18/139) of the 
true negatives. Thus even if there are no differences in the false positive rates 
contributed by each COD between sites, the specificity will differ if the CSMFs vary 
because the total false positive rate is a weighted sum of cause-specific false positive 
rates, where the weights are the proportion of each COD among true negative cases. 
The number of false positive and negative cases for each COD is small in our data set 
and thus one has to be cautious in interpreting the patterns of misclassification. 
Nevertheless these data show that the pattern of misclassification can be influenced by 
differences in the distribution of COD and thereby the sensitivity and specificity of VA. 
5.6. Validity of VAs 
The levels of sensitivity and specificity of VAs by physicians were found to be highest 
for the groups of injuries and maternal causes. The sensitivity was particularly poor for 
non-specific syndromes and it is not surprising since this category includes only 
anaemia which is diagnosed as malaria or CVS disorders. Individual causes that 
resulted in the highest values of sensitivity, specificity and kappa were tetanus and 
rabies. The specificity remained high and the sensitivity and kappa were moderate for 
meningitis, AFI, TB/AIDS and acute abdominal conditions. 
The algorithm demonstrated high levels of validity for some causes (e. g. rabies and 
injuries) and moderate levels for TB/AIDS and direct maternal causes. The sensitivity 
of VA by algorithm was lower than that by physician diagnosis for all causes except 
TB+AIDS. This is not surprising, since 9.5% of cases were classified as unknown by 
algorithms since no diagnosis could be reached. However, it is perhaps surprising that 
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the specificities resulting from the algorithms were also lower or equal to those from the 
physicians for nearly all causes of death. 
Is the validity of VA by physician review or algorithms good enough? There is no 
recognised cut-off point above which the levels of sensitivity, specificity or kappa are 
deemed to be Dacceptable" - the minimum levels required by anyone using results 
obtained by the VA method will depend on the use to which the results are put. 
Furthermore all three measures indicates the validity of VA at the individual level. The 
agreement between the true and observed CSMF of a given cause of death depends on 
the balance of false positive and false negative diagnoses of the given cause of death 
rather than on the sensitivity and specificity of VA per se. This explains our observation 
of robust agreement between the true and VA estimates of CSMFs for all common 
causes of adult deaths in spite of very low sensitivities of VA for several causes of 
death. For example, the sensitivity of VA for renal disorders was just 25% and the 
specificity was 98% in Jimma but there was a 100% agreement between the number of 
true and VA estimates of deaths due to renal disorders (8 vs 8). 
It follows that even if VAs are unable to provide an accurate diagnosis at the individual 
level, they may provide a robust estimate of cause-specific mortality at the population 
level. 
5.7. Validity of VA for maternal causes of death 
Since the number of maternal deaths due to any single cause was small (range 5 to 18), 
the confidence intervals for the sensitivities are very wide, and therefore interpretation 
of the results has to be cautious. Since the CSMF is less than 5% for all individual 
causes of maternal death (except AFI complicating pregnancy) among all causes of 
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death in women of child bearing age, if the sensitivity is around 60% the specificity has 
to be more than 98% to avoid overestimation of CSMFs. For instance the VAs 
diagnoses reached by physicians review overestimated the CSMF of haemorrhage for 
which the specificity was <98%. Similarly VAs by the algorithm overestimated the 
CSMF of AFI which had specificity <98%. The effect of different levels of sensitivity 
on the estimates of CSMF is less striking than that of the specificity and thus a VA tool 
used to estimate the distribution of causes of maternal death would require higher 
specificity than sensitivity. 
If the misclassification between two causes of death is bi-directional, the estimates of 
CSMF will not be affected if the numbers of false negative and false positive diagnoses 
are similar. For instance, in the VAs by physicians, the misclassification between 
abortion and NMC was bi-directional (2 cases of abortion were diagnosed as NMC and 
2 NMC as abortion), and thus the estimated CSMF for abortion is unaffected. Similarly, 
the CSMFs estimated by algorithm were comparable to the expected CSMF because the 
number of false positive and false negative diagnosis was more or less equal for most 
causes of death. There were imbalances between false positives and false negatives for 
some causes of death in VAs by physicians review and this resulted in over-estimation 
of CSMF for haemorrhage and puerperal sepsis and under-estimation of CSMF for 
indirect maternal death due to AFI, TB/AIDS and hepatitis. However, since numbers of 
individual causes of death were small, extrapolation of the observed pattern of 
misclassification and the agreement between observed and expected CSMFs requires 
caution. 
Although the estimated CSMF for individual causes of death are useful for setting 
priorities, it is unlikely that VAs can be used to compare these fractions between groups 
or to measure changes over time, because the number of maternal deaths required to 
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make a valid comparison is too large. However, comparison of CSMF for direct or 
indirect maternal causes as a group is feasible and may be adequate for the evaluation 
and planning of programmes. If we assume that the CSMFs of direct or indirect 
maternal causes are likely to be around 10%, a specificity of 95% would probably be 
adequate. However, since the sensitivity is likely to be higher at this level of grouping, 
a correspondingly higher level of specificity will be needed to produce a comparable 
estimates of CSMFs. 
5.8. Diagnostic algorithms 
We envisage several ways in which the algorithms could be used. The diagnostic 
criteria could be applied in a hierarchical fashion starting with the most specific ones; 
once a diagnosis is'reached, the algorithm is not used any further for that individual. 
However, if there are subcategories sub-algorithms would be applied to reach those 
causes of death. 
The application of the diagnostic criteria in a hierarchical algorithm has certain 
drawbacks. The likelihood of reaching a particular cause of death not only depends on 
the validity of the diagnostic criterion for that cause but also on its rank in the hierarchy. 
For example if a diagnostic criterion for PTB which misclassifies 50% of AIDS is 
ranked above AIDS in the hierarchy, even if the diagnostic criterion for AIDS had 100% 
sensitivity and specificity only 50% of AIDS cases will be diagnosed as AIDS. 
Furthermore, the estimates of sensitivity and specificity of a set of algorithms will vary 
depending on the hierarchical order of the algorithms. For instance the ranking of 
different causes of death in the proposed hierarchical algorithm is debatable. 
Nevertheless a hierarchical algorithm simulates the process of clinical judgement used 
by physicians to reach single causes of death from VAs and thus allows for a reasonable 
comparison of the validity of these two procedures to reach diagnoses from VAs. 
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Diagnostic criteria that include all potential differentiating symptoms could be applied 
in any order without terminating the algorithm once a diagnosis is reached. In this 
approach more than one diagnosis can be reached for some cases. If a single most 
probable cause of death is desired, the diagnostic criteria could then be made more 
specific by including certain associate symptoms or by identifying some additional 
differentiating symptoms. However, inclusion of too many differentiating symptoms is 
likely to increase the proportion of records that are unclassified since the suggested 
differential symptoms are not specific enough to exclude potential misclassifications 
only. 
The performance of the opinion-based algorithm used in this study to diagnose primary 
cause of death was less good than diagnosis by a panel of physicians. However, 
algorithms for determining the cause of death from the responses on the VA 
questionnaire is highly desirable if VAs are to be used on a large scale, since VAs are 
most needed in situations where physicians are not widely available. 
5.9. Adjusting the effect of misclassification error of VA 
VA has been used in several settings to estimate cause-specific mortality of childhood, 
maternal and adult deaths. It is often the only source of cause-specific mortality in 
settings lacking functioning vital registration systems. The fact that VA diagnosis of 
causes of death can be in accurate raises the question whether misclassification error in 
VA can be estimated and adjusted for in VA data; and if so, how to carry out this 
adjustment. 
The validity and reliability of VA estimates of cause-specific mortality depend on 
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several factors such as the `true' underlying distribution of causes of 
death in the 
population, age and sex of the deceased, the specific VA tools used, and the 
data 
collection process. VA estimates of CSMFs can be inaccurate 
if sensitivity and 
specificity of VA are <100%. 
98 One way of overcoming this problem is by adjusting the 
VA estimate of CSMF using the sensitivity and specificity of the VA tool. It 
has been 
proposed that VA estimates of CSMF can be adjusted for the effect of misclassification 
error by the following model: Pt = 
(Pe + specificity -100) 0; where Pt is the 
(sensitivity + specificity -100) 
adjusted CSMF and Pe is the crude VA estimate of CSMF. 
99 However, this assumes 
that sensitivity and specificity of VA tools obtained from particular validation studies 
can be extrapolated to data obtained from demographic surveys or surveillance systems. 
If the sensitivity and the specificity of VA are influenced by the distribution of the 
causes of death then the measures obtained from a validation study are unlikely to be 
useful for adjusting the misclassification error of VA in settings where the underlying 
distribution of COD differs from that of the validation study population. Let us examine 
this proposition in a VA data collected through an ongoing demographic surveillance 
system in Tanzania. 
Since 1992 the Adult Morbidity and Mortality Project (AMM P) has been collecting 
data on causes of death using VA in Morogoro Rural District in Tanzania. 100 In the 
AMMP system, VA interviews are conducted for all incident deaths in a geographically 
defined population of approximately 100,000. VA interviews are normally conducted 
within a month after death by clinical officers using a questionnaire similar to the one 
used in our multi-centre validation study, and the cause of death were determined by a 
panel of physicians on the project team. Using the above-mentioned adjustment 
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model, O let us apply the sensitivity and specificity values for six categories of causes of 
death from the validation study to VA data collected by the AMMP demographic 
surveillance system in Morogoro Rural District, Tanzania. 
When we applied the sensitivity and specificity obtained from Ifakara, the difference 
between the adjusted and crude CSMFs ranged from -83% to +19% (Table 24). When 
the sensitivity and specificity obtained from Bawku were applied, the adjustment model 
returned spurious values for some CSMFs; adjusted AFI mortality was -16.9% and 
adjusted direct maternal causes was -1.7%. It is not clear whether the adjusted CSMFs 
are more accurate than the crude estimates. It is worth noting that Ifakara borders the 
area where the AMMP data were obtained (Morogoro Rural). Yet the adjusted CSMFs 
varied markedly even when we used the sensitivity and specificity values from Ifakara 
to perform the adjustment. 
This shows that sensitivity and specificity of VA depend on the distribution of causes of 
death in the validation study population and that if the causes of death in the general 
population differ from the validation study population then the application of sensitivity 
and specificity to adjust for misclassification error can produce spurious results. All 
validation studies reported to date are hospital based since, community based validation 
studies are almost impossible in areas where only a selective proportion of population 
contacts health facilities for serious illness, and which, in turn, are the same areas where 
VAs are needed. 
Furthermore, the model proposed by Kalter99 assumes that the VA estimate of CSMF 
plus specificity will be more than 100 if sensitivity plus specificity is more than 100; 
conversely it will be less than 100 if the latter is less than 100. This assumption may not 
be true always. For example, the sensitivity and specificity of VA for AFI is 74% and 
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75% respectively in Bawku where the CSMF of AFI among the hospital population was 
40%. Let us assume that a community mortality survey was carried out in Ghana with 
this VA tool and the VA estimate of the CSMF of AFI was 20%. If we adjust this 
estimate using the above sensitivity and specificity, the true CSMF will be -10% 
according to this model. Conversely VA estimates of the CSMF of AFI should always 
be >25% if this VA tool is applied to the data from Ghana. 
The sensitivity and the specificity of VA depend on the distribution of cause of death. 
Thus the use of values of sensitivity and specificity of VA obtained from hospital based 
validation studies in the proposed model for adjusting the effect of misclassification 
error will not be appropriate in settings where the distribution of COD differs markedly 
from the validation study population. We argue that validation studies are useful to 
understand the pattern of misclassification of causes of death and to identify causes of 
death that are likely to have systematic or unbalanced misclassification. However, 
sensitivity and specificity of VA obtained from validation studies are too variable to be 
useful to adjust the effect of misclassification error. 
CSMFs can differ dramatically across a region, between geographic regions within a 
single country, and between hospital user and non-user populations within a single 
area. 92 Thus, not only is there reason to question the validity of applying adjustment 
parameters derived in one location to VA data from another, the application of the 
estimates of sensitivity and specificity obtained from hospital based validation studies 
must also be used cautiously as a de facto `gold standard' for adjusting the 
misclassification error in CSMFs derived from VA. 
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6. Conclusions 
Sensitivity and kappa of VA for all common causes of adult death were low and this 
suggests that the accuracy of VA at the individual level is low. Since VA are used for 
assessing CSMFs or cause specific rates (CSMRs) in a given population, the agreement 
between the true and VA estimates of these measures are more appropriate for deeming 
the usefulness of VA than sensitivity, specificity and kappa. The agreement between 
true and VA estimates of CSMFs and CSMRs depends on a complex relationship 
between sensitivity, specificity and relative frequency of causes of death. This 
relationship and the resulting agreement between true and VA estimates of cause 
specific mortality fractions for any given cause of death depends on the level and pattern 
of misclassification of causes of death. False positive and false negative 
misclassification occurred for all common causes of adult death including injury and 
maternal causes of death. However the misclassification of causes of death was bi- 
directional among causes with similar symptoms and the number of false positive and 
false negative diagnoses for most common causes of adult death tend to be similar. Thus 
the agreement between the true and VA estimates of CSMFs of groups and common 
individual cause of adult death was robust even though the sensitivity and kappa were 
low. 
The age, sex, relationship and language of the respondents did not have a significant 
effect on the sensitivity and specificity of VA. However, the agreement between the true 
and VA estimates of cause specific mortality fractions was better if the respondents had 
looked after the deceased during the final illness and if they spoke the language used for 
the VA questionnaire. This highlights the need for identifying appropriate respondents 
and for conducting VA interviews in the language spoken by the respondents. The 
length of recall period of VA did not affect the validity of VA significantly. It appears 
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that a recall period of three years would be appropriate for VA interviews. 
The sensitivity and specificity of VA depends on the distribution of causes of death in 
the population and thus are site specific. The estimates of sensitivity and specificity of 
VA obtained from hospital based validation studies must be used cautiously as a de 
facto gold standard for adjusting the misclassification error in CSMF derived from VA. 
Use sensitivity and specificity estimates derived from a location specific validation 
study to adjust misclassification in VA data from populations with substantially 
different patterns of causes specific mortality will lead to erroneous results. 
We conclude that VA is likely to be useful for assessing CSMFs common causes of 
adult death in a population for the purposes of ranking the causes of death in a given 
time. However its use for comparison of CSMFs or CSMRs between populations or 
trends over time is limited with the exception of deaths due to direct maternal causes 
and injuries. 
0; R 
Table 1. Study area, period, purpose and sample size of studies using VA 
No Study country Study Age Main objectives of study/purpose of VAs No. of 
period group deaths 
01 India12 88-91 <5 yrs to evaluate the impact of a community-based 337 
intervention for control of pneumonia 
02 Nepal13 86-89 <5 yrs 2101 
03 Tanzania14 83-85 <5 yrs 1198 
04 Kenya'5 85-88 <5 yrs 239 
05 Papua New 81-85 6-59 to estimate the efficacy of pneumococcal 173 
Guinea16 months vaccine against acute lower-respiratory-tract 
infections 
06 The Gambia'? 88-90 <5 yrs to evaluate the impact of insecticide-treated 353 
bed nets on malaria mortality 
07 The Gambia'8 82-83 3-59 to evaluate the impact of chemoprophylaxis or 241 
months community-based treatment for control of 
malaria 
08 Kenya19 81-83 <5 yrs to evaluate the impact of a community- based 592 
malaria control programme 
09 Ethiopia2° 96-98 <5yrs to evaluate the impact of home management of 190 
malaria 
10 Ghana21 89-91 6-90 to evaluate the impact of vitamin A 892 
months supplementation on all-cause child mortality 
and cause-specific mortality 
11 Sudan 22 88-90 9-72 240 
months 
12 Nepal23 89-90 6-60 358 
months 
13 Nepa124 87-89 <5 yrs 305 
14 India25 NR* <5 yrs 117 
15 Benin26 86-87 4-35 to evaluate the impact of a primary health care 284 
months project on all-cause child mortality and cause- 
specific mortality 
16 Sierra Leone27 1990 0-7 yrs To assess the burden of malaria mortality 37 
17 Tanzania28 92-93 <5 yrs  83 
18 Tanzania29 92-94 <5 yrs 118 
19 Ethiopia3° 87-88 <5 yrs to establish the relative public health 492 
importance of causes of death 
20 Bangladesh31 82-85 1349 
69 
21 Bangladesh32 75-77 12893 
22 Bangladesh33 93-94   
828 
23 India34 89-94 286 
24 India35 95-96 1171 
25 Pakistan36 88-91 <5 yrs 52 
26 Guinea 
Bissau37 
79-80 <6 yrs  
144 
27 The Gambia38 82-83 <7 yrs 184 
28 Tanzania39 86-87 <5 yrs to assess the determinants of common causes 
of childhood deaths 
610 
29 Ethiopia4° 88-89 306 
30 Zaire41 89-92 246 
31 Vietnam42 1992   
81 
32 Bangladesh43 91-92 <2 yrs 30 
33 Malawi44 87-90 <1 yr  
388 
34 Indonesia45 97-98 <2yrs 282 
35 Egypy46 92-96 <5 yrs 198 
36 Kenya47 89-91 <5 yrs to estimate the validity of VAs to assess causes 
of childhood deaths 
303 
37 Philippines48 87 <2 yrs 164 
38 Haiti49 89-90 <5 yrs 315 
39 Malawi5° 1994 <12 yrs  36 
40 Nicaragua" 95-97 <5yrs 66 445 
41 Liberia52 87-88 all ages to assess the safety of a community-based 
treatment trial for onchocerciasis control 
25 
42 Papua New 
Guinea53 
91-94 99 To assess the burden of malaria mortality 162 
43 Papua New 
Guinea54 
82-85 to assess the relative public health importance 
of causes of death 
407 
44 Papua New 
Guinea55 
77-83 It to 1789 
45 Senegal56 83-85 to to 808 
46 Bangladesh57 82-83 it it 472 
47 Nigeria58 77-78 228 
48 Yemen59 NR 125 
ýn 
49 Tanzania6° 92-95 4929 
50 Jordan61 95-96 965 
51 
52 
South Africa62 
Lebenon63 
92-95 
93-94 
 
50+ yrs 
932 
416 
53 Jordans' 95-96 All ages 946 
54 Bangla- 
Desh65"67 
76-85 15-44 yrs 
old 
women 
to measure maternal mortality and to establish 
relative importance of causes of maternal 
deaths 
542 
55 Kenya68 87 35 
56 India69 84-85 134 
57 Bangladesh70 82-83 to 58 
58 Indonesia71 80-82 558 
59 Egypt71 81-83 385 
Z 
60 Egypt72 85-86 841 
61 Bangladesh73 67-68 41 
62 The Gambia74 82-83 15 
63 Tanzania75 1993 76 
64 Pakistan 76"77 89-92 218 
65 Cape Verde78 92-93 97 
66 The Gambia79 98-99 18 
67 Tanzania 80 91-92 15-54 yrs To describe symptoms and signs associated 
with deaths due to HIV 
178 
68 Tanzania8' 1995 15+ yrs  
51 
69 Uganda82 90-93 13+ yrs To assess the validity of VA for ascertaining 
HIV related deaths 
155 
* NR: not reported 
Table 2. Methods used in 69 published studies using VA tools 
No Approach to 
mortality 
Format of 
questionnaire 
Interviewer Recall 
period 
Derivation of 
diagnosis 
classification Open Structured Type Education Assessors algorithm 
01 Restricted NR* Yes Lay 12 yrs 1-2 weeks 2 MDs yes 
02 NR NR NR Lay NR <1 month 2MDs yes 
03 NR NR NR Medical MA 1-2 weeks Interviewer no 
04 NR NR Yes Medical CO 1-6 weeks Interviewer no 
05 Restricted NR Yes Medical nurse NR NR yes 
06 NR NR NR Lay NR NR 3 MDs no 
07 NR NR NR Medical MD NR Interviewer yes 
08 NR NR NR Lay NR NR NR NR 
09 restricted yes yes medical MD NR 2 MDs no 
10 Restricted Yes Yes Lay NR 0-9 months 3 MDs no 
11 NR NR NR Lay NR NR NR NR 
12 NR NR NR Lay NR 0-2 months 2 MDs no 
13 NR NR NR Lay NR NR 2 MDs yes 
14 NR NR NR Lay CHW NR NR NR 
15 NR NR NR Medical MD NR Interviewer no 
16 Open NR NR Medical MD 1 month 3 MDs no 
17 Restricted Yes Yes NR NR 1 month NR yes 
18 Open Yes Yes Medical MA NR 2 MDs no 
19 NR No Yes Lay 12 years NR NR NR 
20 NR Yes No Lay CHW NR 1 MD no 
21 NR Yes No Lay 12 years NR Interviewer no 
22 Restricted Yes Yes Lay NR NR No yes 
23 Open NR NR Medical MD NR 1 MD no 
24 NR NR NR NR NR NR NR NR 
25 Restricted Yes Yes Medical MD 0-37 
months 
NR yes 
26 NR NR Yes Lay NR NR NR NR 
27 
F 
Restricted NR NR Medical MD 0-3 months 3 MDs no 
28 11 NR NR NR Medical MA NR Interviewer no 
No Approach to 
mortality 
Format of 
questionnaire 
Interviewer Recall period Derivation of 
diagnosis 
classification Open Structured Type Education Assessors algorithm 
29 NR NR Yes Lay NR NR NR NR 
30 NR NR NR Lay NR NR 1 MD yes 
31 Restricted No Yes Lay NR 1-10 years Interviewer yes 
32 NR NR Yes Lay Degree 6-12 weeks 2 MDs no 
33 NR NR Yes NR NR NR 1 MD no 
34 restricted yes yes medical midwife NR Interviewer yes 
35 NR NR NR NR NR NR NR NR 
36 NR Yes Yes Lay NR 1-16 weeks 3 MDs no 
37 Restricted Yes Yes Lay Degree 1-52 weeks 1MD & 
computer 
yes 
38 Restricted Yes Yes Medical Nurse 1-42 months 3 MDs yes 
39 Restricted Yes Yes Lay NR 5-12 months 3 MDs no 
40 
41 Restricted No Yes Medical MD 1-2 weeks 3 MDs yes 
42 Restricted Yes Yes Lay NR 1-12 months 1 MD yes 
43 NR Yes Yes Medical MD 2-52 weeks Interviewer yes 
44 NR NR NR Lay NR NR NR NR 
45 Restricted Yes Yes Lay 9 yrs 1-8 weeks 1 MD yes 
46 Restricted Yes Yes Lay NR 1-44 weeks 1 MD yes 
47 Restricted No Yes Lay 7 yrs NR Interviewer yes 
48 open NR Yes Lay & 
medical 
Anthropol 
ogist/MD 
0-50 yrs Interviewer no 
49 Restricted Yes Yes Medical MR 0-3 months 3 MD no 
50 Restricted Yes Yes Medical Nurse 2 weeks 2 MDs yes 
51 NR Yes Yes Lay NR NR 3 MDs no 
52 Open Yes Yes NR NR NR I MD no 
53 restricted Yes Yes Medical Nurse NR 2MD yes 
54 open Yes Yes Lay CHW NR 1 MD no 
55 NR NR Yes Lay NR NR NR NR 
Table 2 cont... 
73 
No Approach to 
mortality 
Format of 
questionnaire 
Interviewer Recall 
period 
Derivation of 
diagnosis 
classification Open Structured Type Education Assessors Algorith 
m 
56 NR NR NR Lay NR NR NR NR 
57 NR No Yes Lay 12 yrs NR 1 MD no 
58 NR No Yes Lay NR NR I MD no 
59 NR No Yes Lay NR NR 1 MD no 
60 NR Yes No medical MD 2-6 weeks Interviewer no 
61 NR NR NR medical MD NR Interviewer no 
62 Open NR Yes Lay NR 2-4 weeks 5 MDs no 
63 NR NR Yes medical MD NR NR NR 
64 NR NR Yes medical MD 1-3 
months 
2 MDs no 
65 Open Yes Yes Lay NR 3 months 2 MDs no 
66 Restricted Yes Yes Lay NR NR 2MD no 
67 Restricted Yes Yes Lay 12 years 3-8 
months 
No yes 
68 NR NR NR NR NR NR NR NR 
69 Restricted Yes Yes medical Nurse 2 months 3 MDs no 
NR: not reported 
MD: Medical Doctor 
MA: Medical Assistant 
CHW: Community Health Worker 
# No: Serial numbers in Tables 1 and 2 refer to the same study; references to each study are given in Table 1. 
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Table 3: Working Classification of causes of adult death 
Code No. Causes of death 
1. Communicable Diseases 
1.0. Unspecified communicable diseases 
1.1. Acute Febrile Illness 
1.1.0. Unspecified acute febrile illness 
1.1.1. Malaria 
1.1.2. Meningitis 
1.1.3. Hepatitis 
1.1.4. Pneumonia 
1.1.9. All other specified acute febrile illnesses 
1.2. Tuberculosis/AIDS 
1.2.0 Unspecified TB/AIDS 
1.2.1. Pulmonary Tuberculosis 
1.2.2. AIDS 
1.2.3. AIDS + Pulmonary Tuberculosis 
1.2.9. All other forms of Tuberculosis 
1.3. Diarrhoeal Diseases 
1.4. Tetanus 
1.5. Rabies 
1.9. All other specified communicable diseases 
2. Direct Maternal Causes 
2.0. Unspecified maternal causes 
2.1. Abortion 
2.2. Eclampsia 
2.3. Ante/postpartum Haemorrhage 
2.4. Obstructed labour 
2.5. Puerperal Sepsis 
2.9. All other specified direct maternal causes 
3. Non-communicable diseases 
3.0. Unspecified non-communicable causes 
3.1. Cardiovascular Disorders 
3.1.0. unspecified cardiovascular disorders 
3.1.1. Congestive cardiac Failure 
3.1.2 Ischaemic Heart Disease 
3.1.3. Cerebrovascular Disease 
3.1.9. All other specified cardiovascular disorders 
3.2. Chronic Obstructive Pulmonary Disease 
3.3. Liver cirrhosis 
3.4. Acute abdominal conditions 
3.5. Diabetes 
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3.6 Neoplasms 
3.6.0. Unspecified neoplasms 
3.6.1. Carcinoma breast 
3.6.2. Carcinoma cervix/uterus 
3.6.3. Hepatoma 
3.6.4. Carcinoma of gastrointestinal tract 
3.6.9. All other specified neoplasms 
3.7. Renal disorders 
3.8. Central Nervous System disorders 
3.9. All other specified noncommunicable diseases 
4. Symptoms, signs, syndromes not elsewhere classified 
4.1. Anaemia 
4.9. All other specified symptoms, signs and syndromes 
5. External Causes 
5.0. Unspecified external causes 
5.1. Unintentional Injuries 
5.1.0. Unspecified unintentional injuries 
5.1.1. Transport 
5.1.2. Falls 
5.1.3. Fires 
5.1.4. Poisoning 
5.1.5. Drowning 
5.1.9. All other specified unintentional injuries 
5.2. Intentional Injuries 
5.2.0. Unspecified intentional injuries 
5.2.1. Suicide 
5.2.2 Homicide 
5.2.3 War 
5.2.9. All other specified intentional injuries 
6. Undetermined 
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Table 4: Characteristics of respondents and recall period 
Characteristics Ifakara Jimma Bawku 
n=315 % n=249 (%) n=232 
Sex 
Male 153 (49) 122 (49) 161 (69)**`/ßßß 
Female 162 (51) 127 (51) 71 (31) 
Age group 
15-59 years 256 (81) 216 (87) 193 (83) 
60+ years 59 (19) 33 (13) 39 (17) 
Education 
None 88 (28) 51 (20)$ 187 """ißßß (81) 
Primary (1-6 years) 119 (38) 107 (43) 10 ( 4) 
Secondary (7+ years) 108 (34) 91 (37) 35 (15) 
Relationship to deceased 
Spouse 56 (18) 75 (30)$$$ 46 (20) 
Close relative 196 (62) 100 (40) 127 (55) 
Distant relative/friend 63 (20) 74 (30) 59 (25) 
Appropriateness 
Appropriate 259 (82) 215 (86) 221 (95) "*1"ßß 
Probably Apropriate 56 (18) 34 (14) 11 ( 5) 
Primary language 
VA questionnaire language 286a (91) 214b (86) 132° (57) ýý/ßßß 
Others 29 (9) 35(14) 100 (43) 
Recall period 
1-6 months 105 (33) 84 (34) 68 (29) 
7-12 months 103 (33) 73 (29) 57 (25) 
13-21 months 107 (34) 92 (37) 107 (46) 
"Kiswahili bAmharic or Orominga ° Kusaal 
*** P<. 00 I comparison between Ifakara and Bawku 
** P<. 01 comparison between Ifakara and Bawku 
P<. 001 comparison between Jimma and Bawku 
P<. 01 comparison between Jimma and Bawku 
$$$ P <. 001 comparison between Ifakara and Jimma 
P <. 05 comparison between Ifakara and Jimma 
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Table 5 Response rate & reasons for non response 
Ifakara Jimma Bawku Total 
Total adult deaths recorded during study period 500 519 323 1342 
Deaths excluded because address is >60km 86 192 49 327 
Deaths eligible for inclusion in the study 414 327 274 1015 
Deaths for which a VA was completed 315 249 232 796 
(Response rate) (76%) (76%) (85%) (78%) 
Reasons for non response 
Address was inadequate 95 (23) 74 (23) 30 (11) 199 (20) 
Appropriate respondent had travelled 2 (0.5) 4 (1) 10 (4) 16 (1.5) 
Refused 2 ((0.5) 0 2 (1) 4 (0.5) 
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Table 6 Comparison of causes of death between eligible and actual study noulation 
Causes of death Ifakara Jimma Bawku 
Eligible (%) Actual (%) Eligible (%) Actual (%) Eligible (%) Actual (%) 
Communicable 
diseases 
Acute febrile illness 
Malaria 43 (10.4) 36 (11.4) 43 (13.1) 39 (15.7) 11 (4.0) 10 (4.3)) 
Meningitis 32 (7.7) 28 (8.9) 9 (2.8) 5 (2.0) 39 (14.2) 33 (14.2) 
Hepatitis 6 (1.4) 4 (1.3) 5 (1.5) 4 (1.6) 25 (9.1) 24 (10.3) 
Pneumonia 11 (2.7) 8 (2.5) 7 (2.1) 5 (2.0) 11 (4.0) 10 (4.3) 
Other AFI 10 (2.4) 6 (1.9) 10 (3.1) 8 (3.2) 18 (6.6) 16 (6.9) 
TB/AIDS 
TB 53 (11. ) 30 (9.5) 26 (8.0) 19 (7.6) 9 (3.3) 7 
(3.0) 
AIDS 8 ( 53 35 (11.4) 16 (4.9) 11 (4.4) 13 (4.7) 
9 (3.9) 
TB+AIDS 10 (2.4) . 4) 10 
10 (3.2) 33 (10.1) 25 (10.0) 3 (1.1) 2 (0.9) 
Diarrhoea! 33 (10.5) 11 (3.4) 6 (2.4) 16 (5.8) 12 (5.2) 
diseases 45 (10.9) 
2 (0.6) 6 (1.8) 5 (2.0) 6 (2.2) 6 (2.6) 
Tetanus 2 (0.5) 
7 (1.7) 6 (1.9) 0 0- 1 (0.4) 1 (0.4) 
Rabies 
Direct maternal 12 (2.9) 10 (3.2) 31 (9.5) 22 (8.8) 22 (8.0) 18 (7.8) 
causes 
Noncommunicable 
diseases 
CVS disorders 35 (8.5) 25 (7.9) 19 (5.8) 16 (6.4) 30 (10.9) 24 (10.3) 
Cirrhosis of liver 11 (2.7) 9 (2.9) 16 (4.9) 14 (5.6) 2 (0.7) 2 (0.9) 
Acute abdominal 15 (3.6) 12 (3.8) 27 (10.8) 20 (7.3) 16 (6.9) 
conditions 36 (11.0) 
Neoplasms 15 (3.6) 13 (4.1) 6 (1.8) 5 (2.0) 16 (5.8) 16 (6.9) 
Renal disorders 11 (2.7) 8 (2.5) 10 (3.1) 8 (3.2) 6 (2.2) 5 (2.2) 
Other specified 12 (2.9) 9 (2.9) 8 (3.2) 1 (0.4) 0- 
diseases 11 (3.4) 
Nonspecific signs 
& syndromes 
Anaemia 15 (3.6) 12 (3.8) 2 (0.6) 2 (0.8) 10 (3.6) 10 (4.3) 
Injuries 9 (2.2) 9 (2.9) 24 (7.3) 17 (6.8) 11(4.0) 7 (3.0) 
Unknown 14 (3.4) 10 - 5 (1.5) 3 (1.2) 4 (1.5) 4 (1.7) 
Total 414 315 327 249 (100) 274 232 
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Table 7 Distribution of causes of death (gold standard) in the study hospitals 
Causes of death Ifakara Jimma 
I L Bawku 
No. (CSMF') % confirmed No (CSMF) % confirmed No. (CSMF) % confirmed 
Communicable 
diseases 
Acute febrile illness 
Malaria 36 (11.4) 50 39 (15.7) 51 10 (4.3)) 50 
Meningitis 28 (8.9) 93 5 (2.0) 80 33 (14.2) 94 
Hepatitis 4 (1.3) 25 4 (1.6) 75 24 (10.3) 92 
Pneumonia 8 (2.5) 50 5 (2.0) 100 10 (4.3) 10 
Other AFI 6 (1.9) 67 8 (3.2) 88 16 (6.9) 86 
TB/AIDS 
TB 
AIDS 30 (9.5) 93 19 (7.6) 83 7 (3.0) 86 
TB+AIDS 35 (11.4) 87 11 (4.4) 87 9 (3.9) 100 
10 (3.2) 100 25 (10.0) 80 2 (0.9) 100 
Diarrhoeal 
diseases 33 (10.5) 85 6 (2.4) 100 12 (5.2) 58 
Tetanus 
2 (0.6) 100 5 (2.0) 100 6 (2.6) 83 
Rabies 
6 (1.9) 83 0- - 1 (0.4) 100 
Direct maternal 10 (3.2) 90 22 (8.8) 91 18 (7.8) 89 
causes 
Noncommunicable 
diseases 
CVS disorders 25 (7.9) 68 16 (6.4) 86 24 (10.3) 79 
Cirrhosis of liver 9 (2.9) 78 14 (5.6) 64 2 (0.9) 50 
Acute abdominal 12 (3.8) 92 27 (10.8) 96 16 (6.9) 75 
conditions 
Neoplasms 13 (4.1) 92 5 (2.0) 100 16 (6.9) 81 
Renal disorders 8 (2.5) 75 8 (3.2) 75 5 (2.2) 80 
Other specified 9 (2.9) 67 8 (3.2) 88 0- - 
diseases 
Nonspecific signs 
& syndromes 
Anaemia 12 (3.8) 92 2 (0.8) 100 10 (4.3) 100 
Injuries 9 (2.9) 100 17 (6.8) 100 7 (3.0) 100 
Unknown 10 - - 3 (1.2) - 4 (1.7) - 
Total 315 (100) 78 249 (100) 76 232 (100) 79 
CSMF: cause specific mortality Fraction 
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Table 8: Comparison effect of respondent characteristics on validity of VA by physician review 
Charactristics of Ifakara Jimma Ethiopia 
respondents n WSen WSpe WKap n WSen WSpe WKap n WSen WSpe WKap 
Male 153 59 95 53 122 65 87 67 161 61 89 56 
Female 162 62 93 57 127 65 91 62 71 68 89 57 
Age 
15-59 years 256 62 93 54 216 66 89 69 193 62 88 54 
60+ years 59 54 95 53 33 58 90 53 39 69 92 64 
Formal education 
None 88 58 92 61 51 55 90 53 187 67 90 60 
1-6 years 119 63 93 50 107 64 86 66 10 60 96 56 
7+years 108 60 95 52 91 71* 90 72 35 49" 85 32 
Relationship 
Spouse 56 70 97 80 75 56 85 60 46 63 91 63 
Close relative 196 58 93 47 100 61 83 61 127 63 88 51 
Distant 63 62 94 58 74 69 93 76 59 68 90 60 
relative/friend 
Very approptiate 259 63 94 58 215 64 88 66 221 65 89 59 
Probably appropriate 56 52 94 39 34 71 96 68 11 45 74 01 
Primary language 
Same as VAQ 286 60 94 56 214 65 89 67 132 68 90 61 
others 29 62 95 44 35 66 91 67 100 59 89 48 
Recall period 
1-6 moths 105 62 94 48 84 60 86 63 68 57 84 55 
7-12 months 103 60 93 57 73 70 91 69 57 63 90 50 
13-21 months 107 60 93 57 92 66 90 67 107 66 90 58 
Overall 315 61 94 55 249 65 89 70 232 64 89 56 
*P<. 05 comparison between different classes of characteristics with in a site 
Wsen= Weighted sensitivity 
Wspe= Weighted specificity 
Wkap= Weighed Kappa 
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Table 9: Sensitivity, specificity and Kappa of VAs by physicians for groups of causes of death 
Ifakara Jimma Bawku 
causes of death Rd Vd Sen Spe kap Rd Vd Sen Spe Kap Rd Vd Sen Spe Kap 
Communicable 198 186 82 79 60 127 134 86 80 67' 130 128 78 74 67 
diseases 
Direct maternal 10 13 90 99 83 22 21 77 98 76 18 24 83 96 62 
causes 
Noncommunic- 76 91 75 86 57 78 73 74 91 67 63 65 62 85 47 
able diseases 
Nonspecific 
syndromes 
12 7 42 99 51 2 0 0 100 - 10 5 30 99 35 
Injuries 9 11 89 99 79 17 17 100 100 100 7 8 100 1000 93 
Undetermined 10 7 0 98 0 3 4 0 98 0 4 2 0 99 0 
Rd: frequency of reference diagnoses Sen: sensitivity Spe: specificity Kap: Kappa 
Vd: frequency of VA diagnoses * exact values 99.5 to 99.9% 
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Table 10: Sensitivity, specificity and Kappa of VAs by physicians for selected communicable and non 
communicable causes of death 
Ifakara Jimma Bawku 
causes of death Rd Vd Sen l Spe kap Rd Vd Sen Spe Kap Rd Vd 
1 
Sen Spe Kap 
(%) e/0) 00 (0/0) (0/0) (%) (0/0) N N 
Communicable 198 186 82 79 60 127 134 86 80 67 130 128 
78 74 67 
diseases 
Acute Febrile 82 64 60 94 57 61 54 67 93 63 93 104 
74 75 48 
Illness 
Malaria 36 28 36 95 34 39 22 39 97 42 10 30 0 87 0 
Meningitis 28 23 64 98 68 5 7 40 98 32 33 30 58 95 
54 
Hepatitis 4 1 25 100 40 4 0 0 24 13 42 99 50 
Pneumonia 8 5 25 99 29 5 4 80 100 89 10 10 30 97 
27 
Other AFI 6 7 33 98 29 8 21 63 93 31 16 21 13 91 03 
TB/AIDS 75 74 76 93 70 55 66 82 89 62 18 11 56 100 67 
TB 30 20 59 98 59 19 36 68 90 41 7 4 43 100$ 53 
AIDS 35 41 51 92 40 11 18 64 95 45 9 7 56 99 61 
TB+AIDS 10 6 10 98 10 25 8 20 99 27 2 0 0 - 0 
Diarrhoeal 33 40 73 94 60 6 9 67 98 52 12 9 25 97 25 
diseases 
Tetanus 2 2 100 100 100 5 5 100 100 100 6 3 50 100 66 
Rabies 6 6 83 100* 83 0 0 - - 1 1 100 100 
100 
Noncommunic- 76 91 75 86 57 78 73 74 91 67 63 65 62 85 47 
able diseases 
CVS disorders 25 25 40 95 35 16 13 50 98 55 24 19 54 97 62 
Cirrhosis of 9 13 33 97 25 14 14 50 97 47 2 2 0 99 
0 
liver 
Acute 12 21 92 97 61 27 28 67 96 61 16 16 56 97 51 
abdominal 
conditions 
Neoplasms 13 14 46 97 42 5 9 80 98 56 16 13 44 97 45 
Renal 8 8 25 98 23 8 3 38 100 54 5 11 60 97 35 
disorders 
Other specified 9 10 44 98 43 8 6 50 99 60 0 4 - - - 
diseases 
Rd: frequency of reference diagnoses Sen: sensitivity Spe: specificity Kap: Kappa 
Vd: frequency of VA diagnoses * exact values 99.5 to 99.9% 
Table 11: Sensitivity, specificity and Kappa of VAs by algorithm for groups of causes of oeatn 
Ifakara Jimma Bawku 
causes of death Rd Vd Sen Spe kap Rd Vd Sen Spe Kap Rd Vd Sen Spe Kap 
Communicable 
diseases 
198 194 76 64 41 127 137 80 70 50 130 123 71 70 40 
Direct maternal 10 6 50 100v 62 22 18 64 98 67 18 23 78 96 65 
causes 
Noncommunic- 76 64 54 90 47 78 55 54 92 50 63 48 46 89 38 
able diseases 
Nonspecific 
syndromes 
12 3 25 100 39 2 2 0 99 0 10 4 0 98 3 
Injuries 9 14 89 98 68 17 19 100 99 94 7 10 86 98 70 
Undetermined 10 34 20 89 4 3 18 0 3 0 4 24 25 90 4 
Rd: frequency of reference diagnoses Sen: sensitivity Spe: specificity Kap: Kappa 
Vd: frequency of VA diagnoses * exact values 99.5 to 99.9% 
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Sensitivity specificity and Kappa of VAS uy aigornnm for seiecteu cuan, uumcauw auu nun 
communicable causes of death 
Ifakara Jimma Bawku 
causes of death Rd Vd Sen Spe kap Rd Vd Sen Spe Kap Rd Vd Sen Spe 
Kap 
Communicable 198 194 76 64 41 127 137 80 70 50 130 123 71 70 40 
diseases 
Acute Febrile 82 74 49 86 37 61 51 51 91 46 93 85 58 74 35 
Illness 
Malaria 36 21 17 95 14 39 22 20 93 17 10 41 20 82 1 
Meningitis 28 27 46 95 42 5 16 20 94 7 33 25 33 93 29 
Hepatitis 4 0 0 100 0 4 7 0 97 0 24 17 21 94 17 
Pneumonia 8 7 12 98 11 5 2 20 100' 28 10 6 0 97 0 
Other AFI 6 19 17 94 94 8 4 0 98 0 16 4 6 98 7 
TB/AIDS 75 85 70 86 54 55 74 75 82 50 18 18 47 96 45 
TB 30 17 32 97 32 19 34 53 90 31 7 8 43 98 38 
AIDS 35 35 34 92 26 11 20 27 93 14 9 7 22 98 22 
TB+AIDS 10 33 50 90 19 25 20 32 95 29 2 0 0 100 0 
Diarrhoea) 33 27 48 96 48 6 12 67 97 43 12 7 17 98 18 
diseases 
Tetanus 2 2 50 100' 50 5 0 0 100 0 6 8 33 97 26 
Rabies 6 6 67 100' 66 0 0 - - - 1 0 0 100 0 
Noncommunic- 76 64 54 90 47 78 55 54 92 50 63 48 46 89 38 
able diseases 
CVS disorders 25 22 20 94 15 16 13 40 97 40 24 13 23 96 23 
Cirrhosis of 9 5 22 98 27 14 14 36 96 32 2 4 0 98 0 
liver 
Acute 12 24 75 95 47 27 14 30 97 34 16 19 50 95 41 
abdominal 
conditions 
Neoplasms 13 3 7 99 11 5 6 20 98 16 16 2 0 99 1 
Renal 8 8 38 97 36 8 5 13 98 13 5 9 40 97 27 
disorders 
Other specified 9 2 11 100' 17 8 3 13 99 17 0 - - - - 
diseases 
Rd: frequency of reference diagnoses Sen: sensitivity Spe: specificity Kap: Kappa 
Vd: frequency of VA diagnoses * exact values 99.5 to 99.9% 
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Table 14: Comparison of validity of VA byyhysician review versus algorithm: 
specific communicable and non-communicable causes of death 
VAs by physicians VAs by algorithms 
causes of 
death Rd 
Vd Sen (CI) Spe (Cl) Kappa Vd Sen (Cl) Spe (CI) Kappa 
Communicabl 
e diseases 
Acute Febrile 236 222 67(61-73) 89(86-91) 57 218 55(48-61) 84 (81-87) 39 
Illness 
Malaria 85 80 33(23-43) 93(91-95) 26 84 19(12-29) 90 (88-92) 09 
Meningitis 66 60 59(46-71) 97(96-98) 59 68 38(26-51) 94 (92-96) 32 
Hepatitis 32 14 34(19-53) 100'(99-100) 47 24 16(5-33) 98 (96-99) 15 
Pneumonia 23 19 39(18-61) 99(98-99) 41 15 9(1-28) 98 (97-99) 08 
OtherAFi 30 49 30(15-49) 95(93-96) 19 27 7(1-22) 97 (95-98) 04 
TB/AIDS 148 151 76(68-82) 94(92-96) 68 174 68(60-76) 89 (86-91) 53 
TB 56 60 59(45-72) 96(94-97) 50 59 38(25-52) 95 (93-96) 34 
AIDS 55 66 58(44-71) 94(92-96) 45 62 31(19-45) 94 (92-96) 23 
TB+AIDS 37 14 8(2-21) 99(98-100) 22 53 35(20-53) 95 (93-96) 13 
Diarrhoeal 51 58 61(46-74) 96(95-98) 53 46 43(29-58) 97 (95-98) 42 
diseases 
Tetanus 13 10 77(46-95) 100 87 9 23(5-54) 99 (98-100) 25 
Rabies 7 7 86(42-99) 100' 86 9 100 100' 61 
NonCommuni- 
cable diseases 
CVS disorders 65 57 48(35-60) 96(95-98) 49 48 25(15-37) 96 (94-97) 24 
Cirrhosis of 
liver 25 29 40(21-61) 98(96-99) 37 23 28(12-49) 98 (97-99) 27 
Acute 
abdominal 55 65 69(55-81) 97(95-98) 59 57 46(32-59) 96 (94-97) 40 
conditions 
Neoplasms 
34 36 50(32-68) 98(96-99) 46 11 6(1-20) 99 (98-100) 07 
Renal 
disorders 21 22 38(19-62) 98(97-99) 35 22 29(11-52) 98 (97-100) 26 
other 
specified 17 20 47(23-72) 99(97-99) 46 6 12(1-36) 100'(99-100) 16 
diseases 
Rd: frequency of reference diagnoses Sen: sensitivity Cl: 95% confidence interval 
Vd: frequency of VA diagnoses Spe: specificity * exact value 99.5 to 99.9% 
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Table 24: 
Comparison of cause specific mortality fractions unadjusted and adjusted for misclassification error 
Causes of death Total Unadjusted 
CSMF* 
CSMF adjusted 
to Ifakara 
CSMF adjusted 
to Jimma 
CSMF adjusted 
to Bawku 
Acute febrile illness 1193 16.7 19.8 (+19) 14.1 (-15) -16.9 
Diarrhoeal diseases 1065 14.9 13.3 (-I1) 19.9 (+33) 54.3 (+260) 
TB/AIDS 1486 20.8 20.1 (-3) 13.9 (-33) 36.7 (+76) 
CVS disorders 378 5.3 0.9 (-83) 6.9 (+30) 4.5 (-15) 
Direct maternal causes 190 2.7 1.9 (-29) 0.9 (-66) -1.7 
Injuries 436 6.1 5.8 (-5) 6.1 (0) 5.7 (-7)) 
All other & undetermined causes 2380 33.4 35.1 (+5) 37.5 (+13) 42.5 (+28) 
* CSMF: cause-specific mortality fractions expressed in % 
) Figures in parenthesis are the difference between adjusted and crude CSMFs expressed as % of crude 
CSMFs; adjusted CSMFs do not add up to 100% due to the differences in CSMFs between Morogro district 
population and the validation study population 
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Figure 1: Determinants of Validity of Verbal Autopsies 
Prevalence and Purpose of Age & Sex of 
symptomatology of study deceased 
different causes of 
death 
MORTALITY CLASSIFICATION I- 
DESIGN OF VA TOOLS 
Interviewer D D Type & number of 
A assessors of VAs * Education T R 
* Age & sex A I * Training 
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C I Stage of deriving 
0 N diagnosis 
L G 
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Respondent C j Procedures to 
derive 
T A diagnoses from VA * Proximity 
I G * Age & sex 
* Education 0 N 
* Socio- N 0 
economic & S Simple versus 
cultural factors E multiple causes of 
s death 
VALIDITY OF 
VERBAL AUTOPSY 
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Figure 2: 
PHYSICIAN REVIEW 
Methods for reaching diagnoses from VA 
VA QUESTIONNAIRE 
PREDEFINED "EXPERT" 
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Figure 3: The process of deriving diagnostic criteria for malaria 
headache, malaise, myalgia, loss of appetite, rigor, fever, vomiting, sweating, 
List all symptoms early onset (within 2-4 days of onset of fever) unconsciousness, convulsions, 
black urine, low urine output 
essential: fever 
supportive: early onset unconsciousness, black urine 
Classify symptoms associate: headache, malaise, myalgia, loss of appetite, rigor, vomiting, 
sweating, convulsions, low urine output 
Draft simple diagnostic criteria (1)fever <21 days + early onset unconsciousness or 
including all essential symptoms (2) fever <21 days + black urine 
and one supportive symptom 
Identify potential (1) meningitis* (neck pain/stiffness of neck)# 
misclassifications and their (1) ARI* (cough with sputum and chest pain)# 
differential symptoms (1) Typhoid (none) 
(2) hepatitis@ (pain in the upper abdomen)' 
Include differential symptoms (1)fever <21 days + early onset unconsciousness + absence of (neck 
to the diagnostic criteria pain/stiffness of neck, cough with sputum and chest pain) 
(2) fever <21 days + black urine + absence of pain in the upper abdomen 
* potential misclassifications for criterion 1 
@ potential misclassification for criterion 2 
# differentiating symptoms for respective misclassifications 
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Figure 4: "opinion based" hierarchical algorithm to reach single (primary) causes of adult death 
assault or suicide yes Intentional 
injuries 
NO 
dog bite + (unconsciousness or difficulty to swallow or stiffness of body) yes Rabies 
1 
NO 
stiffness of body <14 days + (difficulty in breathing <14 days + yes Tetanus 
no sudden onset unconsciousness) or (injury) 
1 
NO 
accidental injuries including animal bites < 90 days yes Unintentional 
injuries 
no 
(aborted < ays + no convulsion) or (pregnant < mont s vaginal 
bleeding + no convulsion + no jaundice) = abortion 
NO 
(pregnant >6 months + convulsion) OR 
( delivered <15 days + convulsion) = eclampsia 
NO 
(pregnant >8 months + heavy bleeding before delivery + 
labour pain < 24 hours) OR (delivered <4 days + heavy bleeding yes direct 
after delivery) = antepartum or postpartum haemorrhage maternal 
4, NO causes 
labour pains >24 hours + (assisted vaginal or abdominal delivery 
<15 days or heavy bleeding before delivery) = obstructed labour 1 NO 
delivered <15 days + high fever <21 days + abdominal pain 
= puerperal sepsis 
'No 
had treatment for diabetes yes diabetes 
NO 
weight loss + cough with sputum >21 days + (rash or diarrhoea >21 days r 
difficulty to swallow or became unconscious within 2 days off mal illness) 
=PTB+AIDS I 
NO 
cough >21 days + (bloody sputum or no diarrhoea >21 days) OR es PTB/AIDS 
had treatment for TB + cough + no diarrhoea >21 days = PTB 1 NO 
weight loss + diarrhoea >21 days OR 
severe weight loss + (fever >21 days or became unconscious 
within 2 days o anal illness) = AIDS 
1 NO 
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weight loss + swellinglulcer in the breast >30 days = carcinoma breast 
1 NO 
weight loss + abnormal vaginal bleeding >30 days = carcinoma cervix/uterus i NO yes neoplasm 
weight loss + abdominal swelling >30 days+ jaundice = hepatoma 
NO 
weight loss + (abdominal swelling >30 days or difficulty to swallow >30 days) _ 
carcinoma of gastrointestinal tract 
NO 
severe abdominal pain41- abdominal distension + vomiting + no diarrhoea 
OR yes acute 
abdominal pain + (vomitus looked blood or black or smelled like faeces) abdominal 
conditions 
I NO 
abdominal distension >14 days + (swelling around ankle or jaundice) }. _s. yes cirrhosis 
T of liver 
cough with sputum >21 days + difficulty in breathing on and off es chronic JIPY Iobstructive 
pulmonary 1 
NO disease 
diarrhoea >2 times per day for <22 days + (vomiting or abdominal pain or yes diarrhoeal 
passing blood in stool) disease 
High or moderate or c9n inuous lever <22 days = acute febrile illness yes acute 
YES febrile illness 
AFI + cough with sputum <22 days + chest pain + difficulty in breathing + 
no jaundice = pncumonia 
NO 
AFI + jaundice r hepatitis 
i NO 
AFI + (neck pain or stiff neck or became unconscious within 2 days) = meningitis 
1 NO 
AFI + became uliconscious within 2 days = malaria 
NO 
AFI = unspecified AFI 
1 
NO 
pale looking +(swelling around ankle + difficulty in breathing) es anaemia 
NO 
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difficulty in breathing + (swelling around ankle or abdominal distension) OR 
had treatment for hypertension + (difficulty in breathing or swelling 
around ankle) = congestive cardiac failure 
1 
NO 
age > 45 + suddenly became unconscious or was unable to talk = 
cerebrovascular accident 
NO 
severe chest pain + sudden death = ischaemic heart disease 
NO 
difficulty to pass urine OR 
passed very little or no urine 
NO 
undetermined 
US 
disorders 
yes renal 
disorders 
symptoms shown in bold scripts are essential, those in italics are supportive and those underlined 
are differential symptoms. Detailed classification of symptoms and further criteria to reach each 
ause of death included in the mortality classifications are available on request 
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Figure 5: An opinion-based algorithm to reach causes of maternal death 
(pregnant) or ( aborted <46 days) or (delivered <46 days) 
yes I 
(accident) or (violence) or 
. (aborted <46 days + no convulsion) or (pregnant <7 months + vaginal bleeding + no convulsion + no jaundice) 
no i 
(pregnant >6 months + convulsion) or (delivered <15 days + convulsion) 
no 
(pregnant >8months + labour pain <24 hrs + heavy bleeding before delivery) 
or (delivered <4 days + heavy bleeding after delivery) 
no 
labour pains >24 hours + (assisted vaginal/abdominal delivery <15 days or 
heavy bleeding before delivery) 
non-maternal causes 
external causes 
abortion 
eclampsia 
ante/post- 
partum haemorrhage 
yes obstructed labour 
no 
delivered <15 days + high fever <21 days + abdominal pain yes puerperal sepsis 
no 
loss of weight +( cough >28 days or diarrhoea >21 days or fever >21 days) yes TB/AIDS 
no 
I ankle edema + (breathlessness >21 days or pale looking) 
no 
jaundice 
no 
high fever <22 days 
no I 
unspecified maternal causes 
anaemia/CCF 
hepatitis 
acute febrile illness 
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Appendix 1: Suggested Criteria for reaching diagnosis from VAs 
1.1. Acute Febrile Illness: fever <21 days (E)1 + absence of {cough with sputum 
>28 days (D; PTB)2 and chronic loss of weight (D; AIDS), severe watery or 
bloody diarrhoea (D; Gastroenteritis/dysentery), stiffness of whole body (D; 
Tetanus), severe abdominal pain & distension (D; Acute abdomen), and 
abortion or delivery with in 45 days & distension of abdomen (D; septic 
abortion/puerperal sepsis)). 
1.1.1. Malaria: fever <21 days (E) + early onset unconsciousness (S)3 or black urine 
(S) + absence of (neck pain/stiff neck (D; meningitis), pain in the right upper 
abdomen (D; hepatitis), and cough with sputum and chest pain (D; ARI)}. 
... head ache (A)4, shivering (A) and jaundice (A) 
1.1.2. Meningitis: fever <14 days + rapid onset unconsciousness + neck pain/stiff 
neck (E) + absence of black urine (D; malaria), cough with sputum and chest 
pain, black urine (D; ARI) and jaundice (D; hepatitis and malaria). 
... head ache, vomiting, convulsions (S) 
1.1.3. Hepatitis: fever <14 days + severe jaundice (E) + absence of cough with 
sputum and chest pain (D; ARI). pain and/or swelling in the right side of 
abdomen (S) 
1.1.4. Pneumonia: fever <14 days + cough with sputum + difficulty in breathing (E) 
+ absence of diarrhoea or constipation (D; typhoid), jaundice (D; hepatitis), 
black urine (D; malaria) and neck pain (D; meningitis). 
... chest pain (S) 
1.2.1. Pulmonary Tuberculosis: cough with sputum >28 days (E) + absence of 
diarrhoea >21 days (D; AIDS), slow onset breathlessness (D; CHF), and 
wheezing(D; COPD). loss of weight, blood in sputum and fever on and off (S) 
1.2.2 AIDS: loss of weight + diarrhoea >21 days or neck swelling, or fever >28 
days (E). age <65, partner died recently, repeated episodes of illnesses(S) 
1.3. Gastroenteritis/Dysentery: severe diarrhoea <21 days or bloody diarrhoea 
and abdominal pain <21 days (E). fever, vomiting (S) 
1.4. Tetanus: generalised stiffness of body <14 days + difficulty in breathing <14 
days (E) + absence of rapid onset unconsciousness (D; meningitis). 
1 (E) essential symptoms; all of them should be 
present 
2 (D;... ) differentiating symptom(s) for the diagnosis given within the parenthesis; all of them 
should be absent 
3 Supportive symptoms; any one of them should be 
present 
° Associate symptoms; not included in the suggested 
criteria, but could be useful 
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difficulty to open the mouth, fever, recent injury (S) 
2.1. Abortion: abortion + severe vaginal bleeding (E) or abortion + fever + lower 
abdominal pain (E). 
2.2. Eclampsia: (2.2. ) + swelling around ankles + convulsion (E) + absence of 
generalised stiffness of body (D; Tetanus, high fever or stiff neck (D; 
malaria/meningitis). 
2.3. Antepartum Haemorrhage: (2.2) + severe vaginal bleeding during the early 
stage of labour (E) + absence of prolonged labour (D; ruptured uterus). 
2.3. Postpartum Haemorrhage: (2.2) + severe vaginal bleeding after delivery of 
fetus (E). retained placenta (S) 
2.4. Obstructed labour/ruptured uterus: (2.2) + labour >24 hours + retained 
fetus or abdominal delivery (E). vaginal bleeding, abnormal presentation of 
fetus(S) 
2.5. Puerperal Sepsis: (2.2) + fever + lower abdominal pain or abdominal 
distension (E) + absence of black urine or rapid onset unconsciousness (D; 
malaria), stiff neck (meningitis), severe jaundice (D; hepatitis). 
... labour >24 hours, assisted/operative delivery, still 
birth/neonatal death (S) 
3.1.1. Congestive heart Failure: slow onset breathlessness + swelling around ankles 
(E) + absence of cough with sputum >60 days (D; COPD). 
hypertension, swelling in the right upper abdomen (S) 
3.1.2. Ischaemic heart disease: sudden onset continuous, severe central chest pain 
(E) + absence of cough with sputum (D; ARI). 
3.1.3. Cerebrovascular disease: sudden onset unconsciousness or paralysis of one 
side of body (E) + absence of high fever (D; AFI), delivery with in 2 weeks 
(D; Eclampsia) and injuries. 
3.2. Chronic obstructive pulmonary Disease: cough with sputum >60 days + 
wheezing + recurrent breathlessness (E) + absence of swelling around ankles 
(D; CHF). known asthmatic, smoker (S) 
3.3. Liver cirrhosis: Slow onset distension of abdomen + swelling around ankles 
+ loss of weight (E) + absence of severe abdominal pain (D; Acute abdomen). 
vomiting blood, jaundice, slow onset unconsciousness, alcoholism (S) 
3.4 Acute abdomen: severe abdominal pain + rapid distension of abdomen (E) + 
absence of swelling around ankles (D; Cirrhosis). 
constipation, vomiting, swelling in the groin (S) 
3.5. Diabetes: known diabetic + rapid onset unconsciousness or gangrene of lower 
limb (E). 
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3.6. Neoplasms: Fast growing ulcers or swellings + loss of weight, or post 
menopausal irregular vaginal bleeding or difficulty in swallowing >1 month 
(E). 
3.6.1. Carcinoma breast: swelling or ulcer in the breast (E). 
3.6.2. Carcinoma cervix/uterus: post menopausal irregular vaginal bleeding (E). 
3.6.3. Hepatoma: jaundice + swelling in the right side of abdomen >2 months (E). 
5. Injuries: categories of cause of death in this group are self-explanatory for the 
criteria of their diagnosis. 
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VERBAL AUTOPSY QUESTIONNAIRE FOR ADULT DEATHS 
I: Identification & Demographic Data of Deceased 
Q1. Name Q2. IDNO 
I_I_I_I_I IDN 
Q3. Address 
Q4. Age of deceased ........................................... 
I_I_I AOD 
Q5. Sex of deceased (male=l; female=2) ........................ " 
I_I SXD 
Q6. Marital status of deceased ................. """"""""""""""" 
I_I MSD 
(single=l; married=2; divorced/separated=3; widowed=4) 
Q7. Years of formal education of deceased ...................... 
I_I_I YED 
Q8. Occupation of deceased 
I_I 0CC 
II: Circumstance of Death 
Q9. For how many days was s/he ill before s/he died? (DK=999) 
I_I_I_I DID 
Q10. Date of death (dd/mm/yy) """"""""""""""""""""" 
DOD 
Q11" Place of death (home=l; hospital/clinic=2; others=3)........ 
I_I POD 
(IF THE ANSWER IS HOME OR OTHERS PROCEED TO Q12) 
a. Name of the hospital where s/he died 
b. Did anyone from the hospital tell you why s/he died? ........ II RIF 
no=0; yes=1; not sure(NS)=9) 
Q12. Do you know the cause(s) of his/her death? (no=0; yes=1; NS=9)I_I RKC 
a. IF THE ANSWER IS YES PROBE TO SPECIFY THE CAUSE(S) 
cause (1) I_I_I_I RD1 
cause (2 ) 
Q13. (ASK WHETHER S/HE HAD ANY OF THE FOLLOWING ILLNESS) 
1111 RD2 
Hypertension... (no=0; yes=1; NS=9)......................... 1_I HYP 
Diabetes ...... (no=0; yes=1; NS=9) ......... """""""""""""""" 
1_I DIA 
Epilepsy ...... (no=0; yes=1; NS=9) ......................... I_I EPI 
TB ............ (no=0; yes=1; NS=9) ......................... I_I TB 
HIV/AIDS ...... (no=0; yes=1; NS=9) ......................... I_I HIV 
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IDNO: 
III: Respondents Account of Final Illness 
Summary of symptoms & signs reported by Respondent 
Symptoms duration Severity 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
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IDNO: 1I IDN 
IV: Specific questions to elicit symptoms & signs of the final illness 
S1. Did s/he have fever? (no=O; yes=1; don't know(DK)=9) ........ 
II FEV 
(IF THE ANSWER IS NO OR DK PROCEED TO S2) 
a. How many days s/he had fever? (DK=999) .................. I_I_I_I DFE 
b. Was the fever severe? (severe=l; mild=2; DK=9) ............ II SFE 
c. Was the fever present continuous or on and off?............ (_I TFE 
(continuous=l; on and off =2; DK=9) 
S2. Did s/he have a rash? (no=O; yes=1; DK=9) ................. " I _I 
RAS 
(IF THE AN SWER IS NO OR DK PROCEED TO S3) 
a. How many days did s/he have the rash? (DK=999) .......... I_I_I _I 
DRA 
b. What did the r ash look like? (measles rash=l; rash with 
clear fluid=2; rash with pus=3; others=4; DK=9) ............. I _I 
TRA 
c. Did s/he have sore eyes? (no=O; yes=1; DK=9) ................ I _I 
SEY 
d. Did s/he have itching of skin? (no=0; yes=1; DK=9) ........... I _I 
ITC 
S3. Had s/he lost weight recently before death? (no=O; yes=1; DK=9) I _I 
LOW 
(IF THE ANSWER I S NO OR DK PROCEED TO S4) 
a. Was the loss of weight severe? (severe=l; moderate=2; DK=9).. I _I 
SLW 
S4. Did s/he have swelling around ankles? (no=O; yes=1; DK=9)""" I_ I SAA 
(IF THE ANSWER IS NO OR DK PROCEED TO S5) 
a. How many days s/he had the swelling? (DK=999) .......... I_I_I_ I DSA 
S5. Did s/he have puffiness of the face? (no=O; yes=1; DK=9).... 11 PUF 
S6. Did s/he look pale (anaemic)? (no=O; yes=1; DK=9) ...... """. 
S7. Did s/he have yellow discoloration of the eyes? """"""""""""" (no=0; yes=1; DK=9) 
S8. Did s/he have swelling in the neck? (no=O; yes=1; DK=9)----- 
11 PAL 
11 JAU 
11 SWN 
S9. Did she have swelling in the axilla? (no=0; yes=1; DK=9)... 11 SWA 
S10. Did s/he have swelling in the groin? (no=O; yes=1; DK=9). ". I_I SWG 
511. Did s/he have any other swelling or ulcers? 
(IF THE ANSWER IS 
YES PROBE FOR THE SITE AND DURATION) 
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S12. Did s/he have cough? (no=O; yes=1; DK=9) .......... """"""""" I_) COU 
(IF THE ANSWER IS NO OR DK PROCEED TO S13) 
a. How many days s/he had cough? (DK=999) ...... "........... I_I_I_I DCO 
b. Was the cough productive (sputum)? (no=O; yes=1; DK=9) ...... I_I PCO 
c. Did s/he cough blood (no=0; yes=1; DK=9) .................... I_I BCO 
S13. Did s/he have shortness of breathing? (no=O; yes=1; DK=9).... I _I 
DIB 
(IF THE ANSWER IS NO OR DK PROCEED TO S14) 
a. Was the shortn ess of breathing continu ous or on and off?..... I 
_I 
TDB 
(continuous=1; on and off=2; DK=9) 
b. How many days s/he had breathlessness? (DK=999)......... I_I I I DDB 
c. Did s/he have wheezing? (no=0; yes=1; DK=9) .................. I _) 
WHE 
S14. Did s/he have chest pain? (no=O; yes=1; DK=9) ................ I_) CHP 
(IF THE ANSWER IS NO OR DK PROCEED TO S15) 
a. Where was the pain? ......................................... 
I_I SCP 
(over the sternum=l; over the heart=2; others=3; DK=9) 
b. Was the pain continuous(=1) or on and off (=2)? (DK=9) ...... I_I TCP 
c. When s/he had an attack of severe pain, how long did it last? (_I DCP 
(<30min=1; >30min but <24hrs=2; >24 hrs=3; DK=9) 
S15. Did s/he have diarrhoea? (no=O; yes=1; DK=9) ..... """""""""""" I_I DI 
(IF THE ANSWER IS NO OR NS PROCEED TO S16) 
a. How many days s/he had diarrhoea? (DK=999) ........ """""" I_I_I_I DDI 
b. Was the diarrhoea continuous (=1) or on and off (=2)? (DK=9)" I_I TDI 
c. When the diarrhoea was severe, how many times did s/he 
pass stool in a day? (DK=99) ............................... I_I_I FDI 
d. What did the stool look like? ............................... I_I TST (watery=l; loose but not watery=2; bloody=3; DK=9) 
S16. Did s/he pass blood in the stool? (no=O; yes=1; DK=9)........ (_I BST 
S17. Did s/he have vomiting? (no=O; yes=1; DK=9) ................ "" I _I 
VOM 
(IF THE ANSWER IS NO OR NS PROCEED TO S18) 
a. How many days s/he had vomiting? (DK=999) ................. I_I_I _I 
DVO 
b. Was the vomiting continuous (=1) or on and off (=2)? (DK=9).. I 
_I 
TVO 
c. When the vomiting was severe, how many times did s/he 
vomit in a day? (DK=99) ................................... 1_1 _1 
FVO 
d. What did the vomitus look like? ............................. I I CVO (watery fluid=l; yellowish fluid=2; coffee coloured fluid=3; _ 
blood=4; faecal matter=5; other=6 ; DK=9) 
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S18. Did s/he have abdominal pain? (no=0; yes=l; DK=9) ........... I_I ABP 
(IF THE ANSWER IS NO OR DK PROCEED TO S19) 
a. What was the type of pain? ................................. I_I CAP 
(cramps=l; dull ache=2; burning pain=3; others=4; DK=9) 
b. How many days s/he had the pain? (DK=99) ................ I_I_I_I DAP 
c. Where exactly was the pain? ................................. (_I SAP 
(lower abdomen=l; upper abdomen=2; all over the abdomen=3; 
others=4; DK=9) 
d. What was the severity of the pain? .......................... I_I TAP 
(severe=l; moderate=2; mild=3; DK=9) 
e. Was s/he unable to pass stool for some days before death?.... (_I CON 
(able to pass=0; unable to pass=l; DK=9) 
S19. Did s/he have distension of abdomen? (no=O; yes=1; DK=9) ..... 
I_I ABD 
(IF THE ANSWER IS NO OR DK PROCEED TO S20) 
a. How many days s/he has abdominal distension? (DK=999).... I_I_I_I DAD 
b. Did the distension develop rapidly with in days or 
slowly over weeks? (rapid=l; slow=2; DK=9) .................. I_I TAD 
S20. Did s/he have difficulty in swallowing? (no=O; yes=1; DK=9)"" I_I DSW 
(IF THE ANSWER IS NO OR DK PROCEED TO S21) 
a. How many days s/he had difficulty in swallowing? (DK=999) I_I_I_I DDS 
S21. Did s/he have any 
(IF THE ANSWER IS NO 
a. Where exactly was 
(Rt upper abdomen. 
others (specify 
b. How may days s/he 
mass in the abdomen? (no=O; yes=1; DK=9) "" 
I_I ABM 
DR DK PROCEED TO S22) 
the mass? ................................. II SAM 
=1; Lt upper abdomen=2; Lower abdomen=3; 
= 4; DK=9) 
had the mass? (DK=999) ................. I_I_1_1 DAM 
S22. Did s/he have headache? (no=O; yes=1; DK=9) ... "......... ". ". 11 HEA 
S23. Did s/he have stiff neck? (no=O; yes=1; DK=9) ....... """"""""" I_I STN 
(IF THE ANSWER IS NO OR DK PROCEED TO S24) 
a. If yes, for how many days (DK=999) ...................... I_I_I_I DSN 
S24. Did s/he have any change in the level of consciousness? """""" (_I LUC 
(no=O; 
yes=1; DK=9) (IF THE ANSWER IS NO OR DK PROCEED TO S25) 
a. What was the level of his/her consciousness? ............... .. TUC 
(confused=l; unconscious=2; others =4; DK=9) 
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b. If confused or unconscious, for how many days ? (DK=999) I_I_I_I DUC 
c. How did it start? ............................................ II OUC 
(suddenly=l; rapidly within a day=2; slowly over few days=3; DK=9) 
S25. Did s/he have fits? (no=O; yes=1; DK=9) ...................... 
I_I FIT 
(IF THE ANSWER IS NO OR DK PROCEED TO S26) 
a. How many days s/he had fits? ( DK=999 ) ............. "... DFI 
b. (ASK THE RESPONDENT TO DESCRIBE THE FITS) ....... " ..... " ..... 
I_I TFI 
(repetetive jerking of whole body=l; others 
=2; DK=9) 
c. When fits were most frequent, how many per day? (DK=99)""""" I_I_I FFI 
d. Between fits was s/he awake (=1) or unconscious (=2)? (DK=9)- I_I BFA 
S26. Did s/he have difficulty in opening the mouth? ............... (_I LOC 
(able to open=0; unable to open=l; DK=9) 
S27. Did s/he have stiffness of the whole body? (no=O; yes=1; DK=9)"I_I OPI 
(IF THE ANSWER IS NO OR DK PROCEED TO S28) 
a. How many days s/he had the stiffness? (DK=999)........... 1_1_1 
_1 
DOP 
S28. Did s/he have paralysis of one side of the body? .......... "" I_I HEM 
(no=O; 
yes=1; DK=9) (IF THE ANSWER IS NO OR DK PROCEED TO S29) 
a. How many days s/he had the paralysis? (DK=999)........... I_I_I_I DHE 
S29. Did s/he have paralysis of lower limbs? (no=O; yes=1; DK=9)"" I_I PAR 
(IF THE ANSWER IS NO OR DK PROCEED TO S30) 
a. How many days s/he had the paralysis? (DK=999)........... I_I_I_I DPA 
S30. Was there any change in the colour of urine? ................ I_I CCU 
(no=O; 
yes=1; DK=9) (IF THE ANSWER IS NO OR DK PROCEED TO S31) 
a. What was the colour of urine? ................................ II TCC 
(dark yellow=1; coffee like=2; blood stained=3; DK=9) 
b. How many days s/he had the change in colour? (DK=999).... I_I_I_I DCC 
S31. Was there any change in the amount of urine s/he passed daily? I_) CQU 
(no=O; 
yes=1; DK=9) (IF THE ANSWER IS NO OR DK PROCEED TO S32) 
a. How much urine did s/he pass in a day? ..................... 11 AQU 
(too much=l; too little=2; no urine at all=3; DK=9) 
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b. How many days s/he had the change in amount of urine? )999 I_I_I_I DQU 
S32. Did s/he have difficulty in passing urine? (no=O; yes=1; DK=9). I_I DPU 
(IF THE ANSWER IS NO OR DK PROCEED TO S33) 
a. What type of difficulty did s/he have? ..................... I_I TDP 
(unable to pass urine=l; continuous dribbling of urine=2; 
burning sensation while passing urine=3; others=4; DK=9) 
S33. Did s/he have any operation before death? (no=0; yes=1; DK=9) I_I HOP 
(IF THE ANSWER IS NO OR DK PROCEED TO S34) 
a. How many days before death s/he had the operation? (DK=999)1_1_1_1 OPD 
b. (ASK FOR THE SITE OF OPERATION) ............................. " ... 
11 OPS 
(abdomen=l; others=2 DK=9) 
IF THE DECEASED IS A FEMALE AND >50 YERS OLD PROCEED TO S37 
IF THE DECEASED IS A MALE PROCEED TO S39 
S34. Was she pregnant at the time of death? (no=O; yes=1; DK=9)""" I_I PRE 
(IF THE ANSWER IS NO OR DK PROCEED TO S35) 
a. How many months was she pregnant? (DK=99) ................. 111 MPR 
S35. Did she deliver within 45 days before death? (no=O; yes=1; DK=9)I_I DEL 
(IF THE ANSWER IS NO OR DK PROCEED TO S36) 
a. How many days before her death did she deliver? (DK=99)..... I_I_l EDD 
b. Where did she deliver? (home=l; clinic=2; hospital=3; DK=9)..... I_I PDE 
c. How long was she in labour? (<24 hrs=1; >24hrs=2; DK=9) ......... I_I DDE 
d. Did she have too much bleeding during delivery? .............. 11 BDE 
(no=O; yes=1; DK=9) 
e. (IF YES, PROBE TO FIND OUT WHETHER THE BLEEDING STARTED BEFORE 
OR AFTER THE DELIVERY OF FOETUS) """""...... """.. "".. ""..... 
1I HDE 
f. What was the mode of delivery? .............................. II MDE 
(vaginal delivery=l; vacuum or forceps delivery=2; 
abdominal operative delivery=3; DK=9) 
g. Is the baby alive? (IF NO PROBE FOR THE TIME OF DEATH) """""""I PNC 
(alive=1; still born=2; died within 7 days=3; died after 7 days=4) 
h. Did she have any previous complicated delivery? ............. I_I PCD (no=0; yes=l; DK=9) 
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S36. Did she have an abortion within 45 days of death? ........... ABO 
(no=O; yes=1; NS=9) 
S37. Did she have irregular bleeding per vagina? ".. ".... ""... """. I_I ABV 
(no=O; yes=1; NS=9) 
S38. Did she have any swelling or ulcer in the breast? ............ I_I BT 
(no=O; yes=1; NS=9) 
S39. Did s/he sustain any injury which lead to his/her death? ..... I_I INJ 
(no=O; 
yes=1; NS=9) (IF THE ANSWER IS NO OR DK PROCEED TO S40) 
a. (IF THE ANSWER IS YES . PROBE FOR THE TYPE OF INJURY) ... 
\ 
.... 
I_I TIN 
(assault=l; road traffic accident=2; war injury=3; animal 
bite=4; fire accident=5; accidental poisoning=6; others=7 
(specify) 
b. How many days before death s/he had the injury? (NS=999) I_I_I_I DIN 
S40" Do you think that s/he committed suicide? (no=O; yes=1; NS=9) I_I SUI 
(IF THE ANSWER IS NO OR DK PROCEED TO NEXT SECTION) 
a. How did s/he commit suicide? ................................ I_I TSU 
(hanging=l; poisoning=2; burns=3; others=4 
V. Interviewer's comments and observations 
Interviewer's assessment of cause of death 
Cause of death 1 
Cause of death 2 
Interviewer's IDNO .............................................. III IID 
Date of Interviewe ................. (dd\mm\yy) DOI 
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4 
Introduction 
Verbal Autopsy (VA) is an indirect method to find out the cause of death of a deceased 
person in the absence of a medical diagnosis. A close relative or associate of the deceased is 
interviewed using a Verbal Autopsy Questionnaire (VAQ) to obtain information on 
symptoms, signs and circumstances of the illness which lead to the death, from which a cause 
of death is then assigned. Before undertaking a VA survey it is essential that permission and 
support from the local political and traditional leaders is obtained, and that care is taken to 
acknowledge the sensitive nature of the interviews. Some families may not wish to talk about 
the death of a close relative, and the way in which an interviewer approaches the head of the 
family is likely to play a major role in keeping refusal rates low. 
The interview process has the following six steps: 
1. Identification of the household of the deceased/respondent 
2. Expressing sympathy for the loss of the deceased 
3. Introduction of the objectives and obtaining consent 
4. Identification of an appropriate respondent(s) 
5. Interviewing the respondent(s) using the VAQ 
6. Closing the interview with an expression of thanks 
All of these steps are important and should be carried out each time a VA is conducted. 
1. Identification of the household of the deceased/respondent 
The addresses and other identification landmarks to locate the household of the 
deceased/respondent will be provided by your supervisor. There may be situations in which 
the given address is inadequate and help from community members should be sought. 
Interviewers may need to walk long distances and to withstand frustrations in searching for an 
appropriate respondent, particularly, if the deceased's relatives have moved house. 
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* Seek help from the local community & use the information given to you, to locate the 
households 
* If the information is inadequate or incorrect conduct further enquiries to identify the 
household of interest 
* Be prepared to walk long distances and to withstand the hardships which may arise 
while searching for the households of interest 
2. Expressing sympathy for the loss of the deceased 
Since the nature of the interview is highly sensitive and may touch on the grief of the 
bereaved, it is essential to approach each interview with a sympathetic attitude. Do not forget 
to express sympathy for the loss of the deceased person, before introducing the objectives of 
the interview. 
* Express sympathy for the loss of the deceased before starting the interview 
3. Introduction of the objectives and obtaining consent 
The interviewers will be provided with an introduction letter from the local health authorities 
to introduce themselves and the objectives of the interview. It is important to explain to the 
head of household and the respondent(s) that the information given by them will be 
confidential. It may be useful to explain in general the lack of information on common 
causes of death and the need for such information to identify appropriate interventions. After 
the introduction, verbal consent should be obtained from the head of household and the 
respondent(s) to proceed with the VAQ. 
* Approach with a sympathetic attitude 
* Explain the need for information on common causes of death to identify control 
programmes 
* Reassure that the information obtained from the interview will be confidential 
* Obtain verbal consent before proceeding with the VAQ 
4. Identification of an appropriate respondent(s) 
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4.1. Appropriateness of respondents 
The responsibility of caring for seriously ill patients may vary between different cultural and 
socio-economic groups. Thus it may not be appropriate to identify the respondent by their 
relationship to the deceased, and a detailed enquiry about the persons who looked after the 
deceased during his/her illness should be carried out to identify the appropriate respondent(s). 
The most appropriate respondent is a person who had cared for the deceased during his/her 
final illness and who can remember, recollect and give an accurate account of the 
circumstances leading to the death and the signs and symptoms of the illness. The 
appropriateness of the respondent is graded into the following four categories: (1) looked 
after the deceased during the final illness at home and/or hospital (very appropriate); (2) 
lived in the same house and knows about the illness of the deceased but did not look after 
during the final illness (appropriate); (3) lived at a different house but visited the deceased 
frequently and knows about the illness (probably appropriate); (4) had heard about the 
illness but only visited occasionally or did not see at all (may be appropriate) 
We aim to interview a respondent from the very appropriate category, but there may be 
situations where such a respondent does not exist or is unavailable. In such situations, we 
have to select a person from the next highest category. 
4.2. Availability of respondents 
The respondents may be present at the time of your visit (present); may be away at the time 
of your visit but could be contacted if revisited or moved house but could be reached(absent); 
may be impossible to contact for some reason eg. gone for a long trip, moved house to a far 
away place (unavailable). 
4.3. Identifying the best respondent 
The respondent identification form (RIF) should be used to list all potential respondents and 
to select the best respondent. 
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* List the names, age, sex and relationships of all potential respondents including the 
ones who are absent at the time of your visit in the RIF 
* Enter the grades of appropriateness according to your assessment 
* Enter the categories of availability according to your assessment 
* If you categorize any respondent as unavailable, note the reason(s) in the remark 
section of the RIF 
* If the best respondent refused to participate note in the remark section 
* If the best respondent is present, enter his/her identification and demographic data 
and continue with the interview 
* If the best respondent is absent fix an appointment 
* Do not interview a less appropriate respondent because the best respondent was 
absent! 
* If failed to contact the best respondent on three occasions or the respondents refused 
to participate, report to your supervisor to select an alternative respondent 
* After completing the VAQ tick all the respondents who participated in the interview 
in the RIF 
4.4. Number of respondents 
Often you will come across situations where more than one respondent participate in the 
interview. Do not discourage the additional respondents even if they are not the best ones 
because the information given by them could be complementary and important. 
5. Interviewing the respondent(s) using the VAQ 
The VAQ is a tool to collect in-depth information from a close relative(s) or associate(s) of a 
deceased about the illness which lead to the death. The data from VAQs will be analyzed by a 
panel of physicians and/or by computer algorithms to ascertain the cause(s) of death. 
The VAQ has five sections: (I) Identification & demographic data of deceased; (II) 
Circumstance of death; (III) Respondents account of final illness; (IV) Specific questions to 
elicit symptoms & signs of the final illness; (V) Interviewer's comments & observations. The 
information entered in all these sections should be accurate and complete to derive valid 
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diagnoses from the VA. The general and specific instructions given below should be adhered 
to in order to improve the consistency between VAs. 
5.1. General Instructions 
5.1.1. Attitude, Language and Gestures: Maintain a sympathetic attitude throughout the 
interview. The language used in the VAQ has been field tested, and should be adhered 
to as much as possible for the sake of consistency between the interviews. Some of the 
questions may require certain demonstration/gestures to make them understandable 
and these gestures will be shown to you during the training. In certain situations you 
may have to change the language or use different gestures to make the question 
understandable. Should such a situation arise, make a note of the changes made and 
report to your supervisor. This would allow your supervisor to inform the other 
interviewers about the necessary changes and to improve the VAQ. 
5.1.2. The sequence of the sections in the VAQ: The sequence of the sections in the VAQ 
can be altered if necessary. However, once a section is started it should be completed 
before moving to another section. For example, it is possible that the respondent may 
narrate the history of illness of the deceased as soon as you start the interview. In such 
instances complete the section on the respondents account of final illness (section III) 
first and then come back to the section I. 
5.1.3. Questions and Codes of Responses: The VAQ has 13 stem questions in the first two 
sections and 40 stem questions in the section IV. The stem questions are followed by 
several sub-questions which could be skipped if the answer for the stem question is 
"no" or "not sure/ don't know". Most of the questions have limited number of possible 
responses which are given. However you may come across some responses which are 
not included in the coded responses. Record such responses by the side of the 
respective question and report to the supervisor. The coding scheme for questions 
with yes/no answers are as follows: "no" or "absent" = 0, "yes" or "present" =1 and 
"not sure" or "don't know" = 9. 
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5.1.4. Reporting to the supervisor: If you have any doubts or comments (including the 
questions which were difficult, modified or produced answers different from those 
coded) write in the comments section and report to your supervisor. Your comments 
and observations are vital to improve the VAQ! 
* Maintain a sympathetic attitude through out the interview 
* Adhere to the language used in the VAQ as much as possible for the sake of 
consistency between the interviews (The questions are carefully translated and field 
tested) 
* Should you change the translations or the format of questions, make a note and 
inform your supervisor 
* Be consistent if you give demonstrations or use gestures (You will be given specific 
instructions during the training) 
* Should you modify or use additional gestures/demonstrations, inform your supervisor 
* You can alter the sequence of the sections of VAQ if necessary, but complete the 
section once it is started 
* Skip the sub-questions if the response to the stem question is "no" or "not sure" 
* Should you come across responses which are not given in the VAQ, record them and 
report to your supervisor 
* Verify the codes of responses before entering. It is easy to make an error! 
5.2. Instructions related to specific questions of the VAQ 
(The comments and instructions given below are numbered according to the question 
number in the VAQ; since most of the questions and responses are self explanatory, 
many of them are not explained further in this manual) 
I. Identification and demographic data of deceased 
Names, IDNO, Address, Age and Sex of the deceased person will be filled in by your 
supervisor. 
* Verify that Names, IDNO, Address, Age and Sex of the deceased are filled in when 
L you receive the VAQ, and that the information given is correct. 
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Q7. Years of formal education: 
* Enter the number of years of schooling. eg. never went to school=O, went up to grade 
VI=6, not sure=99. 
Q8. Occupation: 
* Record the reported occupation ( eg. housewife, trader, driver etc) 
(the responses to this question will be coded at a later stage) 
II. Circumstances of death 
Q9. This question aims to find out the duration of the illness which lead to the death of a 
deceased. Respondents may not have difficulties in reporting the duration of a short 
fatal illness. However, some diseases may have very long and recurrent episodes and 
respondents may have difficulties in reporting the duration of such an illness. In such 
circumstances, use of important local events as an aide memoir may be helpful. If 
there is a long history of illness with illness free periods in between, probe and note 
the duration of illness free periods. If the illness free period exceeds 3 months, 
consider the illness prior to this period as past history and the illness after this period 
as the final illness. Usually respondents will report the duration of illness in weeks or 
months or years. Convert these units into days and record in the boxes eg. one year of 
illness will be recorded as 365. If they do not know the duration of illness record as 
n L9 U9. It is assumed that the duration of a final illness is unlikely to be >3 years. If you 
come across >3 years record the number of years and report to your supervisor. 
* Record the duration of the illness which lead to the death 
* Record the duration of the illness in days 
* If the duration is more than 3 years record the number of years (eg. 141ylr1) and report 
to your supervisor 
* Use important local events as aide memoir 
* If there is any doubts about the duration of illness, record reasons for doubt in the 
comments section (section VI) 
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Q10. Date of Death: 
* Probe for the date of death using local events as aide memoir 
* Record the date in the first two boxes, the month in the next two boxes and the year 
in the last two boxes (eg. 2 May 94 will be 1012101519141 
Do not waste time in probing for the exact date; month or year of death would be 
adequate if day is not known 
Q11. Place of death: 
b. "Any one from the hospital" refers to doctors and nurses. 
If the respondent cannot recollect whether they were told about the cause of death, 
then the response is recorded as "not sure L 9j". 
Q12. Cause of death: 
* Probe gently to specify the cause(s) of death 
* Do not ask "Why did s/he die? "; Always ask "What disease caused the death? " (this 
would minimize the reports of non-medical causes such as witch crafts) 
* If more than two causes are reported, record all of them and report to your 
supervisor 
(No codes are given for the possible responses; the recorded responses will be coded by 
your supervisor at a later stage) 
Q13. This question is to elicit whether the deceased was known to have been suffering from 
hypertension, diabetes, epilepsy, TB or AIDS. Some respondents may report that the 
deceased had the disease (eg. TB) a few years ago but was cured after treatment. Even 
if it is reported as cured, the response should be recorded as "yes" (=1). In some areas 
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asking about AIDS may not be acceptable and in such areas you should ask about 
AIDS at the end of the interview. Never fill in no or not sure without asking the 
question! 
* Record the response as "yes", if the deceased had Hypertension, Diabetes, Epilepsy, 
TB or AIDS at any time, even if they are reported as "cured" 
* Delay the question about AIDS until the end of the interview if it is sensitive to talk 
about AIDS 
* Never enter "no" or "not sure" without asking the question 
III. Respondents' account of final illness 
This section has two parts: (i) an open space to record the respondent's verbatim 
account of the final illness of the deceased; (ii) A table to summarise the reported 
symptoms and signs, and their duration and severity. 
* Record the verbatim account of the illness and circumstance of death as complete as 
reported 
* You may probe to elicit the sequence of the reported symptoms, but do not probe for 
additional symptoms 
* List the symptoms mentioned in the order reported by the respondent 
* Ask for the duration and severity of each symptom individually before recording 
IV. Specific questions to elicit symptoms and signs of final Illness 
S1. Fever: Although the symptom fever is carefully translated, in some settings you may 
have to demonstrate fever or "hot body" using gestures (to be shown during training). 
c. Type of fever: It is assumed that the respondents should be able to judge whether the 
fever was "continuous" or "on and off'. If the respondent is unable to report the type 
of fever, probe to find out whether it was a low grade fever with fever free periods in 
between (on and off) or a high fever which was continuous from the onset to death 
(continuous). 
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S2. Rash: Rash is a raised skin lesion which may or may not be itching. In the context of 
VAs we are really interested to know about measles and herpes zoster rashes. 
* Use gestures to demonstrate rashes 
b. Type of rash: measles rash, rash with clear fluid and rash with pus are given as 
possible responses. If the description of rash was different from these three, then enter 
"4" and record the description of the rash. 
c. Sore eyes: this refers to red eyes (conjunctivitis) which is often present in patients 
with measles 
S3. Recent loss of weight: Patients suffering from certain diseases like TB, AIDS and 
cancer, may begin to lose weight before the onset of other symptoms. Therefore, 
"recent" refers not only to the final stages but also to the earlier stages of the illness. 
a. severity: Difficult to standardize the severity of loss of weight. Accept the 
respondent's judgement. 
S4. Swelling around ankle: Fluid collects around ankles and feet in certain conditions 
such as heart failure. This is not a swelling of the ankle joint but around the ankle. 
* Demonstrating "pitting" to clarify this symptom (to be shown during the 
training). 
a. Duration of the swelling: swelling around the ankles could have appeared on and off, 
particularly if the patient was on treatment. 
* If the swelling was on and off record the duration from the time of the first 
episode and also make a remark that it was on and off. 
S5. Puffiness of the face: a swollen appearance of the face especially around the eye lids 
* Use gestures to explain puffiness of face (to be shown during the training) 
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S6. Pale (anaemia): often noticed as pallor of face 
* Use gestures to explain pallor (to be shown during the training) 
S7. Yellow discolouration of the eyes: jaundice 
* Use gestures to explain jaundice 
S8, S9 & S10. Swelling in the neck, axilla (arm pit) and groin: refers to glandular 
swelling in these areas of the body. 
* Show the area and demonstrate the swelling 
Si!. Any other swelling and ulcers: refers to all kinds of swelling in the body including 
hernias. 
* probe by showing the site and appearance of certain swellings and ulcers (to be 
shown during training) 
* record the verbatim account of the type, site and duration (this will be coded at 
a later stage) 
S13. Shortness of breathing: difficulty in breathing or breathlessness usually happens 
after mild exertion but in severe forms even at rest. 
* Demonstrate of shortness of breathing (to be shown during training) 
a. Duration: breathlessness often occurs intermittently. 
* Record the time since the first episode 
b. Wheezing: difficulty in breathing associated with musical noise during expiration. 
* Demonstrate wheezing (to be shown during training) 
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S14. Chest pain: aims to elicit chest pain associated with myocardial infarction and 
pneumonia. 
a. site of pain: 
* Probe by showing the breast bone, the heart and the lateral aspect of chest 
S19. Distension of abdomen: refers to abdominal distension occurring in ascites (chronic 
liver disease) and acute abdominal conditions 
b. Type of distension: the distension related to acute abdominal conditions occur rapidly 
within few days (rapid); the distension develop gradually over weeks or months in 
ascites 
* Use gestures to explain rapid and slow onset distension of abdomen 
S20. Difficulty in swallowing: this refers to mechanical obstruction due to diseases such 
as tumours, but not to the inability or difficulty in swallowing due to weakness (eg. 
unconscious state). 
* Give a demonstration of difficulty in swallowing 
S21. Abdominal mass: refers to any mass including the enlargement of organs such as the 
liver and spleen. 
a. site: 
* Show the right and left upper abdomen and the lower abdomen to elicit the 
site 
S23. Stiff neck: refers to the neck pain and stiff neck occurring in meningitis. In some 
areas this question may have to be changed to elicit neck pain rather than stiffness. 
L* Demonstrate stiff neck (to be shown during the training) 
S24. Level of consciousness: this refers to restless, confused, drowsy or unconscious state, 
but not to the behavioural changes related to mental disorders. 
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* Explain the levels of consciousness using gestures (to be shown during the 
training) 
S25. Fits: refers to convulsions, but not to rigor associated with fever 
* Demonstrate fits and rigor (to be shown during the training) 
S26. Difficulty in opening the mouth: refers to the difficulty occurring in tetanus, due to 
the spasm of certain buccal muscles. 
* Give a demonstration of difficulty in opening the mouth and probe to 
differentiate this condition from severe weakness and drowsiness. 
S27. Stiffness of body: refers to the muscular spasm which occurs in tetanus. 
* Give a demonstration of stiffness of the body 
S28. Paralysis of one side of the body: 
* Give a demonstration of hemiplegia 
S29. Paralysis of lower limbs: 
* Give a demonstration of paraplegia 
S30. Colour of urine: Gentle probing is needed since many respondents are likely to 
answer "don't know". 
S31. Amount of urine: Gentle probing is needed since many respondents are likely to 
answer "don't know". 
S33. Operations: Refers to any operation which was associated with or lead to the death. 
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* If you are in doubt whether an operation was associated with the death, record 
it and discuss with your supervisor 
S34. Duration of pregnancy: 
* If the number of months of pregnancy is unknown, probe and record whether 
she was in early or later stages of pregnancy 
S37. Irregular bleeding: refers to any bleeding other than normal menstruation 
S39. Injuries: refers to any injury associated with or lead to the death. 
* If you are in doubt whether an injury was associated with the death, record it 
and discuss with your supervisor 
V. Interviewer's comments and observations 
Your comments and observations would be very useful for revising the VAQ and for 
training interviewers. Therefore, record everything that is worth mentioning, in your 
opinion, in this section. 
* Write your comments regarding the selection of respondent(s), the degree of 
cooperation and understanding of the respondents, the problems with specific 
questions etc. 
If you have formed an opinion as to the cause of death, record it in the space given 
6. Closing the interview with an expression of thanks 
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* Do not forget to thank the respondent(s) for their time and help, after completing the 
L interview 
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T\4 . %.,.. vi. ". I 
Respondent Identification Form 
Name of the deceased 
I. List of potential respondents 
IDNO 
Names of potential 
respondents 
Age Sex Relationship 
to deceased 
Appropri 
ateness 
Availa 
bility 
Partici 
pation 
Relationship to deceased: T RBIýATZüN58Z n üHsl: LSE'ÖNÖ;::: Tý>;; THQ I1ýCBÄ5ýD 
(eg. If the deceased is a man and the- respondent is his daughter, then tl 
relationship is daughter not father) 
Appropriateness: R iýsrt : q: x : <xirýT uc c N<. i u '> ä ::. ýný x xýcxýrt (very appropriat( 
appropriate; probably appropriate; may be appropriate) 
Availability: fktifbkd absent 
».: v..... ....:..........:: ».:.. ,,.:.::..: ,.:..,... r.,::::::..............,. r.......:......:.:::::.........:.......:, ...,, » 
(present; 
unavailable) 
Participation: Tl: the < : >: ini ' '>::: x :: ':: trýC týnvx t ::: t' OXE$ ::. Ate: > ýs >: ýi<`xMTXCx ABC p ":: r/:..:.. n. i:.... .. S'. ý.....:.:: xiv:.:.. ". iY ry:.. v:.: f :.. n. ný"l: v..::... r.:..:...:::. r. /'r:.. n: ryii:.::.::.:. "//ýý /ls.. 
Ix. Identification & Demographic Data of Principal Respondent 
Q1. Name of the respondent 
Q2. Age of respondent ........................................ 
1_1_1 AOR 
Q3. Sex of respondent (male=1; female=2) ...................... 
Q4. Relationship of respondent to the deceased ................ 
(spouse=l; daughter=2; son=3; mother=4; father=5; 
others=6 (specify) 
SXR 
(_ý ROR 
Q5. Years of formal education of respondent ................... 
1_1_1 YER 
Q6. First language of the respondent 
III. Information about the visits 
7. Date of first Visit 
8. Date of second Visit 
9. Date of third Visit 
10. Reason(s) for abandonin g the interview ( Xdtt' : Ci nc Tu ON :; Dx ctrl 
týtxxýt 
; 
tiv i >'SUP RVXSOR 
d1S 
APPEN'btx -IS" -1 
VERBAL AUTOPSY QUESTIONNAIRE FOR ADULT DEATHS 
2: Identification & Demographic Data of Deceased 
Q1. Jina la marehemu Q2. IDNO IDN 
Q3. Anwani 
Q4. Umri wa marehemu ........................................... AOD 
Q5. Jinsia (me=1; ke=2) ....................................... 
I_I SXD 
Q6. Ndoa ...................................................... MSD 
(hajaoa/hajaolewa=l; ameoa/ameolewa=2; talaka/achana=3; mjane=4) 
Q7. Kiwango cha elimu ya marehemu .............................. YED 
Q8. Kazi ya marehemu ý_ý OCC 
II: Circumstance of Death 
Q9. Marehemu alikuwa mgonjwa kwa muds gani kabla ya kufariki? DID 
(Sijui (SI)=999) 
Q10. Tarehe ya kufariki (dd/mm/yy) ............... DOD 
Q11. Mahali alipofariki ......................................... 
(_ý POD 
(nyumbani=l; hospitali/kliniki=2; penginepo=3) 
(KAM7l: ; a7I8U:; >NINrUM A1dI"''Ati- PENßINEPO , mmr. LEA : NA SWALIµs 
WQf) 
w ........... x sý ..., ..,,. . aib.,..,.. nbYý..... .... n .............. n.. 
i: 
en .. n. xä At'{w ý ........  ,.., w{. aý,:.. . ......,..., ... W. L+ý..... _. 
F ý ....... w .. vk9 . «c rw 
a. Jina la hospitali alikofia 
b. Je kuna mganga yeyote wa hospitali aliyewajulisha sababu ya kifo 
chake? (hapana (HA) =0; ndiyo (ND) =1; sina hakika (SH) =9) ......... 
1-1 RIF 
Q12. Je unajua sababu ya kifo chake? (HA=O; ND=1; SH=9)............ 1_1 RKC 
ý 
a. EA iriAys 
g7IBt7 
n= NDIYÖ, 
m 
v zi RtTJtTA BABABt1 
sababu (1) RD1 
sababu (2) RD2 
Q13. (UftZ ýFALTWÄHY¢ ÄA, Nhd. MÄßOMJWÄ YÄBUATAYý 
Musukumo wa damu (BP)..... (HA=O; ND=1; SI=9) ............... HYP 
Kisukari 
................. 
(HA=O; ND=1; SI=9) ............... 
1_1 DIA 
Kifafa ................... (HA=O; ND=1; S2=9) ............... EPI 
Kifua kikuu (TB).......... (HA=O; ND=1; SI=9)................. TB 
Ukimwi (AIDS) ............. (HA=O; ND=1; SI=9) ............... 
ý_ý HIV 
2 
2. IDNO: 
III: Respondents Account of Final illness 
Summary of symptoms & signs reported by Respondent 
Symptoms duration Severity 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
IDNO: 1-1-1-J-1 LDN 
IV: Specific questions to elicit symptoms & signs of the final illness 
Si. Je aliwahi kuwa na homa ya kuchemka mwili? (HA=O; ND=1; SI=9) I__ I FEV 
(AAA JIBU NI HAPANA AU SIJIII ENDELEA KWA SWALI LA S2) 
a. Alikuwa anachemka mwili kwa inuda gani? (SI=999)......... 
b. Joto hilo ilikuwa kali? (kali sana=l; wastani=2; kawaida=3; SI=9)I_ I SFE 
c. Jota h. ibo ilikuwa la mfululizo (=1) au ya vipindi (=2)? ... 
I_ I TFE 
S2. Je alikuwa na vipele? (HHA=O; ND=1; SI=9) ................... RAS 
(RAMA JIBU NI HAPANA AU SIJUI ENDELEA KWA SWALI LA S3) 
a. Alikuwa rya vipele kwa muda gani? (SI=999) ............... 
1_I---I-I DRA 
b. Vipele vilikuwa vya namna. gani? (surua=l; upele wenye maji=2; 
upele wenye usaha=3; mengineyo=4; SI=9) ..................... 
j_I TRA 
c. Alikuwa na macho mekundu? (HA=O; ND=1; SI=9) ................ 
j_I SEY 
d. Alilkuwa anawashwa ngozi na kujikuna? (HA=O; ND=1; SI=9).... j_I ITC 
S3. Je alikuwa amekonda kabla ya kufariki? (HA=O; ND=1; SI=9).... ý_1 LOW 
(KAMA JIBU NI HAPANA AU SIJUI ENDELEA KWA SWALI LA S4) 
a. Je alikonda sana (=i) au wastani (=2) ? (. SI=9) ................ 
j_I SLW 
S4. Je alikuwa amevimba miguu? (HA=0; ND=1; SI=9) ............... 
SAA 
(KAM JIBU NI HAPANA AU SIJUI ENDELEA KWA SWALI LA S5) 
a. Alikuwa amevimba kwa muda gani? (SI=999)............... DSA 
S5. Je use wake ulikuwa unnevimba? (HA=O; ND=1; SI=9)........... 1_1 PUF 
S6. Je alikuwa anaonekana kuwa na upungufu wa damu? .......... 
j_I PAL 
(HA=O; ND=1; SI=9) 
S7. Je macho yake yalikuwa na rangi ya njano? (HA=O; ND=1; SI=9) I 
_I LJAU 
S8. Je shingo yake ilikuwa na uvinobe? (HA=O; ND=1; SI=9)....... 1_1 SWN 
S9. Je alikuwa na uvimbe kwapani? (HA=0; ND=1; SI=9)............ J__I SWA 
S10. Je alikuwa na uvimbe sehemu za siri (mtoke)? (HA=0; ND=1; . SI=9)ý_ý SWG 
S11. Je alikuwa na uvimbe wowote mwingine au kidonda sehemu nyingineyo 
(KAMA JIBU NI NDIYO ULIZA SEHEMU NA MUDA) 
S12. Je alikuwa na kikohozi? (HA=O; ND=1; SI=9) ................. 
(KAMA JIBU Ni HAPANA AU SIJUI ENDELEA K WA SWALI LA S13) 
a. Alikuwa na kikohozi. kwa muda ga. ni? (SI=999) ............. 
b. Alikuwa anakohoa na kutema makohozi? (HA=O; ND=1; SI=9)... 
c. Aliwahi kukohoa damu? (HA=O; ND=1; SI=9) .................. 
_ý 
cou 
1-1--1-1 DcO 
I PCO 
". I_1 BCO 
S13. Je alikuwa akipumua kwa shida? (HA=O; ND=I; SI=9)......... DIB 
(KAMA JIBU NI HAPANA AU SIJUI ENDELEA KWA SWAZI LA S14) 
a. Alikuwa akipuma kwa shida mfulu]. izo (=1. ) au kwa vipindi (=2)? 1__ITDI 
a. Alikuwa akipumua kwa shida kwa siku ngapi? (SI=999) ...... 
1_1_1_1 DDB 
b. Je kifua kilikuwa kinatoa. mlio wakati wa kupumua? ........... 
ý. 
_j 
WHE 
(HA=O; ND=1; SI=9) 
S14. Je alikuwa na maumivu ya kifua? (HA=O; NJ)=]; S. T=9)........... I) CHP 
(KAMA JIBU NI HAPANA AU SIJUI ENDELEA KWA SWALI LA Si5 
a. Maumivu yal. i. kuwa sehemu gani ya kitua?....................... . _ý 
SCP 
(katikati ya kifua=l; upande wa moyo=2; nyi. ngine=3; SI=9) 
b. Maumivu yalikuwa ya mfululizo(=1) au ya vipindi(=2)? (SI=9).. TCP 
c. Maumivu makali yalipomjia yalichukua muda gani? .............. _ 
DCP 
(nusu saa=1; zaidi ya nusu saa iakini chin! ya saa 24=2; 
zaidia ya siku=3; SI=9) 
S15. Je alikuwa anaharisha? (HA=O; ND=1; SI=9) ................... DIA 
(KAMA JIBU Ni UAPANA AU SIJUI ENDELEA KWA SWAZI LA S16) 
a. Aliharisha kwa siku n. gapi? (SI=. 999) .................... 
I-I--I DDI 
b. Kuharisha kulikuwa kwa mfululizo(=1) au kwa vipindi(=2)? (SI=9)I_I TDI 
c. Alipoharisha sana, aliharisha mara ngapi kwa siku? (SI=99). I_I_I FDI 
d. Choo chake kilikuwaje? ...................................... 
(_I TST 
(maji maji=l; laini lakini si maji maji=2; damu=3; SI=9) 
S16. Je choo kilikuwa na damu? (HA=O; ND=1; SI=9) ................. 
1 
__1 
BST 
S17. Je alikuwa anatapika? (HA=O; ND=1; SI=9)..................... 1 
_1 
VOM 
(KAMA JIBV Ni IiIAPANA AU SIJUI ENDELEA IOWA SWALI LA S18) 
a. Alitapika kwa siku ngapi? (SI=999) ........................ 
1-1-1-1 DVO 
b. Alikuwa anatapika mfululizo(=1) au kwa vipindi. (=2)? (SI=9).. j_I TVO 
c. Alipotapika sana, alitapika mara ngapi kwa siku.? (SI=99) .. 
1_1_1 FVO 
d. Matapishi yalikuwaje? ....................................... 1_1 CVO 
(maji maji=l; njano=2; kahawia=3; damu=4; kama choo=5; 
mengineyo=6 ; SI=9) 
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S18. Je alikuwa na maumivu ya tumbo? (HA=O; ND=1; SI=9) .......... 
1 
_1 
ABP 
(KAMA JIBU NI BAPANA AU SIJUI ENDELEA KWA SWALI LA S19) 
a. Maumivu yalikuwa ya namna gani? ............................ CAP 
(kunyonga=l; maumivu ya kawaida=2; maumivu yanayo choma=3; 
kuwaka moto=4; mengineyo=5; SI=9) 
b. Alikuwa na maumivu hayo kwa muds gani? (SI=99) .......... DAP 
C. Ni sehemu gani iliyokuwa na maumivu kayo? ................... 
j_ 
_j 
SAP 
(chini ya kitovu=l; juu ya kitovu=2; tumbo lote=3; 
mengineyo=4; SI=9) 
d. Ukali wa maumivu ulikuwaje? (sana=l; wastani=2; SI=9)...... TAP 
e. Je alikuwa hawezi kwenda choo kwa siku kadhaa kabla 
ya kufariki? (alikuwa anaweza=O; alikuwa hawezi=l; SI=9)..... 1 _1 
CON 
S19. Je tumbo lilikuwa limevimba? (HA=O; ND=1; SI=9) ............. ABD 
(KAMA JIBU NI HAPANA AU SIJUI ENDELEA KWA SWAZI LA S20) 
a. Tumbo lii. ivimba kwa rnuda gani? (SI=999) .................. 
1_1_. 
_I 
DAD 
b. Je kuvimba kwa tumbo kulitokea kwa muda mfupi(=1) 
au taratibu kwa. muda mrefu(=2) .............................. 
ý 
_ý 
TAD 
S20. Je alikuwa na matatizo katika kumeza chakula? (HA=O; ND=1; SI=9). I_I DSW 
(RAMA JIBU NI HAPANA AU SIJUI ENDELEA KWA SWALI LA S21) 
a. Alikuwa hawezi kumeza chakula kwa muda gani? (S1=999) ... 
I--I--I DDS 
S21. Je alikuwa na uvimbe wowote tumboni? (FHA=O; ND=1; SI=9) I-I ABM 
(KAMA JIBU NI EAPANA AU SIJUI ENDELEA KWA SWALI LA S22) 
a. Uvimbe huo ulik. uwa sehemu gani? ............................. 
I. 
_I 
SAM 
(kulia kwa tumbo=l; kushoto kwa tumbo=2; chini ya kitovu=3; 
nyingineyo = 4; SI=9) 
b. Alikuwa na uvimbe huo kwa muda gani? (SI=999)........... I_I_I-I DAM 
S22. Je alikuwa na maumivu ya kichwa? (HA=O; ND=1; SI=9) ......... 
1 
___1 
HEA 
S23. Je shingo ilikuwa imekakamaa? (HA=O; ND=1; SI=9) ............. 
STN 
(KAMA JIBU NI HAPANA Au SIJUI ENDELEA KWA SWAZI LA S24) 
a. Shingo ilikuwa imekakamaa kwa muda gani? (9I-999) ....... DSN 
S24. Je kulikuwa na mabadiliko katika akili yake? (HPA=O; ND=1; S1=9)1_I LUC 
(KAMA JIBU NI HAPANA AU SIJUI ENDELEA KWA SWALI LA S25) 
a. Ili badilika ikawaje? .................................... TUC 
(alichanganyikiwa=l; alikuwa hatulii=2; alipoteza fahamu=3; 
mengineyo =4; S1=9) 
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b. Mabadiliko yalikuwa ya muda gani ? (SI=999) ............. 
I--I-I-I DUC 
c. Yalianzaje? .............................................. ouc 
(ghafla=l; katika siku moja=2; kwa siku kadhaa=3; SI=9) 
S25. Je alikuwa na hali ya kushtuka (kama degedege)? .............. 
j_I FIT 
(HA=O; ND=1; SI=9) 
(KAM JIBU Ni HAPANA AU SIJUI ENDELEA KWA SWAZI LA S26) 
a. A2. isrituka kwa muda gani? (SI=999) ...................... 
DFI 
b. (ULIZA ALIKUWA ANASRTUKAJE) ......... ...... .... ...... .... 
I_I TF I 
(mwili mzima=l; nyingineyo =2; SI=9) 
c. Alikuwa akishtuka mara ngapi kwa siku? (SI=99) ............. 
H_I FFI 
d. Je kati ya kushtuka alikuwa akipata fahamu? (HA=O; ND=1; SI=9) j_I BF 
S26. Je alikuwa hawezi kufungua mdomo? (HA=U; ND=1: SI=9)......... 1 __. 
1 LOC 
S27. Je mwili wote ulikuwa unakakamaa? (HA=O; ND=1; S1=9)....... OPI 
(KAMA JIBU NI HAPANA AU SIJUI ENDELEA KWA SWAZI LA S28) 
a. Ulikuwa unakakamaa kwa muda gani'? (S. r=999) ............... 
I-I-I-I DOP 
S28. Je alikuwa amepooza upande mmoja wa mwili? .................. 
HEM 
(HA=O; ND=1; SI=9) 
(KAMA JIBU NI HAPANA AU SIJUI ENDELEA KWA SWALI LA S29) 
a. Alipooza kwa muda gani? (SI=999) ......................... 
I-I-I-I DHE 
S29. Je alikuwa amepooza miguu? (HA=0; ND=1; SI=9) ................. 
PAR 
(KAMA JIBU NI HAPANA AU SIJUI ENDELEA KWA SWALI LA S30) 
a. Alipooza kwa muda gani? (SI=999)? ....................... 
I_1_1_I DPA 
S30. Kulikuwa na mabadiliko yoyote katika rangi ya mkojo?......... 1__1 BIU 
(HA=O; ND=1; SI=9) 
(KAMA JIBU NI BAPANA AU SIJUI ENDELEA KWA SWALI LA S31) 
a. Mkojo ulikuwa wa rangi gani? ................................ 
j_1 UCO 
(njano nzito=l; kahawia=2; mchanganyiko na damu=3; SI=9) 
b. Mabadiliko ya mkojo yaliendelea kwa muda gani? (SI=999)... I-I-I-I DBU 
S31. Kulikuwepo na mabadiliko yoyote ya kiasi cha mkojo wa 
kila siku? (HA=O; ND=1.; SI=9) ................................. CQU 
(KAMA JIBU NI K. APANA AU SIJUI ENDELEA KWA SWALI LA S32) 
a. Kiasi gani cha mkojo kilitolewa kwa siku? .................. AQU 
(mwingi=l; kidogo sana=2; hakuna kabisa=3; SI=9) 
b. Mabadiliko ya kiasi cha mkojo yaliendelea kwa muda gani?.. DQU 
7 
$32. Je alikuwa anakojoa kwa shida? (HA=O; ND=1; SI=9)........... DPU 
(KAMA JIBU NI HAPANA AU SIJUI ENDELEA KWA SWALI LA S33) 
a. Ni shida ya aina gani, al. iyokuwa nayo? ...................... 
j_I TDP 
(Kutoweza kutoa mkojo=l; mkojo kutoka rufululizo=2; 
alikojoa kwa maumivu makali kama moto=3; nyingineyo=4; SI=9) 
S33. Je aliwahi kupasuliwa (operesheni) kabla ya kufariki?....... HOP 
(HA=O; AD=2; SI=9) 
(KAMA JIBU NI HAPANA AU SIJUI ENDELEA KWA SWAZI LA S34) 
a. Alipasuliwa siku ngapi kabla ya kufariki? (SI=999)....... 1_1_1_1 OPD 
b. (NI SEHEMU IPI YA MWILI ILIYOPASULIWA) .... .... ...... ...... 
I_I Op s 
(tumbo=l ; nyingineyo=2 SI=9) 
KAMA MAREHEMU NI MWANAMKE ZAIDI YA MIAKA 50 ENDELEA NA SWALI LA S37 
KAMA MAREHEMU NI MWANAUME ENDELEA NA SWALI LA S39 
S34. Alikuwa mjamzito wakati wa kufariki? (KA=1; ND=O; SI=9)...... 1_1 PRE 
(KAMA JIBU NI HAPANA AU SIJUI ENDELEA KWA SWAZI LA S35) 
a. Alikuwa na mimba ya mi. ezi. mingapi? (SI=99) ................ 
1_I_I MPR. 
S35. Je alijifungua siku 45 kabla ya kufariki? (HA=O; ND=1; SI=9). j_I DEL 
(KAMA JIBU NI HAPANA AU SIJUI ENDELEA KWA SWAZI LA S36) 
a.. Al. ijifungua siku ngapi. kabla ya kutariki'? (SI=9.9)........... 1_I_1 EDD 
b. Alijifungulia wapi? (nyumbani=l; kliniki=2; hosipitali=3; SI=9). j_I PDE 
c. Alishikwa na uchungu kwa, muda gani? .......................... 
1_ý DDE 
(chini ya siku=l; zaidi ya siku=2; SI=9) 
d. Je alitokwa na damu nyingi sana wakati wa kujifungua?........ 1_1 BDE 
(HA=O; ND=1; SI=9) 
e. (FAMA NI NDIYO, ULIZA ALIANZA KUTOKUWA DAMU KIPINDI GANZ) ... 
I_I HDE 
(alipoanzwa na uchungu=l; baadye wahati wa uchungu lakini kabla 
ya kujifungua=2; Baada ya kujifungua=3) 
f. Alijifunguaje ? ............................................. --1 
MDE 
(kawaida=l; mtoto kuvutwa=2; kupasuliwa=3; SI=9) 
g. Je mtoto yuko had? (KAMA aAPANA ULIZA NI LINI ALIFARIKI) ..... 
I_I PNC 
(hai=l; alizaliwa amekufa=2; alikufa katika juna moja=3; 
alikufa baada ya juma moja=4) 
h. Je aliwahi kuwa na matatizo ya uzazi hapo nyuma? ........... 
j_ I PCD 
(HA=O; ND=1; SI=9) 
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S36. Je mimba iliharibika katika siku 45 kabla ya kufariki?...... j_I ABO 
(HA=O; ND=1; SI=9) 
S37. Je alipata kutokwa na damu bila mpangilio sehemu za siri? ... 
j_I ABV 
(HA=0; ND=1; SI=9) 
S38. Je alikuwa na uvimbe au kidonda katika maziwa? ............... 
1_1 BT 
(H11=0; ND=1; SI=9) 
S39. Je aliwahi kuumia kabla ya kifo chake? (HA=O; ND=1; SI=9).... 1_1 INJ 
(KAM JIBU NI HAPANA AU SIJUI ENDELEA KWA SWALI LA S40) 
a. (KAMA JIBU NI NDIYO, ULIZA KUJUA AINA YA JERAHA) .......... _I 
TIN 
(kupigwa=l; ajali ya barabarani=2; jeraha la vita=3; kuumwa na 
mnyama=4; ajali ya moto=5; kunyweshwa sumu=6; mengineyo=7 
b. Aliumia siku ngapi kabla ya kufariki? (SI=999)........ DIN 
S40. Je unadhani alijiua? (HA=O; ND=1; SI=9) ..................... 
SUI 
(KAMA JIBU NI KAPANA AU SIJUI ENDELEA NA SEHEMU INAYOFUATA) 
a. Alijiuaje? .................................................. 
Ij TSU 
(kujinyonga=l; kunywa sumu=2; kujichoma moto=3; men_gineyo=4 
VI. Interviewer's comments and observations 
41. Interviewer IDNO .......................................... 
ý.. I 
42. Interviewed on .......................... 
(dd\mm\yy) 
Interviewer's assessment of cause of death 
Cause of death 1 
Cause of death 2 
IID 
DOI 
APPEDtx -( 
Verbal Autopsy Questionnaire for Adult Deaths 
I. ?I %T 09,1. 'NC? IC o'G9 
Q1. ny- Q2.. IDNO I_J_IJJ IDN 
Q3. Ax-1,7r 
Q4. Pal* bfi°g IJ. J AOD 
Q5. R. 0° /m7it=1 .t=2........................ Lj SXD 
Q6. ?I. fP? AY Ukf" ............................. IJ MSD 
p47n*/n = 11 Plq/q* =21u., +1* 1£ tAfl =3 
P9°fin /a3ý =4/ 
Q7" P°X* Poajtfl7 +9°UC+ itz. ...................... 
LI_I YED 
Q8. VOA* pa.. .............................. .. 0CC 
III. J% 7. °R 4- 
Q9. ha o9°'* t ar nd. + n9°7 SVA 4's. j- fr n. lflC? /Mw. - 999/ I_I_I_I DID 
010. ýv. lap (dd/mm/yy) ........ i_I-ICI _I_IýI-I DOD 
011. Q jai-/ trnx. nihn. xh =21 Mn- 3/ I_I POD 
(If the answer is home or others proceed to Q12) 
a. P+70). ßh. 9° (L+ a)-AT la). P9°-b+7 ................ 
b. ° A9'°1 ?. ')R9°+ hhh. 9° (L+ w, +**** fi, 0)C4' MC? 
/PA9° =0 12r p =1 I XC"1m0 }rJRAV. 9° =9/ ........ LJ RIF 
Q12. e9°-bne. 1 9°h-). ff n. M? / ? Ar =01 hp' =11 
nC1m7 hf, RAU-9° =9/ ......................:..... (_j RKC 
a. If the answer is yes probe to sepcify the cause(s) 
cause (1) I_J_J_J RD1 
cause (2) 1 J-J_J RD2 
Q13. (Ask whether s/he had any of the following illness) 
a. g9° flN+ (hypertension) .... (no. =0; yes=1; DK=9)... 
b. A!. c nnfr (diabetea).... (no=0; yes=1; DK=9)........ 
c. ? °7. TA 0*6fr (epilepsy)... (no=0; yes=1; DK=9)........ 
d. w7n y4ci (TB)... (no=0; yes=1; DK=9) .............. 
G. Jt-h (AIDS).... (no=0; yes=1; DK=9) ................ 
I_I HYP 
U DIA 
1J EPI 
Li PTB 
(_J HIV 
154 
IDNO: LJ J 
IV. Respondent's account of final illness of the 
deceased 
Summary of symptoms " igns reported by Respondent 
Symptoms Duration Severity 
1. 
2. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
IDNO: I_J_J__J IDN 
V. questions to probe for symptoms & signs of final 
illness of deceased 
Si. 'tpW" 'fLTm. mj? .................................. I_j FEV 
/AAln/-*r «), Al* =0 ; ynr, w. nfls =1 Mw49° «Ma» =9/ 
(If the answer is no or DK proceed to S2. ) 
a. tr"iJ 9°1 fUA qS. Ifl m.? /Ma' = 999/ .............. 
IJJJ DEF 
b. +trw-b VJ &A7 MC? /nay =o: 'n =111 Mme= 9/.. * ... 0.00*.. J_j SFE 
c. 'trw-h fAOMT ync wrn nit % Ar, ync? ............... J_j TFE 
/fA-07*4T =1 t }, AM hAr= 2 Ma' =9/ 
S2. Amy a=te nJ& n19, + lP. Ia,.? AM =01 M-11 %Aa)-=9/......... Lj RAS 
(If the answer is no or DJ proceed to S3) 
a. '6%0, m- 9") ? VA +S+ jflZQT-or? /h4ar =999/ ............... 
IJ_J_j DRA 
b. ac. +m- 9°7 ßon11A l(lC? ................................. 
I_j TRA 
M-T-15 tºJO+ ý5cf- =1 i m. U V*mz. ý5cfr =2 t oolA Pf ii 
i'icfi=3 M iJ&I+ %TO, /1&7A. T/ =4fh4ar=9/ 
C. W7-To- +A+ y1W/ /, Al =01 }f =11 h4a)- =9/ .............. LJ SEY 
d. f4hhFm. MC? /)r4 =01 'y0 =1 Mw =9/ ................... 
(I ITC 
S3. hoo9°f! Fm. n44- Tij ßxr -00 hhtw- MC? ................. 
U LOW 
/}`Ay =O1 l (l =1 1 Ma- =9/ 
(If the answer is no or DK proceed to S4. ) 
a. b4, +Ta- X'Xý+ MC? ................... "................. SLW 
/n'q9° =1 mann' =2 1h 4a)- =9/ 
S4. X-74-: Fm- h-Om ', nc? /. %A, =01 }n =11 Mw =9/ ................ SAA 
(If the answer is no or DK proceed to S5) 
a. A90 fVA S+ h-lin if1C? /h4m-=9/ ....................... I_J- DSA 
S5. a. fT-w. kiln MC? AM =01l =11 MMa =9/............ Ii PUF 
S6. d., +w rT4 MC wJV /hA' =01 }(1=11 h4m- =9/ ............. II PAL 
S7. gzS7mý w. fl' L 'Aw«m y(1C? /AA' =0: yfl =11 }, +ºý0. =9/ ..... 11 JAU 
s8. n}1 aýw 1 M4lm4- mc? /j i =O M =it Mw =9/.......... Lj SWN 
S9. ýnýnf w &? M1m+ mc? ix4, =0 IM =11 M4 =9/........... II SWA 
SlO. ýýa. ý nJ& ? flm+ WIC? AA =01 10 =11 Mal- =9/ ........ IJ SWG 
S11. M x-nmt mrr 'Mnat flAa fries nj& mc? 
(If the answer is yes probe for the site and duration) 
S12.4aß yfl w.? /nary =0191 10 =11 Mm. =9/, ,00....... *000a00. U cov 
(If the answer is no or DK proceed to S13) 
a. A907 fUA +S AA W-T- .? / }ß+1a. =9/ ................. 
(J-J. J DCO 
b. A. fM wp hhfr 1, maqT-m" Inc? / Jr j =01 If =11 Li PCO 
co Ahrtw- Rp }flew? /hAl =01 }0 -llMto'O9/ ............. 
Ii BCO 
S13.4-74.75 f' Jj . MC? /hAy =0 I yn =11 Mmý=9/ ........... 
U DIB 
(If the answer is no or DK proceed to S14) 
a. t'X. is PTU. 1hAi fAO7* v WIC-11 mtn hAlZ )AC MC 
M09*4T =1: hAM hAb, =2i \4a). =9/ .................... 
U TDB 
b. 9-7 SVA +c J-'}4. n f' U, J n yfC? /hnmv =999/.......... I_1_I_I DDB 
c. AA-149eý +74.7f*m- k9OW J&m Qm" Inc? .............. LJ' WHE 
/hAi =01 111 =11 Mal- =9/ 
S14. jtG, + m- AJ& alao9° WZY0 mpa+ J&A°9*m- ß(1C3 ............... II CHP 
/Mti =0 fl =11 Mm- =9/. 
(If the answer is no or DK proceed to S15) 
a. ghema. fl fr to' nP ý MOM UllVm- MO........... Li SCP 
/ouOA RG, 'T-m- Aj& =11 A'FI w Aj& =21 M MOM =31 
Mai- =9/. 
b. aooaa AA°9*GT j&A°7 tw WC wrn AAlZ AAC U07-Im- 
Inc? ................................................ Lj TCP 
/SAa7*ZT. I, )- =11 ?, AC ß, 4g =2+ Mw =9/ 
C. nfqg° fra w MC '. n g, n9" Ar} PatR '. K Inc DCP 
/30 R*, + =1 I 30 g+1 24 A7 =2t 24 At =3 
Map =9/ 
S15. ++07T Ife4ty-7 /W =01 }n =11 Mm- =9/ ................. Lj DI 
(If the answer is no or DK proceed to S16) 
a. A907 Pt1A +S+ fis°9T ynr. m.? /MAw- =999/ ............. LJ_J_I DDI 
b. 'I-'°9m" fAol*&r ynC mrn MG: % AC ync? ................. 
J_J TDI 
/IIA09*4T =11 AAC hAa =2f Mw =9/ 
c. a-+09mß nnG, 'q m- m++ n+-) 9°-) AM 1.1L M-Yulºl m" MC? ... 
IJJ FDI 
/Mw =99/ 
d. fi+0941- 9°-) fnutiA MC? .................................. Lj TST 
/+'i'7 AUw. Y =1 1 4'm} , fA =2 1h4ca =9/ 
S16. £90 Fn+9°' T-a)- ync? /hAI=O In =1 I %4a)- =9/............ Li BST 
S17. fnf'mýh w. ync? /hAl =01 In =1 1jin. =9/ ............... 
U_j vom 
(If the answer is no or DK proceed to S18) 
a. A907 SVA +c fA; mph au. inc? /Mw =999/ ............. 
I_J. J. J DVO 
b. +mfi-h tAOA*GT MC ah %AC )AC yfC? .................. 
Li TVO 
/QA°9*41P =1 1 %AC % Aa =2f %4m. =9/ 
c. +m-h-h nfl . +tl m- m4,4- 9°7 : UA 'l. 1i lný'arll mý ync? 
/Il%. =99/ ......................................... 
I_J_j FVO 
d. 1M-n-lz 9°7 J&anAA mC?... ................................ II. CV0 
% a)-Y=1". - tLa3 ooAA d. 41 =2: 
(h97°9 &471 =3 1 R9° 4-A4-A =4 w? L, ouAA =5 1M onAh 
hyntwP 01AN =6 1 A40P =9/ 
S18. trWajw f° Vtv- mc? JAI=o: m =1 1 nMw =9/ .............. Lj Asp 
('If the answer is no or DK proceed to S19) 
a. ý7tanaw X1} _ y(IC? .................................. ... 
(J CAP 
/hif. *Cm+ =1m.? ) =2 4°7frmA =3+ M gay =41 
Map- -9/. 
b. A9°' PUA +, 94. w. } P°7: =aP- yfC? /h4co- =999/......... 1_LJJ DAP 
C. Aouao. fl fei 'm. ME, fl? -1-7a)- htill(L AA°Y m- WIC?............ Lj SAP 
/h? %9°, fCf'? %fm f. J'T =11 hh9°i(1Cf-Tcw fl 4J& =21 
004 lPrR-7m-7 =3 M hA J&7AJr -4 1 Mw- -9/ 
d. WA-f ,. chdm9° -f« 1. p IUA in(:? ...................... 
Lj TAP 
/(l, rº1r =11- auhhAY =21 oomy ' =3 1 )%4a)- =9/ 
e. hvalr0+ ,. (1i. 4- T*+ +r 1W A74 Ponar'11 T1C 
(1&OT-aO ........................................... .. 
L_j CON 
AA, =0: 10 =1 t Ma' =9/ 
S19. tr. gT-a fiyc+ ync? /nary =0: 10=11 new=9/ ................ 
Lj ABD 
(If the answer is no or DK proceed to S20) 
a. A907 $VA +174- tr. %Tap ic ynC? /Ma' =999/........... IJ_JJ DAD 
b. ? tr w cvH. i m-%stv+ llh PC JL m-f P MfºZ m 1) +1 
n+n n4yrr '. n i h? .................................. U TAD 
/a)APar iqapC 7. tL=1f +n n+n n4j-r° J fL=2t MA =9/ 
S20. riii AooTT J&hAh4T WIC? / AA 1=01 yfl=1l Mw =9/........ U DSW 
(If the answer is no or DK proceed to S21) 
a. A9"} SUA +S rII Aao1'T J'hAh4-Vm' W1C? / Ma' -999/..... U I_I DDS 
S21. fi lw m-lvr Avnm+ yn4. a. mj&? /j ny=ol In=11 
Ma)- =9/ ............................................. 
Lj ABM 
(If the answer is nor or DK proceed to S22) 
a. nt'R a. wAT x1nm e Mflfl. ync? ........................ (J SAM 
/n+'I nthA/n7*nI hhQai =11 n1l.. (. A=21 hh? ' flCI 
of*a 319, f&4 Jana nary lnsr= 9/ 
b. n9°' fvt +c Xflm' JfZn*w.? /MMw =999/ ............. LiJ_j DAM 
S22.1, nr, ++ yfl w.? /? A =o: m=1. Mw =9/ .................. I_J HEA 
S23. ý z. ýý 1+t ýmý w mc? / Ay=o1 111=1X Mtn =9/........ II STN 
(If the answer is no or DK proceed to S24) 
a. A9°' PUA 9. H. 07kl-a=m-i ? +C J&? IT -aP MC? /h'w. =999/. LjJ_J DSN 
S24. ', n. sa-a 'tnm. in mc? i j tt =o: m =1 xMaP=9/ .............. I_j LUC 
(If the answer is no or DK proceed to S25/ 
a. eaI. sea> auAmT (19-7 t>% 4it Wie? ........................ Lj TUC 
/ooHAL* =11 L-4Im"7 Y'-1'm. i(1C =2i M hLJ' 0IAjr=31_=9/. 
b. n9°ß fVA +c V&. 17-1a)- I Aw to MC? /h4m- =99/ ............. I_I_i_I DUC 
c. nýý. ooi dp? /ný71+ =i: 1W}$ +, ) m. nm=as nos 
a-IT =3: %4m* =9/ ...................................... 
J_j OUC 
S25. f +m-a w. mc? /j tt =O IM =is Mal- =9/ ............... U_j FIT 
(If the answer is no or DK proceed to S26) 
a. AT'-) PVA ýS Pýýmýºýl ar ync? /, h4 =999/ ............. I_J_I_i DFI 
b. xýR. ý- Pýým ýºt mý xýxyný ýýºAý. ý oolt =1: xX10'} 
mf, 7r x°1 L, m-i fns =21jh . =919 9*9. **. a. soo*oo**oo**.. *** 
Lj TFI 
c. nir° & 'ir°narw n+, r, fVA '. n fuofqnrap ync? 
h40). 
V! _ 
=99/ 
............... 000000. ..... ................... 1ýfJ 
FF I 
d. flfnu +T+[ro amYs\ A4eo-i So)-* WIC? /jttY O: W1=1: Mw =9/... 11 BFA 
S26. y, ¢. -cu-i ouhd. + AhAh+1T-m- yflc? //hAS=O's 1fl=1: Mal- 9/ IJ LOC 
S27.0,, d Aar}, 'tw. } 7+C A1i9'Tau- Inc? //hA'i=O1 M41 Ma' =9/..... Li OPI 
(If the answer is nor or DK proceed to 028) 
a. Arl SVA +474- nm-y, +aw) J+C JUxX'fai. 100 /Mw =999/..... I_i_I-I DOP 
S28.1707% Am-y, ' un-7 75f1 t'c yf(:? /hA5=0: S(1=1: Ma,. =9/.......... J_j HEM 
(If the answer is nor or DK proceed to S29) 
a. n907 IUA +s4, 'sny+ ynr, a)-? /n4w=999/ ................. ILIJ DHE 
S29. hmr-n nfY- *sn trym- Inc? /nary=0e yn=1: iw =9/............ I_j PAR 
(If the answer is no or DK proceed to S30) 
a. A9°') $VA +c hwifl (1, +** 'Aiß 'w Inc? 1Mw- =999/....... I J_. J DPA 
S30. P'67 J. ar aoAh ++J&C Wnc? // jAy=O1 yn=1i Ma' =91........... LJ CCU 
(If the answer is no or DK proceed to S31) 
a. 75e}, r. m. 9°7 . aa1iA WIC? ................................ 
I_j TCC 
/. flat =1 n , 7o? =2 .r 4ºA'A =3 )%4w- =9/ 
b. A9°7 ? VA +c PZi-M'a=a- wAh fi+. C MC? /Mw =999/ ..... 
UJ. J DCC 
S31. fl? + Q°zný. + n'+ Pam3 A0 ? Wao-UnAy=o: M-41 MME =91.. II CQU 
(If the answer is no or DK proceed to S32) 
a. nP+Y- P"7ý'iSk P*674. aom7 9°, ) PUA MC?....... " .... ". "... "". 
IJ AQU 
/new -ns- =1 niqs- 4-7% =2 g°r =3 Map-=9/ 
b. n9°7 fVA +c nI aom7 Am-T MC? /Mm- =999/ ......... (-I-I_) DQU 
S32 n7+ im'ds+ J&nnhnta)- me? /)%AI=o: M=1: Mal- =9/ ............. 
IJ DPU 
(If the answer is no or DK proceed to S33) 
a. ASR. cD71S' 1FhAhd w. , lC? .............................. 
(-j TDP 
=2: t, ý Mr Inc =1 . pA°7*LT JG-)mqm-nq a)- Inc 
f r' Ia Inc =3 : MMw. =9/ 
S33. hcoTlfaFo. C-n IIL ni. + hýrtn. Yý +XC14tm' MC? ............. U_j HOP 
/jai=o: in =1 : hýºmý=9: / 
(If the answer is no or DK proceed to S34) 
a. hoo9°"ar ni+ +i 04 + MC NW-AX-7 PfiWAT0 ? /h4ai =999/.. (JJJ OPD 
b. hAa)-S, ' m +1' iTL-A lr, 7 MZ47-fi-16 V11- hhO(L Jca? .............. 
ýJ OPS 
/ IPPIa)- =1 :M Af' hiT, 1M =2/ 
IF THE DECEASED IS A FEMALE AND > 50 YRS OLD PROCEED TO S37 
IF THE DECEASED IS A MALE PROCEED TO S39 
S34. nn44-114- In ylgnm-c Me,? nary=o: m=1: nýºw=9i .............. 
Lj PRE 
(If the answer is no or DK proceed to S35) 
a. PAI+ me lv. Anr(: yn4.? /h40). =99/. ......................... 
I J_j MPR 
S35. how9°. +*m- 45 +c+ flL'I mA. w IOC? ....................... 
U DEL 
/ nAi=Ui 111=14- h4m"=9/....... 
(If the answer is no or DK proceed to S36) 
a. hou9°; f'-Tm" nr» +c. na. ' WIC ? mn. P, +? /Mal- =99/ LjJ EDD 
b P+ Inc PmnR. 44 ..................................... Lý PDE 
/n. =1 : h1Lxh =2 i trhT A =33 &4 fib' =41 h4m. =9/ 
o. 9° n. Ar'} fVA 'I. n 4PQn ap-3. .............................. LJ 
DDE 
/h-)t +7 =1: hh7t q-) n4 , =2 : xnm- =9/ 
d. n. mA-'ý. 411P x9o J&d. 4a: m- mc?............................... I_j BDE 
/ nary=o: 10=1: n4m-=9/- 
e. xr fa. na: m. lntm" Ak hwAJ, flL. + Id)- aAn non ym-?......... 1J HDE 
f. hwi A. 3. j g_ yfC? ..................................... MDE 
/n+hhA 'n4;? - =1; noow¬f =2 =3 Mm" =9/ 
g. X10 . uc lm.? (If no, probe 
for the time of death) U_j PNC 
/ X01; =11 'i°+ tmnR =2 nfimn. n7 cl a). n-r rt =3 
h+mn. h7 +cl non Spa- =4: %4m- =9/ 
h. hN nd. + &. aAR. Pmn. t T07C Inr, m"? hAI=U: In=1: J%4w--9/ ..... LJ PCP 
S36. noa1fa: ap. 45 +e; +. in)-Ar nnmc&Tap- Inc? ................ U Aso 
/ AAI=O1 yn=1: ß. 4m-=9/ 
S37. hAa ?A (FFA. yw. xý ýý. nn ý yncý ................... U ABV 
S38. rte mý 4l& ? %-Om+ mJ&9° hhA MC? ....................... IJ BT 
/jS =os In=1: M ». =9/ 
S39.1. Rß RCAgT-w. yw. P9°-h:? .............................. Lj INJ 
/ hAy=oi 10=1: Mw =9/ 
(If the answer is no or DK proceed to S40) 
a. (If the answer is yes, probe for the type of injury). LJ TIN 
/(19A 1Pf =1i faoh. S i= 2} (1mc = 3; - (ihm. L faoThn =4v 
(U. 4+ ! ºR? = 5f (ouch = 6e fiM im+ mu hL f, 7A* =7 %4a). =91 
b. hA7+ +) nk+ yap- )%x. 9 exZAn*au-7 ..................... I-I-I-I DIN 
S40.0.4a: m-7 ne. Wap e7xM Awonn-, +A? nail=o: m=11 hna)-=9i ....... u SUI 
(If the answer is no or DK proceed to next section) 
a. 11}f. + ym- L. dVt a . 3} P7RAM+?................................. Lj TSU 
/no-h+A=1 i nouC'N =2: nhil nnofrmA =34 fM U-if' M CwIA& =4 
Ma =91 
VI. Interviewer's Comments and Observations 
Interviewer's assessment of cause of death 
Cause of death 1. 
Cause of death 2. 
Cause of death 3. 
42. Interviewer IDNO .................................... I II IID 
43. Date of Interview ....... dd/mm/yy IJ_f / IJ I/U_j DOI 
". '! PPEmix VERBAL AUTOPSY QUESTIONNAIRE FOR ADULT DEATHS 
, I: Eenyummaan namicha 
isa du'ee 
1. Magaa 2. IDNO.. 1_1_1_1 IDN 
3. Teessoo 
4. tlmrii namichi du'ee ....................................... AOD 
5. Saala (dhiira=l; dubartii=2) ............................. SXD 
6. Waayii fudhaf heruma namicha isa du'ee ..................... 
I_ý MSD 
(qeerroo=l; kam fudhee/herumee=2; kan hiikee/gargar bahe=3; 
kan jalaa du'ee=4) 
7. Namicha du'ee sun waggaa hammami barachusa ................. YED 
8. Hojii namicha du'ee I_I OCC 
II: Akkaataa du'aa namicha 
9. Otuu hindu'iin dura guyyaa meegaa dhukubsatani turan?..... 1_1_1_1 DID 
(hin beekne (DK) =999) 
10. Yooin du'an? (dd/mm/YY) ........................ 
DOD 
11. Eessatti du'an? (home=l; hospital/clinic=2; others=3)........ J_1 POD 
(IF THE ANSWER IS HOME OR OTHERS PROCEED TO 12) 
a. Maqaa hospitala isaani keessati du'an? 
b. Dunni isaani maalif akka ta'ee namooni hospitala keessa. 
isintti himaniru? (miti (no) =0; eeyye (yes) =1; DK=9) ...... . 
12. Dhiibeen isaan ittin du'an beekta? (no=O; yes=1; DK=9) ..... 
a. IF THE ANSWER IS YES PROBE TO SPECIFY THE CAUSE (S 
RIF 
ý_ý RKC 
cause (1) 1_1_1_1 RD1 
cause (2) 1_1_1_1 RD2 
13. (ASK WHETHER S/HE HAD ANY OF THE FOLLOWING ILLNESS) 
a. Ba'yeena dhiga (Deembiizaati) ..... (no=0; yes=1; DK=9).... 
I_ I HYP 
b. Dhukkuba shukkaaraa (diabeteesi).... (no=0; yes=1; DK=9).... I_ 1 DIA 
c. Dhukkuba gaggabduu (maraanmartoo; Ep ilepsy) (no=0; yes=1; DK=9)1_ 1 EPI 
d. Dhukkuba sombaa (TB) ................ (no=0; yes=1; DK=9)... 1_ 1 PTB 
e. Eedsii (AIDS) ...................... (no=0; yes=1; DK=9)... 1_ 1 HIV 
161f 
2. DNO: I_1_I-1-1 IV: Respondent's account of final illness of the deceased 
Summary of symptoms & signs reported by Respondent 
Symptoms duration Severity 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
2. IDNO: IDN 
V. Specific questions to elicit symptoms & signs of final illness 
Si. Jismi (dhaqna gubaa), gabu turee? .............................. 
FEV 
(mi ti (no) =0,; eeyye (yes) =1; hin beknee (DK) =9) 
(IF THE ANSWER IS NO OR DK PROCEED TO S2) 
a. Jismi kun guyyaa meeqaa isaan irra turee? (DK=999)....... DFE 
b. Baayy'ee cima turee? (no=0; yes=1; DK=9) ..................... 
ý_. SFE 
c. Jismi guba sun walit-fufee (waluma galaa) irra turee ra moo 
darbe darbetu? (wallt-fufee=1; darbe darbe=2) ................ 
ý_ý TFE 
S2. Dhagna isaani irratti shiffiittoo gabatani turee?............ 
1_1 RAS 
(no=0; yes=1; DK=9) 
(IF THE ANSWER IS NO OR DX PROCEED TO S3) 
a. Guyya meeqaa shiffiitto irra turee? (DK=999) ............. 
DRA 
b. Shiffiittoo s un mal fakkata turee? .......................... 
TRA 
(shi ffiittoo kan gifiraa=l; shiffiittoo bishan qabu=2; shiffiitoo 
malaa qabu=3; kan bira (ibsi) =4; DK=9) 
C. Ijii namichaa du'e diimaatee turee? (no=0; yes=1; DK=9)...... 
SEY 
d. Dhaqna isaani hoqsisaa turee? (no=O; yes=1; DK=9)............ 
ý_ý ITC 
S3. Osoo hinduIiin dura hugqatani turani? (no=0; yes=1; DK=9)..... LOW 
(IF THE ANSWER IS NO OR DK PROCEED TO S4) 
a. Huqqachu isaani bayy'ee cima turee? .......................... 
SLW 
(bayy'ee cima=l; giddu geleessa=2; DK=9) 
S4. Milli isaani dhita'ee turee? (no=0; yes=1; DK=9) ............. 
SAA 
(IF THE ANSWER IS NO OR DK PROCEED TO SS) 
a. Guyya meegaa dhita'ee turee? (DK=999) .................... 
DSA 
S5. Fuulii isaani bookokee (dhita'ee) turee? (no=0; yes=1; DK=9)... 1_1 PUF 
S6. Fuulii isaani addatee (daalacha'ee) turee? (no=O; yes=1; DK=9)I_I PAL 
S7. Ijii isaani keelloottii geeddaramee turee? (no=0; yes=1; DK=9)I_I JAU 
S8. Morznii isaani dhita'ee (xannachee) turee? (no=0; yes=1; DK=9)1_1 SWN 
S9. Boobaan isaani dhita'ee turee? (no=0; yes=1; DK=9) ........... 
1_1 SWA 
S10. Mudamudhin isaani dhita'ee turee? (no=O; yes=1; DK=9)......... 1_1 SWG 
S11. Dhita"aa ykn madaa dhagna iddoobira gabu turee? 
IS YES PROBE FOR THE SITE AND DURATION) 
(IF THE ANSWER 
S12. Qufaa gabu turee? (no=0; yes=1; DK=9) ......... ............ COU 
(IF THE ANSWER IS NO OR DK PROCEED TO S13) 
a. Guyya meeqaa quffaasisaa? (DK=999) ....................... DCO 
b. Qufichi tufaatii qaba turee? (no=O; yes=1; DK=9) ........... 
I_I PCO 
c. Dhiga qufaasisaa turee? (no=0; yes=1; DK=9) ................ 
ý_) BCO 
S13. Afura kuta turee? (no=O; yes=1; DK=9) ....................... DIB 
(IF THE ANSWER IS NO OR DK PROCEED TO S14) 
a. Afura kuta sun walit-fufee irra turee ra moo darbe darbetu?. TDB 
(wali t-fufee=l; darbe darbe=2; DK=9) 
b. Guyya meeqaa afura kuta turee? (DK=999) ................. DDB 
c. Yeroo afuri baha sagaalee (qoksisaa) qaba? (no=O; yes=1; DK=9) ý _ý 
WHE 
S14. Waransa gomaa (laphee) gabu turee? (no=0; yes=1; DK=9)...... CHP 
(IF THE ANSWER IS NO OR DK PROCEED TO S15) 
a. Waransichii eessatti dhaga'aamee turee? ................... 
SCP 
(giddu harmoolee=l; onnee (laphee) oli=2; bakaa bira=3; DK=9) 
b. Waransichii walitifufa turee moo darbe darbetu? ............ TCP 
(walit-fufee=l; darbe darbe=2; DK=9) 
C. Inna waransichii itti jabatuu ammam irra tura turee? ....... DCP 
(<30 dagiqaa=l; >30 daqiqaa - <24 sa'ati; >24 sa'ati) 
S15. Garaa kaasa (boolii) gabu turee? (no=O; yes=1; DK=9) ....... 
ý_ý DI 
(IF THE ANSWER IS NO OR DK PROCEED TO S16) 
a. Guyya meeqaa garaa kaasee turee? (DK=999) ............... 
DDI 
b. Garaa kaasan sun walit-fufee irra turee ra moo darbe darbetu? TDI 
(walit-fufee=l; darbe darbe=2) 
c. Inna itti jabatu guyyaa tokkoo keessa almeeqa kaasa turee? FDI 
(DK=99) 
d. Kaasichi (boolii) isaani mal fakkaataa turee? ............... 
1_1 TST 
(qalla akka bishani=l; xinno qalla=2; akka dhiga=3; DK=9) 
S16. Kaasichi dhiga qaba turee? (no=O; yes=1; DK=9) ............. 
1_1 BST 
S17. Oldeebisa (hoogisaa) turee? (no=O; yes=1; DK=9) ............ 
1_1 VOM 
(IF THE ANSWER IS NO OR DK PROCEED TO S18) 
a. Guyya meeqaa oldeebisa turee? (DK=999) .................. 
DVO 
b. Oldeebisun walit-fufee irra turee ra moo darbe darbetu? .... TVO 
(wallt-fufee=l; darbe darbe=2; DK=9) 
c. Inna. itti jabatu guyyaa tokkoo keessa almeeqa oldeebisa 
-turee? (DK=99) ....................... .................... FVO 
d. Inni oldeebi'ee sun mal fakkaataa turee? ................... CVO 
(waan nyaatameetu bahe/ galla akka bishani=l; dararaa kelloo 
(aldeedoo)=2; buna danffa (buni fakkata)=3; akka dhiga=4; 
akka booli. i boobba=5; kan bira (specify) =6; DK=9 ) 
S18. Dhukkuba gara qabu turee? (no=O; yes=1; DK=9) ............... ABP 
(IF z ANSWER is No OR DK PROCEED TO S19) 
a. Dhukkubichi akkam isaan godha turee? ........................ 
CAP 
(cininna=l; waraani=2; gubina=3; kan bira=4; DK=9) 
b. Dhukkubichi guyya meeqaa irra turee? (DK=999)............ DAP 
c Dhukkubichi iddoo kam dhukkuba turee? ...................... 
SAP 
(hannurasa jala (gara gadi)=1; hannurasa oli (gara oli)=2; 
gara bakka hundaasa=3; hannurasa irra=4; DK=9) 
d. Garaa cininnaan (warani) sun cimaa turee? ................. TAP 
(bayy'ee cima=l; giddu geleessa=2; laafa=3; DK=9) 
e. Osoo hindu'iin dura boolii bahu dhowwee turee? .............. CON 
(no=0; yes=1; DK=9) 
S19. Garaan isaani bookokee turee? (no=O; yes=1; DK=9)............ ABD 
(Ir THE ANSWER Is No OR DR PROCEED To S20) 
a. Garaan isaani guyyaa meeqaaf bookokee turee? (DK=999)... DAD 
b. Garaa bookokin kun al tokkon guddatee moo yeroo dheera 
keessati suuta jedhee guddatee? (al tokkon=l; sutaan=2; DK=9). (_ý TAD 
S20. Waa ligimsun isaani rakkiisa turee? (no=O; yes=1; DK=9)..... 
DSW 
(IF THE ANSWER IS NO OR DK PROCEED TO S21) 
a. Waa Liqimsun guyyaa meeqaaf isaani rakkiisa turee? (DK=999)1_1_J_1 DDS 
S21. Garan isaani keessa dhittoo (dhittaa) qabu turee? .......... ABM 
(no=0; yes=1; DK=9) 
(=F TUE ANSWER IS NO OR DK PROCEED TO S22) 
a. Dhittoon sun iddoo kam turee? .............................. 
SAM 
(gara mirga=l; gara bita=2; gara gadi (hanura jala)=3; kan bira 
(ibsi) =4 DK=9 ) 
b. Dhittichi guyya meeqaa isaan irra turee? (DK=999)........ DAM 
S22. Mata bowwuun isaan gabs turee? (miti=0; eeyye=l; DK=9)...... 
I_) HEA 
S23. Mormi isaani googee turee? (miti=O; eeyye=l; DK=9).......... STN 
(IF THE ANSWER IS NO OR DK PROCEED TO S24) 
a. Guyyaa meeqaaf mormi isaani googee turee? (DK=999)....... DSN 
S24. Qalbii isaani geeddaramee turee? (miti=O; eeyye=l; DK=9)... 
(IF THE ANSWER IS NO OR DK PROCEED TO S25) 
a. Qalbiin isaani geeddharamunsa akkam ture? ................. 
(jonja'uu=1; of wallaaluu (qalbi dhabu) =2; kanbira Mc@@sý ö-) 
=3; 
1_1 LUC 
1_1 TUC 
DK=9 ) 
b. Guuyya meeqqaf galbiin isaani geeddaramee turee? (DK=99).. 1_1_1 DUC 
C. Akkamiti jalgabee? (al tokkon=l; suuta jedhee guyyaa tokko 
keessati=2; suuta jedhee guyyaa ba'yee keessati=3; DK=9) .... 
I_I OUC 
S25. Gagabdu (romfisisa) gabu turee? (miti=O; eeyye=l; DK=9)..... FIT 
(IF THE ANSWER IS NO OR DK PROCEED TO S26) 
a. Guyyaa meeqaaf gagabdu isaani irra turee? (DK=999) ...... 
1_1_1_ I DFI 
b. Ibsi akkataa gagabduchii akkam akka turee? .................. 
TFI 
(jismi (dhagna) hundatu hoollataa=l; kan bira (61ofl(cmdo) 
=2; DK=9) 
c. - Inna gagabdichi bayy'iise itti dhufu, guyyaa keessa 
meeqaa turee? (DK=99) .................................... 
FFI 
d. Giddu gagaabina keessati sirritii of beeka turee? .......... BFA 
(miti=0; eeyye=l; DK=9) 
S26. Afaan isaani banachuuf rakko qabu turee? (miti=0; eeyye=l; DK=9) LOC 
S27. 'Jismi (dhaqna) isaani googee turee? (miti=0; eeyye=l; DK=9).. OPI 
(IF THE ANSWER IS NO OR DK PROCEED TO S28) 
a. Guyyaa meegaaf googee turee? (DK=99) ...................... 
ý_ý_ ý DOP 
S28. Jismi (dhagna) isaani gar tokkeen sochoo'u dadhabee 
(lawwasha'ee) turee? (miti=0; eeyye=l; DK=9) ... .......... 
HEM 
(IF THE ANSWER IS NO OR DK PROCEED TO Q29) 
a. Guyya meeqaaf lawwasha'ee turee? (DK=999) .............. 
DHE 
S29. Jismi isaani mudhi dha gads itti lawwasha'ee tureen ....... PAR 
(miti=0; eeyye=l; DK=9) 
(IF THE ANSWER IS NO OR DK PROCEED TO S30) 
a. Guyya meeqaaf lawwasha'ee turee? (DK=999) .............. 
I 
_I _1_I 
DPA 
S30. Fincaan (bifa) isaani geeddaramee turee? (miti=0; eeyye=l; DK=9)1_1 CCU 
(IF THE ANSWER IS NO OR DK PROCEED TO S31) 
a. Fincaan isaani mal fakkata turee? .......................... 
1_1 TCC 
(Keelloo=l; buna danfa=2; dhiga walmakamee Lure=3; DK=9) 
b. Fincaan isaani guyyaa meeqaaf bifni geeddaramee turee? DCC 
S31. Ba'yeeni fincaan isaani guyyaa guyyaadhan geeddarama turee?. CQU 
(miti=0; eeyye=l; DK=9) 
(IF THE ANSWER IS NO OR DK PROCEED TO S32) 
a. Fincaan isaani guyyaa guyyadhan ammaam ta'aa turee? ......... AQU 
(Caalan baayyee (danu) turee=l; caalan xinno turee=2; 
ooma fincaan hin jiru turee=3; DK=9) 
b. Ba'yeeni Fincaan isaani geeddaramusa guyya meeqaaf turee?. 1_1_1_I DQU 
S32. Fincaan finca'uu hindhowwaa turee? (miti=0; eeyye=l; DK=9).. DPU 
(=F TEM ANSWER IS NO OR DK PROCEED To S33) 
a. Finca'uu dhowwuun akkaamitti turee? ........................ TDP 
(finca'uu hin dandaan turan=l; osoo walirra hinciitin xiqqo xi qqo 
dhaan bu'a=2; yeroo fincaan isaan guba turee=3: DK=9) 
S33. Dhiyootti otoo hindu'iin dura oprasioni godhatani turani? ... 
1_I HOP 
(miti=O; eeyye=l; DK=9) 
(IF THE ANSWER IS NO OR DK PROCEED TO S34) 
a. Otuu hin du'in guyyaa meeqaa dura oprasioni ta'aani turan? 1_1_1_1 OP 
b. Dhaqna isaani iddoo kam oprasioni ta'aani turan?............ 1_1 OPS 
(garan=1; kan bira (ibsi)=2 DK=9) 
IF THE DECEASED IS A FEMALE AND >50 YRS OLD PROCEED TO S37 
IF THE DECEASED IS A MALE PROCEED TO S39 
S34. Yeeroo du'an ulfa turan? (miti=0; eeyye=l; DK=9) ........... 
PRE 
(IF THE ANSWER IS NO OR DK PROCEED TO S35) 
a. Ji'a meeqaaf ulfa turan? (DK=99) ........................... 
ý_ý_ý MPR 
S35. Otuu hin du'iin dura guyyoota 45 keessa da'aani turan? ..... DEL 
(miti=0; eeyye=l; DK=9) 
(IF THE ANSWER IS NO OR DK PROCEED TO S36) 
a. Du'a isaani guyyaa meeqaa dura da'aani turan? (DK=99)...... EDD 
b. Eessatti da'aani turan? .................................... PDE 
(mana=l; kilinikii=2; hospitali=3; kan bira=4; DK=9) 
C. Cininsu ammamitti isaani irra turee? ....................... DDE 
(guyyaa tokko=1; guyyaa tokko oli=2; DK=9) 
d. Yeeroo da'aanu dhigni baayyee dhangala'ee turee? ........... BDE 
(miti=0; eeyye=l; DK=9) 
e. Da'umsa booda dhigni baayyee keessa baha (dhiga) turee? .... 
I_I HDE 
(miti=0; eeyye=l; DK=9) 
f. Akkaata da'uumsa isaani akkam turee? ........................ MDE 
(utuu hin rakkatin=l; meeshaa mana yaalaa tin 
gargaaramudhaan=2; oprasioni gararra=3; DK=9) 
9. Mucichi lubun jira? (IF NO, PROBE FOR THE TIME OF DEATH) .... 
I_I PNC 
(lubun jira=l; du'ee bahe=2; dhalamee guyyaa torban keessa 
du'ee=3; dhalamee guyyaa torba booda du'ee=4; DK=9) 
h. Dahun isani kanan dura rakkina da'uu qabu turee? ......... PCP 
(miti=0; eeyye=l; DK=9) 
S36. Otuu hin du'iin dura guyyaa 45 keessa garatti baasan turan 
(dhigniisan rukkutee turee)? (miti=0; eeyye=l; DK=9) ......... 
j_j ABO 
S37. Jismi (kara dhagna) dubartuma isaani keessa dhigu garmalee gabu 
. turan? (miti=0; eeyye=l; DK=9) ............................... 
1_I ABV 
S38. Harma isaani keessa dhitawuu ykn madaa gabu turan? .......... 
1_ BT 
(miti=0; eeyye=l; DK=9) 
S39. Balaa (adagaa) isanitti ga'es du'an? ........................ 
INJ 
(Miti=0; eeyye=l; DK=9) 
(IF THE ANSWER IS NO OR DK PROCEED TO Q41) 
a. (IF THE ANSWER I3 YES, PROBE FOR THE TYPE OF INJURY) ........ TIN 
" (balaa rukutta=1; balaa konkolaata=2; balaa warana=3; cininii 
bineesa=4; balaa ibidda=5; balaa summii=6; kan bira (ibsi)=7 
DK=9) 
S40. Of in of ajjeesan jattani yaaddu? (miti=0; eeyye=l; DK=9) .... SUI 
(IF THE ANSWER IS NO OR DX PROCEED TO NEXT SECTION) 
a. Akkamitti of ajjeesan turan? ................................ 
TSU 
(of faniisudhan=l; summidhan (maarzidhaan)=2; abbidaan gubidhan=3; 
kan biradhan (ibsi) =4 DK=9 ) 
VI. interviewers comments and observations 
42. Interviewer IDNO ........................................ 
IID 
43. Date of . 
interview 
....................... (dd\mm\YY) 
DOI 
Interviewer's assessment of cause of death 
cause of death 1 
cause of death 2 
cause of death 3 
° APPFN3IX- a 
VERBAL AUTOPSY QUESTIONNAIRE FOR ADULT DEATHS 
I: Identification & Demographic Data of Deceased 
Qi. Kpiim la yuure 
Q3" Address 
1 
Q2. IDNO IDN 
Q4. Kpiim la yuma ............................................. AOD 
Q5. Kpiim la ane dao be poa (dao=1; poa=2) ..................... SXD 
Q6. Kpiim la more poa/sida .................................... 
1_1 MSD 
Co po mor poa/sida=l; mor poa/sid=2; ba da bas taaba=3; 
poakor/dakor=4) 
Q7. Kpiim la sukur zamisug a yuma ala ......................... 
j_ IJ YED 
Q8. Kpiim la tuuma a ho I-I CCC 
II: Circumstance of Death 
Q9.0 be dabsa alla ka nyaa n'kpi? (m'zi=999) ................ 
1-1-1-1 DID 
Q10.0 k, dabsir (dd/mmlyy) ..................... DOD 
Q11.0 kum ziiga (yin=1; sibiti=2; zii sia=3) ................... 
1_J POD 
(IF TäE 'ANSWER I3 ': 80kt OR - OTÜER3 "P, - ..., h..,.... «ao- __. _ ......,. , ,.. -. aý:. wý w. «..  -oha...... +oa..... ... ý....,... «.. ew4. +A.., , ., m...... ........ w.. 
a. 
CEED PTO Q12 
Sibiti kan ka o kpi la yuure 
b. Sibiti ni tumtum so yelif dine kuu o?...................... RIF 
(ayeei (ayi)=0; ee=1; m'zi (MZ) =9) 
Q12. Po bang ba'a kerne kuuo? (ayi=O; ee=1; MZ=9).............. RKC 
a. Ii Tom" ANSWERISyYE3PROBE =,. TQ' 3PECIFY: TßE "CAÜSE 3 
cause (1) RD1 
cause (2) RD2 
(ASK" HiHETBER S i8E 
IWI 
:: 8AII ý. ANY'` OF ~ THE `: FOLLOWING,, ' ILL S. 4 ) 
Ziim ba'a (ziim galis)........... (ayi=0; ee=l; MZ=9)...... 
Sikir ba'a ...................... (ayi=O; ee=l; MZ=9)... ý.. 
Kpisinkpiir ....................... (ayi=0; ee=l; MZ=9)...... 
Kosunkudug (Koskuruk) ............ (ayi=0; ee=1; MZ=9)...... 
AIDS (anii)........................ (ayi=0; ee=1; MZ=9)...... 
1_1 HYP 
1_I DIA 
EPI 
TB 
ý_ý HIV 
i'-i 
2 
IDNO: 
III: Respondents Account of Final Illness 
Summary of symptoms & signs reported by Respondent 
Symptoms- duration Severity 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
3 
IDNO: IIIII IDN 
V: Specific questions to elicit symptoms & signs of the final illness 
Si. 0 daa mor ningwalisugo (ningtulim)? (ayi=0; ee=1; m'zi(MZ)=9) 1_1 FEV 
(IF THE ANSWER IS NO OR MZ PROCEED TO S2) 
a. Daba ala ka o ningwaiisug daa be? (MZ=999) .............. DFE 
b. Ningwalisug la daa muguse? (biela=0; mugus=l; MZ=9)........ 1_1 SFE 
C. Ningwalisug la daa be ne ala bee le daa kyen ne ka lebida?. TFE 
(be ne alla=1; kyen ne ka bas=2; MZ=9) 
S2.0 daa mor sangkpana? (a_vi=0; ee=1, MZ=9) ................... 
RAS 
(IF THE ANSWER IS NO OR MZ PROCEED TO S3) 
a. Daba ala ka sangkpana la daa morj? (MZ=999) ............. 
DRA 
b. Sangkpana la daa wene bo? (dankong=l; sangkpana mor kuom=2; 
sangkpana mor met=3; sieba=4; MZ=9) ......................... 
I_1 TRA 
C. 0 nini daa muoe? (ayi=O; ee=1; MZ=9) ........................ 
SEY 
d. 0 daa ebisida? (ayi=O; ee=1; MZ=9) ........................... 
ý_. ITC 
S3.0 daa wangim ka nyaa n'kpi? (ayi=C; re=. 1; MZ=. 9) ................ 
LOW 
(IF THE ANSWER IS NO OR MZ PROCEED TO S4) 
a. 0 daa wangin bedigo? (bedigo=l; biela=2; MZ=9) ............... 
ý___. SLW 
S4.0 nop pumpama daa fuusim? (ayi=0; ee=1; MZ=91 ............... 
SAA 
(IF THE ANSWER IS NO OR MZ PROCEED TO S5) 
a. Daba ala ka o nop--paung la daa fuusim? (MZ=999)........ I-1-I- I D`ý 
S5. 0 nindaa daa fuusim? (ayi=O; ee=1; MZ=9) .................... 
PUF 
S6. 0 pelige (ziem kai)? (ayi=0; ee=l; MZ=9) ............... daa 
PAL 
S7. 0 nini daa wenne dobuulim (wet duunum)? ..................... 
JAU 
(ayi=0; ee=1; MZ=9) 
S8. 0 ningoor daa fulise? (ayi=0; ee=1; MZ=9) ................... 
SWN 
S9. 0 bauk daa fuusim? (ayi=0; ee=l; MZ=9) ..................... 
SWA 
S1o. 0 kpalpuweogin daa fuusim? (ay! =O; ee=1; MZ=9)............. SJG 
S11.0 zii-sia daa lem mod be, mor feeds? (IF THE ANSWER IS 
YES PROBE FOR THE SITE AND DURATION 
II sou 
4 
S12. 0 daa kosida? (ayi=O; ee=', ; MZ=9) .......................... 
COL' 
(IF THE ANSWER IS NO OR MZ PROCEED TO S13) 
a. Daba ala ku daa kos-d: a? 9......................... -ý -ý 
DCO 
b. 0 kosung la daa lakida? (ayi=O; ee=l; MZ=9) ................. 
1 
_1 
PCO 
C. 0 daa mii kos ziim? (ayi=0; ee=1; MZ=9) .................... 
1 
_1 
BCO 
S13.0 daa vosid kali pu paagidaa? (ayi=0; ee=1; MZ=9)............ DI 
(IF THE ANSWER IS NO OR MZ PROCEED TO S14) 
a. Vosid kali pu paag; d 1a aaa kpem be daar causa (_. ) bee, 
di bene ka basida (=2) ? (MZ=9) ........................... 
ý_. TDB 
b. Daba ala ka o da puton vosida? (MZ=999) ................. 
1_1_1_1 DDB 
C. Lida mugusu (osib) o gama? (ayi=O; ee=1; MZ=9) ............... 
1_1 WHE 
S14.0 nyoog daa zabida? (ayi=0; ee=1; MZ=9) ...................... 
I_I CHP 
(IF THE ANSWER IS NO OR MZ PROCEED TO S15) 
a. Zabir la daa be zii--kare? ................................... 
I-I SC 
(nyoog zug=1; susuf zug=2; zii-sieba=3; MZ=9) 
b. Zabire la da bene daar wusa(=1) be li da zabide 
ne ka basida(=2)? (MZ=9) ..................................... 
1_1 TCP 
c. Zabir la ne daa mukko la le daa yuuge? ....................... 
1_1 DCP 
(<30min=1; >30min but <24hrs=2; >24 hrs=3; MZ=9) 
S15. 0 daa saadaa? (ayi=0; ee=l; MZ=9) ............................ 
I- I DI 
(IF THE ANSWER IS NO OR NS PROCEED TO S16) 
a. Daba ala ku daa saa? (MZ'=999) . ...... .... ........... .. " 
I---I-I- I DDI 
b. Saa la daa kpem bene daar wusa(=1) bee, di bene 
ka basida(=2)? (MZ=9) ....................................... ... . 
TDI 
C. Saa la daa muukk la n ora ala ku daa saad daari yini? (MZ=99)1_1- 
I FDI 
d. 0 bin la, daa a wela? (kuom-kuom=l; ga-alug=2; ziim=3; MZ=9).. 
I_ H TST 
S16. Ziim daa gyerdig bin la ni? (ay! =0; ee=1; MZ=9) .............. 
j. 
_1 
BST 
S17.0 daa tiida? (ay! =0; ee=l; MZ=9) ............................. 
I__' VOM 
(IF THE ANSWER IS NO OR NS PROCEED TO S18) 
a. Daba ala ku, o tii? (MZ-999) ..................................... 
DVO 
b. Tiid la daa kpem bene daar wusa (=1) bee, di bene 
ka basida (=2)? (MZ=9) ....................................... 
rvo 
C. Tiid la daa muukk la nora ala ku tiid daari yini (MZ=99)... 1_1_1 FVO 
d. Tiid la daa a wela? ......................................... 
1_1 CVO 
(kuom maa=1; dobuulim=2; sablek=3; ziim=4; bin tiid=5; 
sieba=6 ; MZ=9) 
5 
S18.0 puug daa zabidaa? (avi=C; ee=1; MZ=9) ..................... 
(IF THE ANSWER IS NO OR MZ PROCEED TO S19) 
a. Puug is daa zabid weia? .................................... ; _i 
C? P 
(welligid=l; non=2; kabit=3; zab sieba=4; MZ=9) 
b. Daba ala ka o puula zabe? (MZ=999) ...................... 
ý_. 
_... 
DAP 
c. Zabir la daa be yaane tutuaa ne? ............................ 
SAP 
(sangin=l; nyoog baba=2; poog la wosa=3; zii sieba=4; MZ=9) 
d. Zabir la daa toe welawela? .................................. i_. 
TAP 
(zabid pam=1; zabid biel biet=2; MZ=9) 
e. 0 daa pu yang nye bine ka naan kpi? .......................... 
ý_. CON 
(o daa nye=0; o daa pu yang nyeda=l; MZ=9) 
S19.0 puura daa uk-kee? (ay! =C; ee=_, MZ=9) ...................... 
AED 
(IF THE ANSWER IS NO OR MZ PROCEED TO S20) 
a. 0 puura daa uk daba ala? (MZ=999)........................ _. _I-I 
DA=D 
b. 0 puura daa uk ne toto bee, bielabiela? 
(toto=l; bielabiela=2; MZ=9) ................................ 
TAD 
S20.0 ya daa von le da toi yaa? (ayi-O; ee=l; MZ=9) .............. 
I_I I)Siti 
(IF THE ANSWER IS NO OR MZ PROCEED TO S21) 
a. Le daa nok daba ala ka o puyang von-na? (MZ=999) ...... ". " 
I-I-I-I DDS 
S21. Siel daa bee o poogin kpiongo? (ayi=0; ee. =1 ; MZ=9) . ... .... .I __ 
! ABM 
(IF THE ANSWER IS NO OR MZ PROCEED TO S22) 
a. Ya baba ka kpiongo la daa be?.... ..... ........ """. 
I_I SAM 
(datiu-lugur=l; dagobug lugur=2; sa-ang=3; 
ne zisiaba (specify = 4; MZ=9) 
b. Kpiongo la daa be pae daba ala? (MZ=999) ................ 
DAM 
S22.0 zug daa zabida? (ayi=0; ee=1; MZ=9) ....................... 
1_1 HEA 
S23.0 ningor daa kpar kangkang ne? (ayi=0; ee=1; MZ=9)........... STN 
(IF THE ANSWER IS NO OR MZ PROCEED TO S24) 
a. Le daa nok da,, -)a ala (ATZ=999) ............................ 
I_ý_ DS 
S24.0 yam daa tieke (o da mi o meng ziga)? (ayi=0; ee=1; MZ=9).. __ý 
LUC 
(IF THE ANSWER IS NO OR MZ PROCEED TO S25) 
a. 0 yam daa tiek wel. a-wela? .................................. 
1_1 TUC 
(yam tulima=l; daa likni=2; ne sieba =3; MZ=9) 
6 
b. 0 yam-la ne daa a yam tuiima la, le daba ala ? (MZ=999). I-I-I-I DUC 
c. Le si'ing welawela? .......................................... 
I_I OUC 
(tooto yim=1; tooto daar yinni poogin=2; biel biel dabsa 
poogin=3; MZ=9) 
S25.0 daa damida (niis)? MZ=9) ..................... 
I... 
_ý 
FIT 
(IF THE ANSWER IS NO OR MZ PROCEED TO S26) 
a. Daba ala ka ba'as la qba iý? ý)... ............... 
DFI 
b. (ASK THE RESPONDENT TO DESCRIBE THE FITS) .................... 
II TFI 
(o ningwusa daa dammed ne=1; s; eba 
=2; MZ=9) 
c. Nora ala ka o lut ka damid daa yini? (MZ=99) ............... 
I-I-I FFI 
d. 0 ya eti li ka due, o ye mor ya'am (=1) be o pu 
mor yaam (=2)? (MZ=9) ........................................ 
ý_I BFA 
S26.0 daa yang ya'ad o pore? ..................................... 
1_1 LOC 
(o daa toe yaad=(-, '; o da, - pu toe yaada=l; MZ=9) 
-I 
OF'r S27.0 ping daa pirr kangkang be? (a_vi"=0; ee=1; MZ=9)............... 
(IF THE ANSWER IS NO OR MZ PROCEED TO S28) 
a. Le daa nok daba ala? (MZ=999) ............................ 
I-I-I- DOP 
S28.0 lua yinni daa kpii? (ay-4=0; ee=1; MZ=9) ................. 
1. 
_1 
HEM 
(IF THE ANSWER IS NO OR MZ PROCEED TO S29) 
a. Le daa nok daba ala? (MZ=999) ............................ -I--I 
DHV 
S29.0 noba daa kpii? (ay-4=0; ee=l, MZ=9) ........................ 
PAR 
(IF THE ANSWER IS NO OR MZ PROCEED TO S30) 
a. Daba ala ka oo nobala da kpi_i? (MZ=999) ................... 
I 
--I _. _I _I 
DPA 
S30.0 dun-tim in ý. ý. n;, n Ann ti cak malm? (.:; wi=n- 2P_=1 ; MZ=9) 
(IF THE ANSWER IS NO OR MZ PROCEED TO S31) 
................ . a. 
0 dunum la wen im a wala? ......... ..... 
(dobulum=l; zie=2; ziim=3; MZ=9) 
b. Daba ala ku o dunum la tieke? (MZ=999) ................. 
I CCU 
1_1 TCC 
1-1_1_1 DCC 
S31. Tiakre dabe o dunum la zuor pugun ne? (ayi=0; ee=l; MZ=9).... 
i_I CQU 
(IF THE ANSWER IS NO OR MZ PROCEED TO S32) 
a. 0 dunit ka l. i zemi wala ? .................................. i_i a)U 
(bedigo galis=l; fii Balis=2; kpankpan=3; MZ=9) 
b. Daba ala ka o dunum la daa tieke? (MZ=999) .............. 
ý_j_IJ DQU 
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S32. Duunug daa toe tis o? a__ :'e =' ; tii: 91 ............ ..... ..... 
DPU 
(IF THE ANSWER IS NO OR MZ PROCEED TO S33) 
a. Duunug toog la caa a we'awe=a:? ............................. 
TDP 
(po ton duunuda=l; duunug tuasid ne yinne yinne=2; 
duunug zabid bedigo=3; zii sieba=4; MZ=9) 
S33. Ba daa ladigu, sibitini ku naan kpii? (ay-= ; ee=l; MZ=9).... HOP 
(IF THE ANSWER IS NO OR MZ PROCEED TO S34) 
a. Ba daa ladigu dada ala ka c ryaa n'kpi? lMZ=999)........... 1-ý-ý-ý opr) 
b. (ASK FOR THE SITE OF OPERATION) ...... ...................... 
1-1 OPS 
(poorin=l; zii sieba=) MZ=9) 
IF THE DECEASED IS A FEMALE AND >50 YRS OLD PROCEED TO S37 
IF THE DECEASED IS A MALE PROCEED TO S39 
S34.0 ne daa kpiid-la, o daa mor puuga? (ee=. 1; d/ =1; AI =9)...... j_I PRE 
(IF THE ANSWER IS NO OR MZ PROCEED TO S35) 
i a. Puug La daa a nwadis aia? (MZ=99,1 ......................... 
ý_. 
_ý 
MPH 
S35.0 daa dua dabisa piis naasi ne anu pugon ka nan kpii bee? 
(aye=0, ee=i; MZ=S) ... .................................. 
DEL 
(IF THE ANSWER IS NO OR MZ PROCEED TO S36) 
a. 0 daa dua daba ala ka nyaa n'kpi? (MZ=99) ........................ EDD 
b. 0 daa dua ne yin ne? (yin=1; sibiti billin=2; sibitini=3; MZ=9)PDE 
c. One sa-a la, la yugiyabee la puyuge ku naan dua? 
(<24 hrs=1; >24hrs=2; MZ=9) .................................... 
DDE 
d. Ziim daa yi bedigu one daa dua la? ........................... 
BDE 
! ay==0; ee=1; MNIZ=9) 
e. (IF YES, PROBE TO FIND OUT WHETHER THE BLEEDING STARTED BEFORE 
OR AFTER THE DELIVERY OF FOETUS) ........................... 
I_I HDE 
f. 0 daa dua wela--wela? ........................................ 
1_1 MDE 
(poa tuon=l; nok siel veeg biig la yis na=2; 
poor ladigir duam=3; M ==9) 
9. Bi la voyaa? (IF NO PROBE FOR THE TIME OF DEATH) .............. 
1_1 PNC 
(bila voi=1; bila daa kpiini=2; bila daa kpiini dabisa 
ayopoi dar=3; daba ayopoi daa gaad ne bila naan kpii=4) 
h. 0 duam daa enti kpemma? (ayi=O; ee=1; MZ=9) ................ 
ý_. PCD 
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S36.0 daa kpai poog dabsa pisnaase ne anu poogin ka nyaa n'kpi bee 
S37. Ziim daa yit o tuan kali ka o kpanne? 
S38. Obisa nda mode mode? 
(ayi=O; ee=l; MZ= 
S39.0 daa paam sapuad ka nyaa nlkpi be? .... ................ "" 
(ayi=C'; ee=_ý; ? ýZ 9 
(IF THE ANSWER IS NO OR MZ PROCEED TO S40 
a. (IF THE ANSWER IS YES, PROBE FOR THE TYPE OF INJURY) ....... 
(boot=2; for=2; tapp=3; burnkobug daa dum o=4; buguni=5; 
tiim daa ku-u=6; sieba=7 (specify) __' 
b. Daba ala ký, : r)aarr. ýapuad la nvaa n' kpi ? (MZ= 999) :?: "ýi 
S40. Fo tees ka o daa ku ne o meng bee? t ay-i= ü; ec= ",... 
(IF THE ANSWER IS NO OR MZ PROCEED TO NEXT SECTION) 
a. 0 daa ku o meng welawela? .................................. 
(o yul o meng=l; c ra re -i . _., -: .! c: pm 
dieu-3; siena=4 
VI. Interviewer's comments and observations 
Interviewer's assessment of cause of death 
Cause of death 1 
Cause of death 2 
Interviewer's IDNO ............................................. 
Date of Interview (dd/mm/yy) ....................... 
